Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,39477,-0.482455494901143,0.0108403464103621,-0.503702573865453,-0.461208415936834,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,39858,-0.203010004092797,0.00377416640295483,-0.210407370242588,-0.195612637943005,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,39788,-0.308029861492341,0.00799172723392235,-0.323693646870829,-0.292366076113854,1.11659208138253e-308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40058,-0.178438065701345,0.00481166531411885,-0.187868929717018,-0.169007201685672,5.23953279246266e-289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.173072331470526,0.00472844470197141,-0.18234008308639,-0.163804579854662,9.13867871915634e-282
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,37445,0.170160397395888,0.004760286997187,0.160830234881401,0.179490559910374,1.54548954864434e-267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.127764358471817,0.00361083863504582,-0.134841602196507,-0.120687114747127,2.08143797181879e-262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,37021,-0.290632573871241,0.00828408872479315,-0.306869387771836,-0.274395759970646,7.47106906301535e-258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40030,-0.20799642259084,0.0059952207407079,-0.219747055242627,-0.196245789939052,1.89448489481826e-254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37437,-0.248737485799172,0.00742630535552595,-0.263293044296003,-0.234181927302341,2.1300057943364e-236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,39758,-0.225376417151355,0.00693386667146817,-0.238966795827433,-0.211786038475278,1.95176095767265e-224
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.170093215123914,0.00585313616060951,-0.181565361998708,-0.158621068249119,6.6755723029473e-181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,39854,-0.211173262974986,0.00727030522723942,-0.225423061220375,-0.196923464729597,8.26550273909595e-181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.147252659471114,0.00506664527939728,-0.157183284218732,-0.137322034723495,3.47108580501094e-180
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,39868,0.0942863029267946,0.0033940945677215,0.0876338775740604,0.100938728279529,6.4393890316722e-166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.073946322999195,0.00266633062951397,-0.0791723310330423,-0.0687203149653476,2.33662655378432e-165
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,39805,-0.100430865368695,0.00367285299986316,-0.107629657248426,-0.0932320734889628,6.38636119626897e-161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,39868,-0.154612765629613,0.00573029721834378,-0.165844148177567,-0.143381383081659,7.65929919927612e-157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.106442801869994,0.00399104102145648,-0.114265242272049,-0.0986203614679394,1.12260554464922e-152
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37039,-0.19359295525373,0.00730203500588165,-0.207904943865258,-0.179280966642202,6.14134768582199e-151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.324526098620046,0.0127297570292785,-0.349476422397432,-0.29957577484266,1.38435728173376e-140
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.155215868011326,0.00611550817797406,-0.167202264040156,-0.143229471982497,2.38838123182622e-139
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,39949,0.0639730164682742,0.00254887788145038,0.0589772158206315,0.068968817115917,2.14426770920507e-136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0733614662604121,0.00294016095068715,0.0675987507970653,0.0791241817237589,7.53301179047837e-135
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.278694074281026,0.0113037383104965,0.256538747192453,0.300849401369599,8.75689217761692e-132
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0767698262626708,0.00312118707628166,-0.0828873529321828,-0.0706522995931587,3.51827790933032e-131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.0626676075329054,0.0025926810197275,0.0575859527342395,0.0677492623315713,8.16729320045955e-127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0438651692546704,0.00182410234740793,0.0402899286537509,0.0474404098555899,1.5166659478181e-125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,39826,-0.21861977956139,0.009225233954065,-0.236701238111357,-0.200538321011422,4.7934486389565e-122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,39899,-0.0646701131888961,0.00276019918634637,-0.070080103594135,-0.0592601227836572,2.14755553240812e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.162318325925782,0.00694007318213982,-0.175920869362776,-0.148715782488788,6.01279540683292e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,39949,-0.0669058586970986,0.00287058939178488,-0.072532213904997,-0.0612795034892003,3.36533248298138e-118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.247923917208033,0.0110114716675785,-0.269506401676487,-0.226341432739579,1.47748237287706e-110
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0774730412902377,0.00344135147007275,-0.0842180901715803,-0.0707279924088951,1.55926199388033e-110
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.109594230408262,0.00487746478107668,-0.119154061379172,-0.100034399437352,4.13770422863155e-110
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.102866997362862,0.00458823025700527,-0.111859928666593,-0.0938740660591322,1.31024203903317e-109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,39489,-0.10381535068085,0.00467330471592528,-0.112975027924064,-0.0946556734376367,1.14552890649261e-107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37445,0.0528839222219238,0.00238786403545901,0.0482037087124241,0.0575641357314234,8.571683423491e-107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.057907170044237,0.00266803137848226,-0.0631365115460622,-0.0526778285424118,5.73650855932837e-103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.289356483656935,0.0133801295044608,-0.315581537485678,-0.263131429828192,3.15179050809226e-102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.140133621071101,0.00660370509648221,-0.153076883060206,-0.127190359081996,2.46135191877471e-98
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.061794510228215,0.00293445375988105,-0.0675460395975819,-0.0560429808588482,4.06161587674171e-97
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,39868,-0.119501978538615,0.00570826532917402,-0.130690178583796,-0.108313778493434,4.96899367493757e-96
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,37124,-0.102403425417967,0.00488779258105564,-0.111983498876836,-0.0928233519590979,6.54220097782251e-96
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,39587,-0.152640739012198,0.00731809737480956,-0.166984209866825,-0.138297268157571,2.50947479339176e-95
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.0906196984516505,0.00436939024834408,-0.0991837033384048,-0.0820556935648961,2.59547066817747e-94
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39464,-0.112916552681347,0.00545711268665024,-0.123612493547181,-0.102220611815512,7.47176318660357e-94
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0816504293415131,0.00395352255223024,-0.0893993335438844,-0.0739015251391418,1.4924419508967e-93
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0571866296467622,0.00279423807605174,-0.0626633362758236,-0.0517099230177007,6.48837009996438e-92
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.101796963040999,0.00498177529916507,0.0920326834546359,0.111561242627363,1.27757151800495e-91
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,39788,-0.0679138309298057,0.00332393131832968,-0.0744287363137319,-0.0613989255458795,1.30019752098615e-91
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0979809019387085,0.00482080544339562,-0.107429680607764,-0.0885321232696531,1.88420947142751e-90
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.110740716223345,0.00548037395292821,-0.121482249171084,-0.0999991832756057,1.1912282738614e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.14657081253446,0.00735801043983494,-0.160992512996536,-0.132149112072384,3.14885511605683e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.140886458201066,0.0070823732952421,-0.154767909859741,-0.127005006542392,8.18640302607549e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,39868,0.086175764344995,0.00437907384037599,0.077592779617858,0.0947587490721319,3.3115651017722e-85
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,38721,-0.0712692425039914,0.00363705949389568,-0.078397879112027,-0.0641406058959559,1.96765608785156e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,39788,-0.142290447021143,0.00729181235456271,-0.156582399236086,-0.1279984948062,7.97906756554699e-84
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0577781815307626,0.00296093236793193,-0.0635816089719092,-0.051974754089616,1.32383417265855e-83
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0373337221426764,0.00196303238784895,-0.0411812656228603,-0.0334861786624924,8.94144558733439e-80
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40030,0.061858124663656,0.00325691240614965,0.0554745763476027,0.0682416729797093,1.43393160139833e-79
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.152198997923598,0.00805250762096673,-0.167981912860692,-0.136416082986503,8.1715500246618e-79
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0673236417590889,0.00356819476667709,0.0603299800164019,0.074317303501776,1.48316466580357e-78
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.102625533945552,0.00545104132644382,-0.113309574945382,-0.0919414929457218,3.1322872043306e-78
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,39919,-0.101623163558561,0.00544490931363906,-0.112295185813293,-0.0909511413038281,6.33655801193822e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40052,-0.0901707931699035,0.00483661821409598,-0.0996505648695317,-0.0806910214702754,9.08967869669625e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.183598518406356,0.00988426570029233,-0.202971679178929,-0.164225357633783,3.27555641424743e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0641620859479821,0.00345576878974206,-0.0709353927758766,-0.0573887791200877,5.47661596681541e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,39976,0.0613828272430396,0.00333239570556154,0.054851331660139,0.0679143228259402,5.33641820824592e-75
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,39933,-0.11000455587304,0.00597662562332204,-0.121718742094751,-0.0982903696513284,6.93538072167553e-75
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.141107272853438,0.00766668621421658,-0.156133977833303,-0.126080567873574,7.37055925117018e-75
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,39913,-0.0577105422160307,0.00314261229301263,-0.0638700623103355,-0.051551022121726,1.48180258744005e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37124,-0.048976850138848,0.00267387718419949,-0.054217649419879,-0.043736050857817,4.95930977676489e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.14285416338734,0.00781441323827015,-0.15817041333435,-0.127537913440331,6.84234078916483e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,39839,-0.0819412082519441,0.00450032217503528,-0.0907618397150132,-0.0731205767888749,2.46336162154865e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,39955,-0.0578201776950701,0.00319324174229174,-0.0640789315099619,-0.0515614238801783,1.47089717167026e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37437,-0.154048593298883,0.00852715040850693,-0.170761808099557,-0.137335378498209,4.14365114668142e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,37437,-0.0561729755444664,0.00311130569157533,-0.0622711346999541,-0.0500748163889788,5.05063586146364e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,37411,-0.0739948198965648,0.00411116348685379,-0.0820527003307982,-0.0659369394623314,1.36169379495149e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.10383418093883,0.00579574852833364,-0.115193848054363,-0.0924745138232956,4.5818645433354e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0544490425661393,0.00305306644021473,-0.0604330527889601,-0.0484650323433184,1.84113423225211e-70
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0561761367954767,0.00315417364100524,0.0499939564591064,0.062358317131847,2.76121319024542e-70
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,40003,-0.0318299803502416,0.00179533494203743,-0.0353488368366349,-0.0283111238638482,1.13976718248092e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.0756027316058685,0.00432228708725103,-0.0840744142968805,-0.0671310489148564,7.24775603438639e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,39913,-0.0653156777663207,0.00375674312295174,-0.0726788942873061,-0.0579524612453353,4.31586628036973e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0527886002641535,0.00303798818475709,-0.0587430571062774,-0.0468341434220296,5.07713858030923e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37382,-0.178051521200161,0.0102387145702627,-0.198119401757876,-0.157983640642446,5.25297019998246e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0672913384315502,0.00388917108944042,-0.0749141137668535,-0.059668563096247,1.81981328672862e-66
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.081454980027851,0.00473939942247678,-0.0907442028959055,-0.0721657571597965,1.33623212631206e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.133817521428428,0.00782298753770502,-0.14915057700233,-0.118484465854527,6.48856868854902e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0445014062070491,0.00261397122885854,-0.0496247898156118,-0.0393780225984863,1.96999936595283e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,39858,0.0421973237447558,0.00247852652725897,0.0373394117513282,0.0470552357381834,1.97319884338103e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0549419249115616,0.00323655061597,-0.0612855641188628,-0.0485982857042604,4.51859751838442e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37088,-0.0597597603791947,0.00351758255316833,-0.0666542221834046,-0.0528652985749848,4.73685405599416e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0904797645705745,0.00533317963452287,-0.100932796654239,-0.0800267324869096,7.03707707778089e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0638767394410032,0.00382313862796167,-0.0713700911518081,-0.0563833877301983,3.83639681950182e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0665688851291627,0.00403120187597877,-0.0744700408060811,-0.0586677294522443,9.22095364047969e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0946490769092225,0.00577492007182192,0.0833302335684515,0.105967920249993,6.89684651374003e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0855876948504657,0.00525893472551636,-0.0958952069124778,-0.0752801827884536,4.44885314172429e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.150150437246573,0.00930381816961645,-0.168385920859021,-0.131914953634124,4.06442036088294e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0849218490911332,0.00526571243061723,-0.095242645455143,-0.0746010527271234,5.66293091362607e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.0948813196678635,0.00589233521283363,0.0833323426507096,0.106430296685017,7.01629396289333e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.045113876909359,0.00280201503090018,0.0396219274487946,0.0506058263699234,8.91894674879935e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0672091917985457,0.00420444732261684,0.0589684750462167,0.0754499085508747,4.48339879983137e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,39858,-0.0351677483838419,0.0022059912923059,-0.0394914913167615,-0.0308440054509223,8.87164323654198e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0284752594712109,0.00178944241771611,-0.0319825666099345,-0.0249679523324873,1.44343834956603e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.134254677192176,0.00844699269042366,-0.150810782865406,-0.117698571518946,1.92451347744037e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40009,-0.05487892748183,0.00345817935137741,-0.0616569590105297,-0.0481008959531303,2.75264488162043e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.0788473020259876,0.00497564169755345,-0.0885995597531924,-0.0690950442987829,3.97125139861147e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.075882995106288,0.00486246482122788,-0.0854134261558947,-0.0663525640566814,1.66039975566279e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0867781659815892,0.00558560465609542,-0.0977259511075362,-0.0758303808556422,4.86975495254844e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.0436898960706031,0.0028341963082172,0.0381348713064974,0.0492449208347088,3.11924537589141e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40058,-0.0484950101546607,0.00316191503935942,-0.0546923636318052,-0.0422976566775163,1.01197256941392e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0364547105365505,0.00237828629817929,-0.0411161516809819,-0.0317932693921191,1.38527757068157e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,39660,-0.0536128396703488,0.00350192361979174,-0.0604766099651406,-0.0467490693755569,1.57302004114087e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.065348885330915,0.00427350462765489,-0.0737249544011186,-0.0569728162607114,2.0227751414376e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0395158647407997,0.00258821407099319,-0.0445887643199464,-0.0344429651616531,2.93383077864415e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.0967283420667494,0.00635448196955829,-0.109183126727084,-0.0842735574064152,6.97784453295393e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,37124,-0.0585306214151967,0.0038529905615001,-0.0660824829157369,-0.0509787599146565,1.10435705881348e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,39846,-0.0408545348745682,0.00269546918907966,-0.0461376544851644,-0.0355714152639721,1.55967878767915e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.0552909394584426,0.00365086365892859,-0.0624466322299427,-0.0481352466869426,1.85149422935162e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,39862,-0.0742297446169062,0.00491191025099964,-0.0838570887088655,-0.0646024005249469,3.0381379220939e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.122134631664295,0.00809792760356373,-0.13800656976728,-0.10626269356131,4.86366197742141e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.0905227182065927,0.00599988127238768,-0.102282485500473,-0.0787629509127128,5.07646309663992e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.107351741815521,0.00712348554478033,-0.121313773483291,-0.0933897101477517,5.67843765469257e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0435789546414139,0.00289317956506918,-0.0492495865889495,-0.0379083226938783,6.34203245034052e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0484472337723687,0.00321839172911224,-0.0547552815614287,-0.0421391859833087,7.30988252256032e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.107138262323424,0.0071191885258411,-0.121091871834072,-0.0931846528127751,7.93449261041722e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0538891474452544,0.0035825703346283,-0.0609109853011259,-0.046867309589383,8.58549994200724e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,39868,-0.0880872426537844,0.00589867455979158,-0.0996486447909759,-0.0765258405165929,4.34361202166484e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,39788,-0.0647894315569299,0.00435583659596391,-0.0733268712850191,-0.0562519918288406,1.04550013705018e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,37453,0.0913746612481596,0.00614931880938084,0.0793219963817731,0.103427326114546,1.48178899799324e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.106071893084065,0.00714813814763717,-0.120082243853434,-0.0920615423146961,1.73004407943542e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,39908,-0.0251309538455545,0.00169486120661429,-0.0284528818105185,-0.0218090258805905,2.05860964147313e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,40058,-0.0381951335325249,0.00257931078679021,-0.0432505826746337,-0.033139684390416,2.72092188468144e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0357173701592669,0.00241171068288918,-0.0404443230977297,-0.0309904172208041,3.06909334033315e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0584338021255134,0.00394966518231703,-0.0661751458828547,-0.050692458368172,3.3250342075124e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0832693432713425,0.0056410736146189,0.0722128389866895,0.0943258475559956,6.39623632878482e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0571244482503507,0.00389554022595424,-0.064759707093221,-0.0494891894074804,2.28440076352022e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0501831639397774,0.0034245734037354,-0.0568953278110988,-0.0434710000684561,2.61667541646997e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0541218780837325,0.00369428532767624,-0.0613626773259779,-0.0468810788414871,2.79583606272924e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,39866,-0.062235156277704,0.00425472935106692,-0.0705744258057951,-0.0538958867496128,3.84708974466979e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,40058,-0.051907571942255,0.00355525686462699,-0.0588758753969239,-0.0449392684875861,5.64627125895433e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.068853081651654,0.00471905930553999,-0.0781024378905124,-0.0596037254127956,6.56162182445057e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.163597896548561,0.0112585145811498,-0.185664585127614,-0.141531207969507,1.79121767951884e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.173536650093122,0.0120184536265761,-0.197092819201212,-0.149980480985033,5.74734706721185e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.113963011078459,0.00791174330223975,-0.129470027950849,-0.0984559942060693,9.54296252211996e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,37309,-0.0337941751766798,0.00234519156855146,-0.0383907506510407,-0.0291975997023189,9.9760077571391e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.0724409822976988,0.00503911869869111,-0.0823176549471333,-0.0625643096482642,1.44013574075506e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40052,-0.0765183961936252,0.00535151412301612,-0.0870073638747368,-0.0660294285125136,4.26920068206738e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.0899580822237554,0.00629905895645147,-0.1023042377784,-0.0776119266691106,5.58287211127798e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,39931,-0.0682005903735914,0.00478848449135042,-0.0775860199766382,-0.0588151607705446,9.45799319098094e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0578365075276386,0.00406651224138411,-0.0658068715207515,-0.0498661435345258,1.26154607476799e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0475707548740032,0.00334767261572668,-0.0541321932008275,-0.0410093165471789,1.50790493153964e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,39931,0.0573711156832704,0.00405132638330939,0.049430515971984,0.0653117153945568,2.98551987371574e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.0751315352882811,0.00530542889487143,-0.0855301759222291,-0.0647328946543331,3.34979497935671e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.0977425299537017,0.00690970508571116,-0.111285551921696,-0.0841995079857078,3.7320328859667e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0478269671909286,0.00338508568747925,-0.0544617351383879,-0.0411921992434693,4.74786082184192e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0749834058332586,0.00530773423416718,-0.0853865649322263,-0.0645802467342909,4.79207813770861e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,40058,-0.0338098390802556,0.00239683114898723,-0.0385076281322705,-0.0291120500282406,6.42855405722975e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0367506990937224,0.00261156684882084,-0.0418693701174112,-0.0316320280700335,1.03604330443607e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40030,-0.0344388895302438,0.00245430592497635,-0.0392493291431974,-0.0296284499172901,1.80994646903794e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,39858,-0.0541175603266222,0.00386130714285817,-0.0616857223266242,-0.0465493983266202,2.29779794546156e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,39865,-0.0405263341878401,0.00289231552993523,-0.0461952726265131,-0.034857395749167,2.41588514391977e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0778803977765294,0.00555974155388928,-0.0887774912221524,-0.0669833043309065,2.53381521477373e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0373243049702593,0.00266630823205577,0.03209834083543,0.0425502691050886,2.88393587131143e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,37437,-0.145034387838953,0.0103607893585366,-0.165341534981685,-0.124727240696221,3.23474465425238e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0280568982068587,0.00200981961431686,-0.0319961446509197,-0.0241176517627976,4.95249188549845e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,39908,-0.0438206856277562,0.00314002055855662,-0.0499751259225272,-0.0376662453329852,5.26252712440438e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0679456504963338,0.00486940115874664,-0.0774896767674772,-0.0584016242251904,6.03644041386772e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,39984,-0.0639484678794716,0.004587888453334,-0.0729407292480062,-0.0549562065109369,6.64136970713649e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0424813018790879,0.00304967114602345,0.0365039464328819,0.0484586573252938,7.50986823300954e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0524266494562368,0.00376652548905021,-0.0598090394147752,-0.0450442594976984,8.72762397021406e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,37043,-0.0840707285308321,0.00603984729188686,-0.0959088292229304,-0.0722326278387339,9.85243755409368e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0690128460435016,0.00497036537712693,-0.0787547621826704,-0.0592709299043329,1.40018801777354e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0771793802986538,0.00555601021450439,-0.0880691603190824,-0.0662896002782252,1.42754595113709e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,39846,-0.036288939771554,0.00262934544563502,-0.0414424568449986,-0.0311354226981093,4.40798816524484e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0744901593419061,0.0053978721987958,-0.0850699888515459,-0.0639103298322664,4.98568885688318e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.0926677839980754,0.00672132053033214,-0.105841572237526,-0.0794939957586244,5.39279434138121e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.050064063020404,0.00364946775087987,-0.0572170198121286,-0.0429111062286795,1.37979280167163e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.124483156040756,0.00910314041253752,-0.14232531124933,-0.106641000832182,2.49177567888518e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0860349234184489,0.0063089646246934,-0.098400494082848,-0.0736693527540498,4.1260943413196e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.105464265504137,0.00774015478038439,-0.12063496887369,-0.0902935621345834,4.90544052966849e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40058,-0.0522368254154593,0.00383874079171938,-0.0597607573672293,-0.0447128934636894,6.11993965599255e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,39868,0.0647244499875852,0.0047740718652939,0.0553672691316091,0.0740816308435612,1.21455528685313e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.0748605383978652,0.00552517713381729,-0.085689885580147,-0.0640311912155833,1.35717686564453e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,37388,-0.146100068148945,0.0108053086572246,-0.167278473117105,-0.124921663180785,2.17890105561783e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,39880,-0.0732566672819627,0.00545474305850776,-0.0839479636766379,-0.0625653708872875,6.72319654854116e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0398194895060593,0.00296441215435169,-0.0456297373285887,-0.03400924168353,7.16022499636236e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.041375761904946,0.00309137770819553,-0.0474348622130092,-0.0353166615968827,1.22998147032084e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.113760837323657,0.00849863882911846,-0.130418169428729,-0.0971035052185847,1.32449305147672e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.136780730350611,0.0102707708639547,-0.156911441243963,-0.11665001945726,3.03677233005253e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0414293700083152,0.00311206496940302,-0.0475290173483451,-0.0353297226682853,3.20047584878233e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0302961983092346,0.00227783042395655,0.0258316506782798,0.0347607459401895,3.73665548769621e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37437,0.0718743020683323,0.00541331721208784,0.0612642003326401,0.0824844038040245,5.56345024651543e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,37043,-0.0745252051175989,0.00563621035782061,-0.0855721774189273,-0.0634782328162705,1.1623160442889e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,39974,-0.0313505081804895,0.00237640167707978,-0.0360082554675659,-0.0266927608934131,1.55515027880752e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0578137942138403,0.00438117592290148,-0.0664008990227272,-0.0492266894049534,1.62390931375074e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,37453,-0.0233356095310191,0.00176849034855057,-0.0268018506141782,-0.0198693684478599,1.63534809258283e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0435813655579002,0.00330483939833893,-0.0500588507786445,-0.0371038803371559,1.6761292692975e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,39788,-0.0845415869120816,0.00642119376636953,-0.0971271266941659,-0.0719560471299973,2.2105539437696e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.060992197738055,0.0046326270983267,-0.0700721468507754,-0.0519122486253347,2.21482628598986e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.11209035224189,0.00851409139331297,-0.128777971372783,-0.0954027331109966,2.22417820996987e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,39836,-0.112450036946765,0.00855320781785873,-0.129214324269768,-0.0956857496237622,2.82721484484881e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0848989799739374,0.0064554080823949,-0.0975515798154315,-0.0722463801324434,2.90307223807157e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0368975275926502,0.00280842524823842,-0.0424020410791975,-0.0313930141061029,3.18323536910357e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,39489,-0.063301519651376,0.00481827438055741,-0.0727453374372685,-0.0538577018654835,3.22676077988032e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0332404610692934,0.00253284519487909,-0.0382048376512564,-0.0282760844873304,4.21667659973008e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.033613013821258,0.00257635216226127,-0.03866266405929,-0.0285633635832259,1.13904737026558e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0487520400100862,0.00374062235434338,-0.0560836598245992,-0.0414204201955731,1.24709359430035e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,37437,0.0449901695184511,0.00345993586112158,0.0382086952306528,0.0517716438062494,1.99039749632437e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0877974184001589,0.00676080502793052,-0.101048596254903,-0.0745462405454151,2.28102845294824e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0764909778520197,0.00589331532921281,-0.0880418758972769,-0.0649400798067626,2.50378672648015e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.137891770055689,0.0106356779060666,-0.158737698751579,-0.117045841359798,3.01643672755971e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0454483738217352,0.00350917028922692,-0.05232634758862,-0.0385704000548505,3.89493403088746e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0628636037028667,0.00486044534806037,-0.0723900765850651,-0.0533371308206684,4.52082532910134e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0856055735900053,0.00662050896569817,-0.0985817711627737,-0.0726293760172369,4.75634461814804e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,39866,-0.0391121951702313,0.00302669933816873,-0.045044525873042,-0.0331798644674206,5.21313733109633e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0781305088298841,0.0060685646208688,-0.0900248954867869,-0.0662361221729812,9.58511167950862e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.0657058865442691,0.00510499131742933,-0.0757116695264306,-0.0557001035621077,1.01734943753936e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37445,0.057065523490334,0.00444403276724971,0.0483552192665246,0.0657758277141434,1.59810413608955e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0310519113153355,0.00242336060753062,0.0263021245245755,0.0358016981060955,2.0913481332298e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.148054498789654,0.0116167017197856,-0.170823234160434,-0.125285763418874,5.04266678258267e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,40012,0.0626064550091526,0.00491484431986888,0.0529733601422096,0.0722395498760956,5.46096261817924e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0702876021677248,0.00551810165457503,-0.0811030814106918,-0.0594721229247577,5.49687742800258e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0413060215726791,0.00324773259456887,-0.047671577458034,-0.0349404656873241,7.04663209748146e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0707588494730533,0.00556725628225538,-0.0816706717862739,-0.0598470271598328,7.87290599693534e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0647109481729482,0.00510565162437225,-0.0747180253567178,-0.0547038709891786,1.22999681359089e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,39858,0.0336821689695068,0.0026595456079334,0.0284694595779573,0.0388948783610562,1.39121527822924e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37241,-0.0275032724388707,0.00218184097346036,-0.031779680746853,-0.0232268641308884,3.16167118455157e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.101208526548034,0.00803351659198865,-0.116954219068332,-0.0854628340277363,3.48524027762876e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,39749,-0.104807489206786,0.00832973515588727,-0.121133770112325,-0.0884812083012466,3.92718600831944e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0803764342654571,0.0063979573431389,-0.0929164306580093,-0.0678364378729048,4.98800059341737e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37056,-0.0987451948178684,0.00789517932529917,-0.114219746295455,-0.0832706433402821,1.08881852290837e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0302862924960017,0.00242680574194924,-0.0350428317502222,-0.0255297532417812,1.410772622062e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,39749,-0.0609918241150962,0.00489209058635036,-0.0705803216643429,-0.0514033265658495,1.6475639059582e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,39720,-0.059902019706418,0.00480668292705173,-0.0693231182434394,-0.0504809211693966,1.7587028050175e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0307519881783475,0.00246877527772702,-0.0355907877226925,-0.0259131886340025,1.8828940263561e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0272710526683521,0.00219016711565981,-0.0315637802150453,-0.0229783251216589,2.00078696484163e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0994369046542663,0.00799352187534853,-0.115104207529949,-0.0837696017785831,2.31508438712425e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0333971526422657,0.00268595391425725,0.0281326829703214,0.0386616223142099,2.48547578642614e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0812977687478562,0.00653955761209887,-0.09411530166757,-0.0684802358281424,2.77271608063857e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37368,-0.115014119669652,0.00929010585481339,-0.133222727145086,-0.0968055121942178,5.1739050219563e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,40009,-0.0277029717299998,0.00224017766131765,-0.0320937199461824,-0.0233122235138172,5.71793867163775e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0244718184226191,0.00198781546985939,0.0205757001016947,0.0283679367435435,1.13190858331331e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,40058,-0.0521659016022047,0.00424275372433488,-0.0604816989019011,-0.0438501043025084,1.36948033282857e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,39931,-0.115890981015419,0.00943109730582955,-0.134375931734845,-0.0974060302959929,1.49849286758666e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0228377566442102,0.0018600554398977,-0.0264834653064097,-0.0191920479820107,1.70177717794917e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,37420,0.0388006713169878,0.00316338484669447,0.0326004370174666,0.0450009056165089,2.10974078733978e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.109820977664535,0.00898079841403704,-0.127423342556048,-0.0922186127730226,3.10576218758032e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0337853481879298,0.00276206751705416,-0.039199000521356,-0.0283716958545037,3.18376069658596e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0633169057410882,0.00518632062683578,-0.0734820941696863,-0.05315171731249,3.96996841107538e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0420841988886538,0.0034535914116138,-0.0488532380554169,-0.0353151597218908,5.25954298474533e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0536511348070755,0.00440588894764272,-0.0622866771444553,-0.0450155924696958,5.81384390264625e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.0923688794963823,0.00759201167282441,-0.107249222375118,-0.0774885366176464,6.62096273819184e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,37043,-0.0687364001910074,0.0056563991129813,-0.0798229424524507,-0.057649857929564,8.4889884513818e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,39788,-0.0632228803885273,0.00522479864518316,-0.0734634857330863,-0.0529822750439684,1.47262811616145e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.123600240132234,0.0102104043080825,-0.143612632576075,-0.103587847688392,1.47557074407909e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.119794937041386,0.0099188467228988,-0.139235876618267,-0.100353997464504,1.94097463587128e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0535803459964557,0.00443517251602199,-0.0622732841278588,-0.0448874078650526,1.9993683513432e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0719858963234552,0.00596361130679142,-0.0836745744847664,-0.0602972181621441,2.1203262549697e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.056843850349783,0.00471138113233052,-0.0660781573691508,-0.0476095433304152,2.26858784118363e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0439077821818253,0.00363822312556039,-0.0510386995079237,-0.0367768648557269,2.31768274812218e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0552633249538955,0.0045817681108437,-0.0642435904511491,-0.0462830594566418,2.51792406548878e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,39995,-0.0420920579703506,0.0034999147391918,-0.0489518908591665,-0.0352322250815347,3.57073548329952e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0430667333250647,0.00358055100923311,-0.0500846133031616,-0.0360488533469678,3.73930526973929e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.0767294113671575,0.00638327317182861,-0.0892406267839416,-0.0642181959503734,3.86311731251856e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39314,-0.10269531215177,0.00856018723021482,-0.119473279122991,-0.0859173451805487,5.17294942709768e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0829689526278206,0.00691770407263422,-0.0965276526101837,-0.0694102526454576,5.3093377324612e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.032562924412093,0.00273388366684056,-0.0379213363991005,-0.0272045124250854,1.43342947023354e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0604306805264388,0.00507748943595463,-0.0703825598209099,-0.0504788012319677,1.59319939571748e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0217696752109947,0.00182996762212702,-0.0253564117503636,-0.0181829386716257,1.69887305367358e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.10224809783368,0.00859823899331699,-0.119100646260581,-0.0853955494067789,1.78996617723285e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0471618898700937,0.00397340796066026,-0.0549497694729878,-0.0393740102671996,2.33079202783875e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0581411748630365,0.0049046964825893,-0.0677543799689116,-0.0485279697571615,2.79422512388e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40009,-0.0463293007881742,0.00391001968056624,-0.0539929393620841,-0.0386656622142644,2.96708488894366e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.108386818181726,0.00915558131963068,-0.126331757568203,-0.0904418787952503,3.36980511610045e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0881251279993225,0.00745197249064294,-0.102730994080983,-0.0735192619176624,4.13760074443443e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.042807403263364,0.00362597631316051,-0.0499143168371586,-0.0357004896895694,4.96067028977177e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0623174967833212,0.00527931941707919,-0.0726649628407965,-0.051970030725846,5.04863745808291e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0675611171560497,0.00572297173468226,-0.0787781417560269,-0.0563440925560725,5.31728843598678e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0281110138708371,0.00238267427855706,-0.0327810554568089,-0.0234409722848652,5.41724676245786e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0927928219583786,0.00788292257304995,-0.108243350201557,-0.0773422937152007,7.4289595658856e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,37445,-0.0291227725957651,0.00247644271912399,-0.0339766003252481,-0.0242689448662821,8.95211782548828e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,39846,0.197834422179711,0.0168528768664982,0.164802783521374,0.230866060838047,1.08637030321066e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0610510749359683,0.00521252937123413,-0.0712676325035872,-0.0508345173683494,1.48177001899143e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0306228715566217,0.00261588416532238,-0.0357500045206536,-0.0254957385925898,1.58918075599066e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,39866,-0.0434903879710845,0.003721174391331,-0.0507838897780932,-0.0361968861640757,1.98666585837499e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,40052,-0.054222677327974,0.00464915313540369,-0.0633350174733652,-0.0451103371825828,2.63048915831245e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0472694236328205,0.00405393351588103,-0.0552151333239473,-0.0393237139416937,2.72602672261939e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0261881077362759,0.00224852796479403,-0.0305952225472722,-0.0217809929252796,3.18508713119667e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0780673450080606,0.00670737384768804,-0.0912137977495291,-0.064920892266592,3.47331112686265e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,39788,-0.0554968581920808,0.0047728799248747,-0.0648517028448352,-0.0461420135393264,3.988223157419e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0812122743252197,0.0069846199112917,-0.0949021293513514,-0.0675224192990879,4.24860253502938e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.0924877883400955,0.00796051817122205,-0.108090403955691,-0.0768851727245002,4.45555382664214e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.0156782358737928,0.00134983947703984,0.0130325504987947,0.0183239212487909,4.85756341596892e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0727069529044012,0.0062824264566247,-0.0850205087593856,-0.0603933970494168,7.95564967258881e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0588606124855103,0.00509170459903392,-0.0688403534996168,-0.0488808714714038,8.76761386188864e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0483660128973346,0.00418349824371705,-0.05656566945502,-0.0401663563396491,9.12089285917796e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.03255620184355,0.00281827264135452,-0.0380800162206048,-0.0270323874664951,9.54702483803311e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0433665184874526,0.00375686565355777,-0.0507299751684258,-0.0360030618064793,1.05280099569036e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,37124,-0.0495508999620203,0.0043017343899451,-0.0579822993663127,-0.0411195005577279,1.4819551112088e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0349636642128731,0.00303882173324326,-0.0409197548100299,-0.0290075736157163,1.62321522753329e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.0962428914166448,0.00836772765639557,-0.11264363762318,-0.0798421452101095,1.7092289694458e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0379850751792228,0.0033033985274795,-0.0444597362930826,-0.031510414065363,1.85028127737887e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.052799583482122,0.0046061082748867,-0.0618275557009,-0.0437716112633441,2.67674039294186e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0807013155242131,0.00705931579483323,-0.0945375744820862,-0.0668650565663399,3.97911423541216e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0301062676183383,0.00263478736374119,-0.035270450851271,-0.0249420843854055,4.23375487139876e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0208192733984816,0.0018248584941433,0.0172425507499608,0.0243959960470025,4.94097624980353e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0432357721112824,0.00379507371670164,0.0357974276265472,0.0506741165960176,5.94495662732508e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0867518290468537,0.00764476804819823,-0.101735574421322,-0.0717680836723851,1.03582556442153e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0470962390887703,0.00415941610451093,0.0389437835239289,0.0552486946536117,1.3084624569755e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0876788543216249,0.0077558888203814,-0.102880396409572,-0.0724773122336773,1.60618256815943e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0747484928647041,0.00661456979140261,-0.0877130496558532,-0.061783936073555,1.69371719840948e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,39866,-0.100228351825389,0.0089094845640652,-0.117690941570957,-0.0827657620798213,2.99467845206857e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0378267796468074,0.0033713200224727,-0.0444345668908539,-0.0312189924027609,4.15696750743773e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.0742691865624901,0.00663044476126518,-0.0872648582945698,-0.0612735148304103,5.38787161358787e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,39585,-0.0547514106732227,0.00490082484773941,-0.0643570273747919,-0.0451457939716534,7.19077727398756e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0329970349710849,0.00296166760023309,-0.0388019034675418,-0.0271921664746281,1.05074344556072e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.110325533135829,0.009929880263516,-0.12978809845232,-0.0908629678193373,1.48313040695605e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,39713,-0.0829192213147376,0.00746616709688307,-0.0975529088246284,-0.0682855338048468,1.49499500792726e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.037624747962789,0.00338933919662568,-0.0442678527881753,-0.0309816431374027,1.5737791064873e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,39868,-0.0702024230801914,0.00632906975640573,-0.0826073998027466,-0.0577974463576361,1.74107711757855e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,39931,-0.0594689584219004,0.00536386084827299,-0.0699821256845154,-0.0489557911592853,1.84052714636116e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0455671843283396,0.00411482872303825,-0.0536322486254946,-0.0375021200311847,2.13203123772312e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,39866,-0.0797598368003371,0.0072072905218318,-0.0938861262231274,-0.0656335473775468,2.31006055536826e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0442851721307808,0.00400830998545481,-0.0521414597022722,-0.0364288845592893,2.81772058865625e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.0820093265727738,0.00743466852903959,-0.0965812768896914,-0.0674373762558562,3.60899153878641e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0423066975057702,0.00383768515762643,-0.0498285604147179,-0.0347848345968224,3.69267276276111e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37437,-0.0706482632831537,0.00640694906271163,-0.0832058834460685,-0.0580906431202389,3.73554943847887e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,40052,0.027423059231781,0.0024888040305348,0.0225450033319328,0.0323011151316292,3.91445307307721e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37124,-0.1196706042987,0.01086704395606,-0.140970010452578,-0.0983711981448228,4.41371071914362e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.111881295712971,0.0101916471838836,-0.131856924193382,-0.0919056672325588,6.4171450857265e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,39846,-0.0382275265428107,0.00348392263257895,-0.0450560149026654,-0.0313990381829559,6.51356143855895e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0306975469639032,0.00280122177132964,-0.0361879416357093,-0.0252071522920971,7.59354573781915e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0288226992903713,0.00262989693630191,-0.0339772972855231,-0.0236681012952196,7.81623545417595e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.0777024703777637,0.00709598693096024,-0.0916106047624458,-0.0637943359930817,8.71878390227278e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0627642880980602,0.00573775314747863,-0.0740102842671183,-0.0515182919290021,9.42820263136876e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.12336097798729,0.0112963376937772,-0.145501799867093,-0.101220156107486,1.20901212063103e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,39866,-0.0827259725113201,0.00758269001028511,-0.0975880449314789,-0.0678639000911613,1.29385125544865e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,37411,-0.0437176007807181,0.00400677013898592,-0.0515708702531305,-0.0358643313083057,1.33120115313805e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0465736322615909,0.00428536991398611,-0.0549729572930037,-0.0381743072301781,2.0402713390001e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0417489474098369,0.00384345981068358,-0.0492821286387768,-0.0342157661808971,2.25998332748925e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0674790589506439,0.00621560007963681,-0.0796616351067321,-0.0552964827945558,2.31698879734666e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0675736938355622,0.00623338560957756,-0.0797911296303343,-0.0553562580407902,2.7438273984287e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0621206705221407,0.00573124126978677,-0.0733539034109228,-0.0508874376333586,2.81403724320026e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0582338908731277,0.00537702231317204,-0.0687728546069449,-0.0476949271393105,3.07509749796181e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.0987005022012715,0.00912474345869129,-0.116584999380306,-0.0808160050222365,3.70016239333114e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,39866,-0.086728353614049,0.00802970528780467,-0.102466575978146,-0.0709901312499519,4.22491973038764e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0277831951164804,0.00257681749839616,-0.0328337574133369,-0.0227326328196239,5.19700369211165e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.0783810924230107,0.00727590682925969,-0.0926418698083597,-0.0641203150376617,5.73184858424322e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,39642,0.0275140658085079,0.00255476309924903,0.0225067301339798,0.032521401483036,5.93684294813176e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40030,0.045400311648217,0.00421877706525856,0.0371315086003102,0.0536691146961237,6.45405650822222e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.114021357352708,0.0105996842208982,-0.134796738425668,-0.0932459762797471,7.08000446694767e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0615390820367197,0.00573211667560107,-0.0727740307208978,-0.0503041333525417,8.5326579939963e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0225615687657065,0.00210810319912043,-0.0266934510359826,-0.0184296864954305,1.22123526580435e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,39587,-0.0476255169917666,0.00445274936074838,-0.0563529057388334,-0.0388981282446997,1.31530564255871e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0756015898959152,0.0070871972679041,-0.0894924965410072,-0.0617106832508232,1.77161878261508e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37437,-0.0293684326341213,0.0027528147159255,-0.0347639494773353,-0.0239729157909074,1.8190829037636e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,39913,-0.0702595784347236,0.0065894476452239,-0.0831748958193624,-0.0573442610500848,1.87038068488921e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.0964979844003314,0.00904812967618728,-0.114232318565658,-0.0787636502350043,1.89106115996373e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0449450502767211,0.0042375820294486,-0.0532507110544403,-0.0366393894990018,3.40960461231475e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0212805796227769,0.002007191622955,-0.0252146752037687,-0.0173464840417851,3.54776729868916e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,39868,-0.0347597738371582,0.0032787475569773,-0.0411861190488337,-0.0283334286254827,3.57952682058477e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,37437,-0.0451985242626359,0.00426822124613112,-0.0535642379050529,-0.0368328106202189,4.21211879831815e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,39897,-0.0262951970244449,0.00248431505264182,-0.0311644545276229,-0.0214259395212669,4.28810690574978e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.0517281312372939,0.00489715880175961,-0.0613265624887427,-0.042129699985845,5.38121127753817e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0289503736615322,0.00274095198297387,-0.034322639548161,-0.0235781077749034,5.43290338735304e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,37124,0.0219923364135056,0.00208154092130062,0.0179125162077564,0.0260721566192548,5.46756650178081e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.0837904362887167,0.00794304474713517,-0.0993588039931016,-0.0682220685843318,6.51817807754384e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,40040,-0.0191542350732094,0.00181669922775176,-0.0227149655596029,-0.0155935045868159,6.61056461911635e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0695541284344257,0.00659706099524642,-0.0824843679851087,-0.0566238888837427,6.92110431252918e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0299640066927504,0.00284577534500334,-0.0355417263689569,-0.0243862870165438,7.69656130004187e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37169,-0.12654782345965,0.0120169484100993,-0.150101042343444,-0.102994604575855,7.87360641629941e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0189481631305865,0.00180045728084651,-0.0224770594010457,-0.0154192668601273,8.13028941325355e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,39715,-0.0714969493561658,0.00679381964839266,-0.0848128358670154,-0.0581810628453162,8.1621258319017e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,39913,-0.0558297831690595,0.00531240195902968,-0.0662420910087577,-0.0454174753293614,9.48595067877251e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.0826971930278227,0.00790036261605701,-0.0981819037552945,-0.067212482300351,1.47424113041507e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,39908,0.0259951581681859,0.00249072247398512,0.021113342119175,0.0308769742171967,2.03105221841259e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0265233907295432,0.00254134018192014,-0.0315044174861067,-0.0215423639729797,2.04168731057046e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39455,-0.0383008577561707,0.00367053936844955,-0.0454951149183319,-0.0311066005940096,2.0880105787296e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0795330720284377,0.00762570407209496,-0.0944794520097438,-0.0645866920471315,2.19071822895372e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0320499642754665,0.00307348704373029,-0.0380739988811779,-0.0260259296697551,2.22694279282208e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.101132676424047,0.0097051488335508,-0.120154768137806,-0.0821105847102872,2.40888163081758e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,39866,-0.089370948165558,0.00858670318158951,-0.106200886401473,-0.0725410099296426,2.74330654680245e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0579971750915486,0.00558321072830597,-0.0689402681190283,-0.0470540820640689,3.40005208946643e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,37445,-0.0217055712242783,0.00209697986153788,-0.0258156517528926,-0.0175954906956641,5.13670325681974e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0569351957515143,0.00550451407094902,-0.0677240433305744,-0.0461463481724542,5.40133168356357e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,37385,-0.0933003805084358,0.00902161922732179,-0.110982754193987,-0.0756180068228851,5.644340777848e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,39908,-0.0550722231218292,0.00533214620916876,-0.0655232296918,-0.0446212165518584,6.27929367799671e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,39868,-0.104238708786531,0.0100953288665071,-0.124025553364885,-0.0844518642081773,6.4736515838283e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,40030,-0.0386532933402564,0.00374574172208823,-0.0459949471155493,-0.0313116395649634,6.88861411040635e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0257467804600665,0.0024958222370001,0.0208549688755463,0.0306385920445866,7.14225417181375e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0838194607652563,0.00812883599724399,-0.0997519793198545,-0.067886942210658,7.48765310623278e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.080958499108189,0.00785575034564012,-0.0963557697856436,-0.0655612284307344,7.94527325173383e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37149,0.0296752669630769,0.00288045017015953,0.0240295846295642,0.0353209492965896,8.52763964450547e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.0523216151955735,0.00508175726502412,-0.0622818594350208,-0.0423613709561262,8.80725839506819e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39477,-0.0710470398900584,0.00690592164443385,-0.0845826463131487,-0.057511433466968,9.58940458017678e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0325119211639027,0.00316164187337707,-0.0387087392357217,-0.0263151030920836,9.99587365559734e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.135274147034672,0.0131641716952033,-0.161075923557271,-0.109472370512074,1.11487923034557e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,36780,0.0415610152584534,0.00405437112357057,0.0336144478562551,0.0495075826606518,1.45571038699855e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0284854110412479,0.00277921042502134,-0.0339326634742897,-0.023038158608206,1.4660551077972e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0602878063903285,0.0058883562563292,-0.0718289846527338,-0.0487466281279233,1.63792403355367e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,40058,-0.0286285834835079,0.00279747561778711,-0.0341116356943706,-0.0231455312726452,1.66276102247754e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,37043,-0.0714639426035012,0.00698239373255655,-0.085149434319312,-0.0577784508876903,1.7086465115932e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0492065828906596,0.00483270942540551,-0.0586786933644544,-0.0397344724168649,2.83406015019798e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,39749,-0.0401386141237532,0.00394408413783698,-0.0478690190339136,-0.0324082092135927,2.98369576216847e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,39796,-0.0306432902121133,0.00301146572477156,-0.0365457630326655,-0.024740817391561,3.02437888807525e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0266519949563832,0.00262152057235819,-0.0317901752782052,-0.0215138146345611,3.31029492773946e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0614797788772963,0.00606102436793412,-0.0733593866384472,-0.0496001711161454,4.2080468261989e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0927901503918606,0.00915257514576596,-0.110729197677562,-0.0748511031061593,4.56095037917049e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.0753868812068805,0.00743614111589889,-0.0899617177940423,-0.0608120446197187,4.56858576130604e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,39315,-0.0381796462975554,0.00376782591382484,-0.045564585088652,-0.0307947075064587,4.6854452905958e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0582451732320693,0.00574815483775853,-0.069511556714076,-0.0469787897500625,4.68710937115044e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,37382,-0.0985590168543927,0.00973096759907368,-0.117631713348577,-0.0794863203602083,5.03599267765343e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0480265028994163,0.00475234839604333,-0.0573411057556612,-0.0387119000431713,6.16566636242658e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0814603472039694,0.00806453656210879,-0.0972668388657027,-0.0656538555422362,6.44583829329275e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,39858,-0.0308125503590769,0.00305059107266326,-0.0367917088614969,-0.0248333918566569,6.48169695350332e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,39749,0.0314545866158026,0.00311439555791198,0.0253503713222951,0.0375588019093101,6.54034726456917e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0492924732187572,0.00489894182372242,0.0396905472442613,0.0588943991932532,9.5819979593394e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0473492270246253,0.00470650256746466,-0.0565739720568561,-0.0381244819923946,9.72657400111146e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0777854555719758,0.00774539194767684,-0.0929664237894225,-0.0626044873545292,1.20045605724323e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40058,-0.046753994673306,0.00465895045465547,-0.0558855375644307,-0.0376224517821813,1.25000313120215e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0723671166936184,0.00722101176363994,-0.0865202997503527,-0.0582139336368841,1.47803074562707e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37371,-0.0794981754116676,0.00794096889735537,-0.0950624744504841,-0.0639338763728511,1.64437264945442e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0435190875499501,0.00435618898602279,-0.0520572179625548,-0.0349809571373455,1.97288954675257e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37445,0.0480177889974422,0.00482265177079759,0.0385653915266789,0.0574701864682054,2.83219079113826e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0460600417253951,0.00463304726152996,-0.0551408143579938,-0.0369792690927964,3.19878599973232e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0339707133368098,0.00342295642401182,0.0272617187457466,0.040679707927873,3.80439210178651e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0675693901006201,0.00680707921534379,-0.0809112653626939,-0.0542275148385463,3.85492760003215e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0598106369769064,0.00603105924708301,-0.0716315131011891,-0.0479897608526237,4.20324376881743e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0816355685149717,0.00823277631835476,-0.097771810098947,-0.0654993269309963,4.25567091690219e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,39713,-0.0564705415674508,0.00570473672730175,-0.0676518255529623,-0.0452892575819394,4.9094952041904e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0289522366740272,0.00293215115444058,-0.0346992529367307,-0.0232052204113236,6.47704250835327e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.0961876041524309,0.0097636838630918,-0.115324424524091,-0.077050783780771,7.84426527171527e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,39858,-0.0331251730371231,0.00336637130103571,-0.0397232607871531,-0.0265270852870931,8.78480049367439e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40058,-0.086946186043915,0.00885251282017586,-0.10429711117146,-0.0695952609163703,1.05136729639068e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0337370885804757,0.00343388360098229,-0.040467500438401,-0.0270066767225504,1.05428145227594e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.064515376146872,0.00658103688464587,-0.0774142084407779,-0.0516165438529661,1.26601721504051e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,39843,-0.0463308437410192,0.00472966474637227,-0.0556009866439088,-0.0370607008381296,1.3587415925749e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40009,0.0335488999379386,0.00342850279269157,0.0268290344642631,0.0402687654116141,1.50435970818377e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0429552439296844,0.00439301232428336,-0.0515655480852798,-0.034344939774089,1.61652964141663e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,39931,-0.0297955894885921,0.0030488415144695,-0.0357713188569523,-0.0238198601202318,1.70260371769452e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,39788,-0.0938365984199768,0.00960767122515406,-0.112667634021279,-0.0750055628186748,1.80669390149363e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0359958787749202,0.00368644795139058,-0.0432213167596458,-0.0287704407901947,1.85616514031494e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0487875797851404,0.00500006410254466,-0.0585877054261279,-0.0389874541441529,1.98278243123807e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0266471081959638,0.0027345437267921,-0.0320068139004763,-0.0212874024914513,2.302402405989e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0523807768905641,0.0053781314396921,-0.0629219145123606,-0.0418396392687676,2.36035686242567e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0338440504741975,0.00347909394287923,-0.0406630746022407,-0.0270250263461542,2.65167016610083e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.0722886357335002,0.00743862975791077,-0.0868683500590053,-0.0577089214079951,2.92140623678441e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0696535343123744,0.00717757605718209,-0.0837215833844513,-0.0555854852402975,3.32935619136942e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.103690116609665,0.0106877437186138,-0.124638094298148,-0.0827421389211819,3.50023857986137e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.068025603637107,0.00701224147181431,-0.081769596921863,-0.0542816103523509,3.52461409164815e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,39785,-0.0647380391301956,0.00667800212552415,-0.077826923296223,-0.0516491549641683,3.6738318534882e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0652130171289616,0.00672965144082816,0.0520229003049384,0.0784031339529848,3.90801013550522e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0529149412902831,0.00546357666437972,-0.0636235515524674,-0.0422063310280989,4.00967613651218e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0279095691997178,0.00288228080625147,0.0222602988194649,0.0335588395799707,4.08226675155299e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0770931777774125,0.00796919474439508,-0.0927127994764269,-0.0614735560783982,4.48881700899835e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0242991634692141,0.00251203679492118,-0.0292227555872596,-0.0193755713511686,4.50648232068379e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0522644973507281,0.00541576558852178,-0.0628793979042308,-0.0416495967972254,5.61127406434488e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,39587,-0.0464415721204021,0.00481625028770117,-0.0558814226842964,-0.0370017215565078,6.07124539376593e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.0530261879316174,0.00550357793079494,-0.0638132006759754,-0.0422391751872593,6.69464454998481e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39476,-0.0627918813335379,0.00652298590524949,-0.0755769337078269,-0.0500068289592489,7.12503132486085e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0685656268476851,0.00713101099866172,-0.082542408405062,-0.0545888452903081,8.09988959977489e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,37437,-0.0236420500635078,0.00245939943915862,-0.0284624729642587,-0.0188216271627569,8.27351731501025e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0432834295865462,0.00451782432519831,-0.0521383652639349,-0.0344284939091575,1.13073553226087e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0345045339309147,0.00360527338506094,-0.0415708697656341,-0.0274381980961952,1.24923582382634e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39477,-0.0556569684885707,0.00583344497021522,-0.0670905206301925,-0.0442234163469489,1.61894425017505e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0500227908567968,0.00524643633904154,-0.0603058060813182,-0.0397397756322754,1.76478908610702e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0692056779598502,0.00727753302238571,0.0549417132359742,0.0834696426837262,2.18192255602401e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0457738179684082,0.00481891348043628,-0.0552188883900633,-0.0363287475467531,2.42462642625021e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0488652108137013,0.0051524550285029,-0.058964022669567,-0.0387663989578356,2.79562213599472e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0461466983737869,0.00486707532584189,-0.055686166012437,-0.0366072307351368,2.85207206855919e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0734763091628596,0.00775992453139559,-0.088685761244395,-0.0582668570813243,3.22089527417689e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0612311871482931,0.00648053619983504,-0.0739330380999698,-0.0485293361966165,3.99404484959896e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0231174488105997,0.00244917955140761,-0.0279178407313586,-0.0183170568898408,4.27387017227826e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0758095193804716,0.00803796795634868,-0.091563936574915,-0.0600551021860282,4.69498938334487e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0392952296119701,0.00416800810372106,-0.0474645254952634,-0.0311259337286768,4.87602196548993e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,37383,0.016442236320453,0.00174577042954538,0.013020526278544,0.0198639463623619,5.31488894437389e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.121021682830376,0.0128736903814451,-0.146254115978008,-0.0957892496827437,6.14115663169056e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0224877995572001,0.0023936229212363,0.0177962986315769,0.0271793004828232,6.62858507137418e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0905971336702013,0.00964803228197644,-0.109507276942875,-0.0716869903975275,6.77043764637992e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0830468498071847,0.00885103164528626,-0.100394871831946,-0.0656988277824236,7.26980277525804e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.0653496346295355,0.00698225789995072,-0.0790348601134389,-0.0516644091456321,9.3011897766741e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37124,-0.0556478278416183,0.00595280822370594,-0.0673153319600819,-0.0439803237231547,1.03260579884854e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0492688908787722,0.00528428216832118,-0.0596260839286817,-0.0389116978288627,1.27132799524715e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0220843456593036,0.00237597922126669,0.0174274263856209,0.0267412649329864,1.69557118328636e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0188218625657741,0.00202637059783023,-0.0227935489375213,-0.0148501761940269,1.80585190848117e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,37453,0.0262885553199396,0.00283440246476495,0.0207331264890003,0.0318439841508789,2.04393878898558e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,39504,-0.0430705570604128,0.00464712473738375,-0.052178921545685,-0.0339621925751407,2.13462960812201e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0251225924323203,0.00271119496481359,-0.0304365345633549,-0.0198086503012857,2.22141194055113e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0862773053306394,0.00931496446330973,-0.104534635678726,-0.0680199749825524,2.24798490422298e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0582558391854412,0.00628967043846854,-0.0705835932448395,-0.0459280851260428,2.25936073654367e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,39720,-0.0239536159005002,0.00259033921919625,-0.0290306807701248,-0.0188765510308755,2.58973734667733e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,37437,0.0232404064747711,0.00252047650290034,0.0183002725290864,0.0281805404204557,3.38238990075207e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37382,-0.071614956068484,0.00780089688884475,-0.0869047139706197,-0.0563251981663483,4.91247072913831e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.0745996100414418,0.00812870307716869,-0.0905318680726925,-0.0586673520101912,5.0519882355099e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,39795,-0.0390588893862386,0.00426167962834718,-0.0474117814577991,-0.0307059973146781,5.53984452252991e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0267899521367564,0.00292374011157733,-0.032520482755448,-0.0210594215180648,5.64513079476681e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0182960705305007,0.00199996207854466,0.0143761448565531,0.0222159962044482,6.48490044527573e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0279559657341073,0.00305760922603713,-0.0339488798171401,-0.0219630516510745,6.78856391448409e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,39866,-0.056518226995962,0.0061826549820763,-0.0686362307608316,-0.0444002232310925,6.88949536981927e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.107827491997772,0.0118102536717923,-0.130975589194485,-0.0846793948010587,7.64937338003067e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,37124,0.0431079797864075,0.00472543704445078,0.0338461231792839,0.052369836393531,8.38327101927689e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0251379774530676,0.0027589258609756,-0.0305454721405798,-0.0197304827655554,9.28269186361031e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0636677177221476,0.00699999612316333,-0.0773877101235477,-0.0499477253207474,1.05185100239866e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0738866580329171,0.00813103321233741,-0.0898234831290984,-0.0579498329367358,1.13471975654942e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,39858,-0.0381923555917011,0.00420442209317897,-0.0464330228943318,-0.0299516882890703,1.16818583146635e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.037776272289837,0.00415909886570624,-0.0459281060666212,-0.0296244385130527,1.18034841334807e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0697645007990156,0.00769315125576746,-0.0848430772603199,-0.0546859243377114,1.34410621268653e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37056,-0.038710881577677,0.00427798817256251,-0.0470957383958995,-0.0303260247594545,1.64466837921807e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0339188221671618,0.00375350516083823,-0.0412756922824047,-0.0265619520519189,1.83329749555519e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0370353065494382,0.00409913133391237,-0.0450696039639064,-0.0290010091349699,1.86135564793143e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0263009270176908,0.00291793421722159,0.0205817759519365,0.0320200780834451,2.21600410939309e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0553708222152251,0.0061476854445148,-0.0674202856864741,-0.0433213587439761,2.40192559630408e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0533849130937154,0.00594416911087855,-0.0650354845510374,-0.0417343416363934,2.97503687516977e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,39788,-0.0464251752524835,0.00517013782827501,-0.0565586453959026,-0.0362917051090645,3.01915969326152e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,39866,-0.0746755438783654,0.008327351342511,-0.0909971525096869,-0.0583539352470438,3.36274242145994e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0574636273232813,0.00641718279109029,-0.0700413055938182,-0.0448859490527443,3.77678581379838e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0938624843424683,0.0104887503439888,-0.114420435016686,-0.0733045336682502,3.98215943370908e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,37437,0.0331487831860348,0.00370368162539544,0.0258895672002597,0.0404079991718098,4.00238784795057e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0486032767332521,0.00543376182365487,-0.0592534499076156,-0.0379531035588885,4.13437647586601e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0551565668685713,0.00618152134833423,-0.0672723487113064,-0.0430407850258362,5.1234114676268e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0400704700942633,0.00449358767744197,-0.0488779019420495,-0.031263038246477,5.29681132083857e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,39866,0.028322503253637,0.0031795550081493,0.0220905754376644,0.0345544310696096,5.76120526396579e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37051,-0.0216565957779789,0.00243402418879323,-0.0264272831880136,-0.0168859083679442,6.45154588849332e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0516297596384596,0.0058043228345007,-0.063006232394081,-0.0402532868828382,6.452669689954e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,39730,0.0234396650043883,0.00263658843679961,0.018271951668261,0.0286073783405155,6.74818383619707e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0281315647752688,0.00316933629522113,-0.0343434639139022,-0.0219196656366354,7.65983153031156e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39489,-0.0505173592901161,0.00569668531219455,-0.0616828625020175,-0.0393518560782148,8.25027510917055e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,37306,-0.077952232273813,0.00878971005831694,-0.0951800639881142,-0.0607244005595118,8.33202523091279e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.0604708960601389,0.00682461179688129,-0.0738471351820262,-0.0470946569382515,8.77708113335545e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0445248855978952,0.0050240664300326,-0.0543720558007591,-0.0346777153950313,8.82113986400425e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0816741537756132,0.00922064616444658,-0.0997466202579285,-0.0636016872932979,9.0298346915239e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0248366486215529,0.00280522028629072,0.0193384168604231,0.0303348803826827,9.33329445763899e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0358400141424889,0.00405113493816079,-0.0437802386212841,-0.0278997896636937,1.0120049442011e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0476398391346347,0.00539176274301637,-0.0582076941109467,-0.0370719841583226,1.09858430252648e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0399139006516713,0.00452039701072234,0.0310539225106555,0.0487738787926871,1.17662675347459e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0560369215696731,0.00635117360672169,-0.0684852218388476,-0.0435886213004985,1.22630659253383e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.0940405443653347,0.010666321365785,-0.114946534242273,-0.0731345544883961,1.30001963292666e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0352674986827023,0.00400680118639425,0.0274141683573696,0.0431208290080351,1.48045868312198e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37124,-0.0568627846326194,0.00646996712321535,-0.0695439201941215,-0.0441816490711173,1.69680652727953e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0296057916387323,0.00337026022509781,-0.036211501679924,-0.0230000815975406,1.75904466682247e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0564116808975843,0.00643543826412745,-0.0690251398952741,-0.0437982218998945,2.03631988210331e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0592169021312781,0.00675454011701253,-0.0724558007606227,-0.0459780035019336,2.05106904330002e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0415900741777811,0.0047459543308901,-0.0508921446663257,-0.0322880036892365,2.1248577181676e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0595569820433974,0.0067983219775294,-0.072881693119355,-0.0462322709674398,2.17216573042614e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0736473594790399,0.00843087413978403,-0.0901718727930166,-0.0571228461650632,2.6642727116022e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,39931,-0.0396356483258685,0.00453944121586769,-0.0485329531089692,-0.0307383435427678,2.75926857369576e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,39868,-0.100056275605396,0.011476716507412,-0.122550639959924,-0.0775619112508686,3.09996161679579e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0194078911881097,0.00222669628765792,0.0150435664643002,0.0237722159119192,3.15949681149731e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0485101871556131,0.00557225305508821,-0.059431803143586,-0.0375885711676402,3.46618158168062e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0411315251096753,0.00472484844567034,-0.0503922280631892,-0.0318708221561615,3.52858894658321e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0786564373880391,0.00904044765794686,-0.0963757147976149,-0.0609371599784633,3.62692412306277e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.0882041857740445,0.0101377254572087,-0.108074127670174,-0.0683342438779154,3.67923124316169e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0846081093781895,0.00973457808010781,-0.103687882415201,-0.0655283363411781,3.91684630522097e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,39858,-0.0590442857882231,0.00679519884749699,-0.0723628755293172,-0.045725696047129,4.00117915536504e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39489,-0.0281127382695322,0.00323649692213556,-0.0344562722369179,-0.0217692043021465,4.11491584887392e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37388,-0.0306378795709621,0.00353487401512503,-0.0375662326406072,-0.0237095265013171,4.92211074058067e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.044918985095324,0.0051841952703815,-0.0550800078252717,-0.0347579623653762,5.03936430753451e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.0430258266342454,0.00497481481020231,-0.052776463662242,-0.0332751896062489,5.69032156692182e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0431854755212102,0.00499733042948023,-0.0529802431629914,-0.033390707879429,6.05447885824537e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0231072101579263,0.0026743431335269,0.0178654976162136,0.028348922699639,6.12760783569372e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,39931,0.0519731095591542,0.00601968279651781,0.0401745312779793,0.0637716878403291,6.48015865505342e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0246963472770464,0.00286223003461998,-0.0303063181449016,-0.0190863764091912,6.91140155351034e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0553255586682055,0.00642332831390594,-0.0679152821634612,-0.0427358351729499,7.90415585949134e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0629515615055904,0.00731010979837891,-0.077279376710413,-0.0486237463007677,8.01249833255317e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.07624372873326,0.00885785199628256,-0.0936051186459738,-0.0588823388205462,8.15921886209439e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0854080400441617,0.00993481757440961,-0.104880282490005,-0.0659357975983189,8.93879666985881e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,39448,0.0957609498525266,0.0111621100156947,0.073883214221765,0.117638685483288,1.0450562846177e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0301646821017718,0.00352102045850369,-0.037065882200439,-0.0232634820031045,1.15979362730416e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37411,-0.084397437305916,0.00985440212464427,-0.103712065470219,-0.0650828091416133,1.20214226998526e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,37453,-0.0163745261745371,0.00192023662821565,-0.0201381899658398,-0.0126108623832345,1.65415268440528e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0417766506278686,0.00491214795475802,-0.0514044606191943,-0.0321488406365428,2.01299222677454e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0578674252546981,0.00680778174586669,-0.0712106774765968,-0.0445241730327994,2.09481319684433e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0824677089994742,0.00970534544120497,-0.101490186064236,-0.0634452319347125,2.1128177277213e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0580353354249517,0.0068326598661064,-0.0714273487625202,-0.0446433220873831,2.17656365073156e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0576049278853034,0.00678221362343523,-0.0708980665872364,-0.0443117891833703,2.21163441350203e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0338751727546123,0.00400013889143929,-0.0417154449818333,-0.0260349005273912,2.69915582973294e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0283133390848045,0.00334354951504992,-0.0348666961343023,-0.0217599820353066,2.70943304197665e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0445185766554607,0.00527293870285459,-0.0548535365130557,-0.0341836167978657,3.36621020010927e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0442349116948998,0.00524161735967145,-0.0545084817198558,-0.0339613416699437,3.46292496539085e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0126590271759128,0.00150039321500042,0.00971825647451193,0.0155997978773136,3.52349152170592e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0269880765112199,0.00320003864690258,-0.033260152259149,-0.0207160007632909,3.63974208824384e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0264896156140838,0.00314198989959189,-0.0326479158172839,-0.0203313154108837,3.72323122914631e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0214743684541715,0.00254979313027099,0.0164767739188404,0.0264719629895027,4.0113133054053e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,37453,-0.0326530228887852,0.00387849372338036,-0.0402548705866107,-0.0250511751909597,4.17426660988955e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0488573212950642,0.00580759978310927,-0.0602402168699584,-0.0374744257201701,4.34564916988106e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37382,-0.0531804830925502,0.00633915689487383,-0.0656052306065029,-0.0407557355785975,5.3759558636377e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0181780130471091,0.00217196478758644,-0.0224350640307785,-0.0139209620634397,6.35379539963437e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,40012,0.0352132893096941,0.00420991212440557,0.0269618615458592,0.043464717073529,6.53160694275616e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.0298933026039938,0.00357467599481702,-0.0368996675538352,-0.0228869376541525,6.64196297420851e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0846656423202102,0.010126533949178,-0.104513648860599,-0.0648176357798214,6.83540029753172e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,39749,0.0198664118930436,0.00237697814297802,0.0152075347328067,0.0245252890532805,6.91071161171863e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0207694909512367,0.00248719987182533,-0.0256444027000143,-0.015894579202459,7.34513748423589e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0303638366020888,0.003640487808214,-0.0374991927061882,-0.0232284804979893,7.99104368824129e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0397866884143821,0.00477299508478338,-0.0491417587805575,-0.0304316180482067,8.458569518833e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0198831004928461,0.0023885827740174,-0.0245647227299203,-0.015201478255772,9.1648934808522e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37386,-0.0215285022529165,0.00258734557769851,-0.0265996995852056,-0.0164573049206274,9.57673786950655e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.100646727684413,0.0121223417908137,-0.124406517594408,-0.076886937774418,1.09899302971264e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0643591649813311,0.00775105163184685,-0.0795512261797509,-0.0491671037829113,1.10834377800546e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40031,0.0316714392147946,0.00382150704463157,0.0241812854073167,0.0391615930222725,1.24448918834392e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0412927297139805,0.00498629141250845,-0.051065860882497,-0.0315195985454639,1.33268895738488e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0423681235069013,0.00512036543936102,-0.0524040397680489,-0.0323322072457537,1.39189049959766e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0402279893360815,0.00486851138876481,0.0306857070141025,0.0497702716580606,1.5321970945623e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,37368,-0.0494564459593906,0.00599152512868651,-0.0611998352116161,-0.037713056707165,1.66732381180571e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37249,-0.0849484878987075,0.0103021092399028,-0.105140622008917,-0.064756353788498,1.79341732039864e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0385042742357012,0.00467214618374199,-0.0476616807558356,-0.0293468677155669,1.83617065012996e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0222233459145988,0.00269905073628427,-0.027513485357716,-0.0169332064714816,1.95643574703688e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0502408720283692,0.00610539470228647,-0.0622074456448507,-0.0382742984118877,2.06388549819902e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,39788,0.058801129042058,0.00715176931274554,0.0447836611890768,0.0728185968950393,2.15608957502211e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37388,-0.0829814214239655,0.0100911697283229,-0.102760114091478,-0.0632027287564527,2.16140230881922e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0311787945427888,0.00379226094295544,-0.0386116259909815,-0.0237459630945961,2.19309188004718e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,37430,-0.0433098278352309,0.00526983615932244,-0.0536387067075029,-0.0329809489629589,2.24736701122838e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0492945451642599,0.0059997403554207,-0.0610540362608845,-0.0375350540676353,2.29142288110784e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0542810519735499,0.00661077067741496,-0.0672381625012832,-0.0413239414458166,2.36061002167733e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0497805003778016,0.00607492401910002,-0.0616873514552376,-0.0378736493003655,2.70505683611495e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,39913,-0.0412425624654457,0.00504121695914202,-0.0511233477053641,-0.0313617772255274,3.02220723687381e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0346829480772216,0.00424215920991775,-0.0429975801286604,-0.0263683160257828,3.16367248760162e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39405,-0.0904513157465815,0.0110747169579587,-0.112157760984181,-0.0687448705089825,3.39217133652689e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0477535154007439,0.00584657795776015,-0.0592128081979538,-0.036294222603534,3.42611270576056e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0593922582916365,0.00727577930382349,-0.0736527857271305,-0.0451317308561425,3.5068021510081e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0237460736990518,0.00291069021854289,-0.0294510265273959,-0.0180411208707078,3.69780060063929e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0588859542061586,0.00722028377211138,0.0447341980128203,0.0730377103994969,3.72847382048623e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0613066112107885,0.00751639193092416,-0.0760387393953998,-0.0465744830261771,3.75371386676457e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0242558923704633,0.00297509512782931,-0.0300870788210087,-0.0184247059199178,3.81111155373267e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.0153671792782534,0.00188533053770219,0.0116719314243571,0.0190624271321496,3.87554745807835e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0439921605316552,0.00539716611851205,-0.0545706061239389,-0.0334137149393716,3.93189691368922e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0501681381485288,0.00616559533806471,-0.0622527050111357,-0.038083571285922,4.35354963742104e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,40058,-0.0257380656029007,0.00316340437774687,-0.0319383381832845,-0.0195377930225168,4.37251530833253e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0466715617041165,0.00573645279387049,-0.0579150091801027,-0.0354281142281304,4.43953296698093e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0325915266188572,0.00400710686242456,0.024737597168505,0.0404454560692093,4.4781513699172e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37348,-0.0332699058481509,0.00410829173929055,-0.0413221576571604,-0.0252176540391414,6.05202783508354e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.050954419869395,0.00629598281495447,-0.0632945461867058,-0.0386142935520843,6.23817113883523e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,37453,-0.0416455193615154,0.00514901070709746,-0.0517375803474264,-0.0315534583756044,6.57254049459802e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,39788,0.0333424245096202,0.00412881670172304,0.025249943774243,0.0414349052449973,7.19488363272571e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0444667699729303,0.00550985026296687,-0.0552660764883453,-0.0336674634575152,7.5124450966101e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0161241232165178,0.00199762813966113,-0.0200394743702537,-0.012208772062782,7.51929700403268e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0577322920074877,0.00716684702262459,-0.0717793121718319,-0.0436852718431435,8.57546318688885e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.038084322471717,0.0047289737154985,-0.047353110954094,-0.0288155339893399,8.62903294157964e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0584960761485842,0.00726560347404571,-0.0727366589577138,-0.0442554933394547,8.8857460721782e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0577348226134027,0.0071799295820466,-0.071807484594214,-0.0436621606325913,9.63634214648687e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,39885,0.029238635740272,0.00363874025776751,0.0221067048350476,0.0363705666454963,9.97454985682078e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.037524065467796,0.0046744229391518,-0.0466859344285336,-0.0283621965070585,1.07829037367915e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,36879,-0.0525064818286283,0.00654130107503399,-0.0653274319356949,-0.0396855317215617,1.08484018291772e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0249463816413907,0.00311215576155004,0.0188465563487526,0.0310462069340288,1.16925005575039e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,40052,0.0228666598962178,0.00285340727047823,0.0172739816460805,0.0284593381463552,1.18734971041545e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0533386754943748,0.00666095244556205,-0.0663941422876765,-0.0402832087010732,1.26406931294362e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0185314841188076,0.00231652017260787,0.0139911045804962,0.023071863657119,1.3309394221379e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0432231361568513,0.00540688200525822,-0.0538206248871575,-0.0326256474265452,1.3929495039787e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,39477,-0.0349070270893217,0.0043692448295525,-0.0434707469552446,-0.0263433072233988,1.45169243100962e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0477092155743071,0.00598304764253603,-0.0594359889536777,-0.0359824421949365,1.65750388776112e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.0811759999869428,0.0102050095369135,0.0611741812945924,0.101177818679293,1.94955045751703e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,37411,0.0334009777061546,0.00420179440452395,0.0251654606732877,0.0416364947390216,2.02462831154643e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0466101432082707,0.00586926557236014,-0.0581139037300965,-0.0351063826864448,2.15592344914412e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.040606446748045,0.00512072680831444,-0.0506430712923413,-0.0305698222037487,2.3423007481391e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,39585,0.0173040849038241,0.00218348797380329,0.0130244484751696,0.0215837213324785,2.43403696865497e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0198412723120563,0.00251086829851399,0.0149199704469688,0.0247625741771437,2.91849615353135e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37388,-0.0452847472500287,0.00573060953161054,-0.0565167419319854,-0.0340527525680721,2.94973797713443e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0235837979549079,0.00298973193533516,0.017723923361651,0.0294436725481649,3.30433237876985e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,39788,-0.0214087752879016,0.00271916954453341,-0.026738347595187,-0.0160792029806161,3.6759823236306e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0393231721911493,0.00499594075859736,-0.0491152160780002,-0.0295311283042985,3.73933092064551e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0719977709600545,0.00914530243829352,-0.0899225637391098,-0.0540729781809992,3.74199870964761e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,37056,-0.0308939015417922,0.00392585052553991,-0.0385885685718504,-0.0231992345117339,3.84149978464778e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,39749,0.0309139506613366,0.00392979696970856,0.0232115486007078,0.0386163527219654,3.87878342319972e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0430236258287489,0.00547477420809674,-0.0537541832766185,-0.0322930683808793,4.18537571875373e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0436888336577869,0.00556317585023073,-0.0545926583242391,-0.0327850089913347,4.35948952908305e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0459358223330215,0.00585559919920328,-0.05741279676346,-0.0344588479025831,4.66147501862783e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0621443672399557,0.00792448943894808,-0.0776763665402939,-0.0466123679396175,4.711278317372e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.06677767677379,0.0085332963189977,-0.0835029375590255,-0.0500524159885545,5.43819682498996e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0566967928884244,0.00724721044029424,-0.0709013253514011,-0.0424922604254476,5.52687081805883e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.0612539582157723,0.00783785221508628,-0.0766161485573414,-0.0458917678742032,5.89388709298132e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0748346951596967,0.0095831317460085,-0.0936176333818733,-0.05605175693752,6.18703009691555e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0598927389572753,0.00767097315947843,-0.074927846349853,-0.0448576315646976,6.24866094432606e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,37388,-0.0155279910052435,0.00199348649475988,-0.0194352245349729,-0.0116207574755142,7.22344856419145e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0660206486979536,0.00847967823919014,-0.0826408180467662,-0.0494004793491409,7.43204430994789e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0265883135213462,0.00341617445494459,-0.0332840154530376,-0.0198926115896548,7.60399993328455e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0187828658614312,0.00241645116542038,0.0140466215772073,0.0235191101456552,8.21985219983427e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0440396295506028,0.00566831577779652,-0.055149528475084,-0.0329297306261216,8.35959948660743e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0232953060003004,0.00299796320751083,-0.0291713138870216,-0.0174192981135792,8.40207102378313e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37445,-0.0452596264317449,0.00582668069910612,-0.0566799206019929,-0.0338393322614969,8.56658708248597e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40058,-0.0565151697471523,0.00728071941722615,-0.0707853798049156,-0.0422449596893891,8.83560234650581e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0446240312411382,0.0057563433243588,-0.0559064641568815,-0.033341598325395,9.57415258690665e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0473263318568386,0.00611664902436338,-0.0593149639445908,-0.0353376997690864,1.07592699627531e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0461791080539617,0.00597002445206667,-0.0578803559800124,-0.034477860127911,1.09554244352809e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0251455884438624,0.00325116730048574,0.0187733005349104,0.0315178763528145,1.10116094488783e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,39906,0.0278799221664673,0.00361193893497968,0.0208005218539071,0.0349593224790274,1.24295399561615e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0285253125880179,0.00369568501159578,-0.0357688552107456,-0.0212817699652902,1.26148149346606e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39489,-0.0468187694175734,0.00607329467478153,-0.0587224269801452,-0.0349151118550016,1.34456027506634e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0675388571794402,0.00876354131271707,-0.0847153981523657,-0.0503623162065148,1.37960809684795e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,39489,0.0530027393187394,0.00688598589919531,0.0395062069563166,0.0664992716811622,1.47380239529293e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,39788,-0.0646328960598828,0.0084010429142213,-0.0810989401717565,-0.048166851948009,1.51588832979001e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,39858,0.0171467476157627,0.0022320632180897,0.0127719037083069,0.0215215915232185,1.65642200607554e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0316117432315859,0.00411486094796222,-0.0396768706895918,-0.0235466157735799,1.66889181297582e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,37453,-0.0143329434278544,0.00186856433208128,-0.0179953295187337,-0.0106705573369751,1.82856451194466e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0565896403757614,0.00737826327634761,-0.0710510363974027,-0.04212824435412,1.84339031050001e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0700946347975525,0.00914301467782819,-0.0880149435660957,-0.0521743260290092,1.87171374748784e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_E,,39866,-0.0196347325013739,0.00256189681920656,-0.0246560502670187,-0.014613414735729,1.90324304551742e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0560534886993289,0.00731487055642627,-0.0703906349899244,-0.0417163424087334,1.92095372549991e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0192078873143009,0.00250671202218809,-0.0241210428777896,-0.0142947317508123,1.92710358128527e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0236761715404684,0.00309099672381919,-0.029734525119154,-0.0176178179617828,1.9951105533139e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0182857303534796,0.00238905579306751,-0.0229682797078919,-0.0136031809990673,2.05932347280613e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0589670606901855,0.00771353817666229,-0.0740855955164436,-0.0438485258639274,2.23602894042413e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0402749639473056,0.0052713765279208,-0.0506068619420304,-0.0299430659525809,2.2892293672879e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,37445,-0.0518245110743399,0.00678836775201659,-0.0651297118682924,-0.0385193102803874,2.42146966587494e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,39858,-0.027459245873792,0.00359978436322232,-0.0345148232257077,-0.0204036685218762,2.51749623055797e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0444906355739159,0.00583520841619826,-0.0559276440696645,-0.0330536270781673,2.61219359807717e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0374476288680737,0.00491495480853095,-0.0470809402927943,-0.027814317443353,2.70029272501205e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,39713,-0.0459042192684367,0.00603488778352796,-0.0577325993241515,-0.0340758392127219,2.97442641346085e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0381408001277238,0.00501336861775263,-0.047967002618519,-0.0283145976369286,2.97635217864788e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0281787364352587,0.00370427030501197,-0.0354391062330821,-0.0209183666374352,2.98828777140127e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0734473504882305,0.00966202542203101,-0.0923849203154113,-0.0545097806610498,3.12106923508857e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0306060461539579,0.00403383336072766,0.0226997327669317,0.0385123595409841,3.4439582242576e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0318591446665577,0.00420256921729299,-0.040096180332452,-0.0236221090006635,3.66122044628764e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.069001624995988,0.00912240758106928,-0.0868815438548838,-0.0511217061370923,4.12168386013731e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0347814162180418,0.00459860645249556,-0.0437946848649331,-0.0257681475711505,4.1841905139029e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0717377146892202,0.00949390646278555,-0.0903457713562799,-0.0531296580221605,4.3746375938967e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.030877033920381,0.00408934299673569,-0.038892146193983,-0.0228619216467791,4.61405440334524e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0350899402761631,0.00464972287864888,-0.0442033971183149,-0.0259764834340113,4.70492393759909e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,37411,-0.0387314041921289,0.00513596304155142,-0.0487978917535697,-0.0286649166306882,4.95183610184089e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0208011951702075,0.00275918585876182,-0.0262091994533807,-0.0153931908870344,5.04127029564317e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0541326375161635,0.00718570501999784,-0.0682166193553592,-0.0400486556769677,5.20729998605113e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0240270915236067,0.00319061031191452,0.0177734953122542,0.0302806877349592,5.32123131327265e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0284801326168919,0.00378200803955232,-0.0358928683744145,-0.0210673968593694,5.37741743397789e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,39897,0.0253021691184268,0.0033644706442284,0.0187078066557392,0.0318965315811145,5.74940039026209e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,39789,-0.0528958440126351,0.00703884855679027,-0.066691987183944,-0.0390997008413261,6.0001889308408e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,39984,-0.0165858865998928,0.00220746447092797,-0.0209125169629116,-0.012259256236874,6.05597459926192e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0263548781250159,0.00351007318761897,-0.0332346215727491,-0.0194751346772828,6.29916747362552e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0315288727792385,0.00420653127175755,-0.0397736740718833,-0.0232840714865937,6.96624940596866e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0233029573563661,0.00310994666672863,-0.0293984528231542,-0.017207461889578,7.07752867225655e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0361705761883594,0.00482828975954875,-0.045634024117075,-0.0267071282596439,7.1705113276284e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40058,-0.0347890790828544,0.00464451182903169,-0.0438923222677565,-0.0256858358979522,7.22184265719467e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.027749739149479,0.00371195770657727,0.0204743020445876,0.0350251762543704,8.070921074791e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0655813768376005,0.00878093391813527,-0.0827920073171456,-0.0483707463580554,8.52955410977332e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0496311515035998,0.00664760709663817,-0.0626604614130107,-0.036601841594189,8.69086719236779e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0511243614561319,0.00685213415016287,-0.0645545443904511,-0.0376941785218127,9.02131097763942e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0289513590675587,0.00388595490913093,-0.0365678306894553,-0.0213348874456621,9.78893594130883e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0736294218999173,0.00988567829263192,-0.0930053513534758,-0.0542534924463587,9.95480721394241e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37124,-0.0203674664131113,0.0027343697588462,-0.0257268311404499,-0.0150081016857727,1.00095780549301e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.036009392506994,0.00483558001265787,-0.0454871293318035,-0.0265316556821846,1.00531502220874e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0193743576321314,0.00260301967216114,-0.0244762761895672,-0.0142724390746956,1.04459371710541e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0281195635320257,0.00378119773014541,-0.0355307110831107,-0.0207084159809406,1.0856706864391e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0593099635582426,0.00798002241788787,-0.0749508074973029,-0.0436691196191824,1.12120041686758e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0422723439810767,0.0056977795577193,-0.0534399919142066,-0.0311046960479469,1.23839008375841e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.013051208103344,0.00176032660951089,0.00960096794870266,0.0165014482579853,1.29723354041423e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,37437,-0.0388396464725776,0.00523863761038074,-0.0491073761889238,-0.0285719167562313,1.29725362147164e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.0178694798878717,0.00241426361760145,-0.0226014365783706,-0.0131375231973729,1.41188060333634e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0322142608249965,0.0043563280924726,-0.0407526638862428,-0.0236758577637502,1.48609670141741e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,39788,-0.0374644723863477,0.0050685196668549,-0.0473987709333833,-0.027530173839312,1.52272762293587e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0390276276194804,0.00528416893741896,-0.0493845987368216,-0.0286706565021392,1.59178863565202e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0207430525092327,0.00281619827335786,0.0152233038934513,0.0262628011250141,1.84882382624394e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0254714211399497,0.00345858923593268,-0.0322502560423778,-0.0186925862375217,1.86207490983431e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,39713,-0.0222515810995658,0.00302276472153453,-0.0281761999537735,-0.0163269622453581,1.91014177821454e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0444849223439248,0.00605502395179004,-0.0563527692894332,-0.0326170753984163,2.12851169095699e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0251336307129452,0.0034213441720669,-0.0318394652901964,-0.0184277961356941,2.13935744572011e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0586257546968139,0.00798817734686283,-0.0742825822966651,-0.0429689270969628,2.25676492506685e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0449375462908025,0.00612425947390594,-0.0569410948596582,-0.0329339977219469,2.29794408561429e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,39749,-0.0446408860530215,0.00608720984544576,-0.0565718173500951,-0.0327099547559478,2.34931939172666e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0414133008128536,0.00565248714812954,-0.0524921756231875,-0.0303344260025197,2.47288842349348e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0332232336271288,0.0045354202535954,-0.0421126573241758,-0.0243338099300818,2.49959081038286e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0350282694735474,0.00478130475532296,-0.0443996267939804,-0.0256569121531144,2.50737215214115e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0423672038580479,0.00578539702193639,-0.0537065820210432,-0.0310278256950525,2.55946076418462e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0267784409954384,0.00366297315473651,-0.0339578683787219,-0.0195990136121548,2.78517619378963e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.041274439100687,0.00564844804075978,-0.0523453972605762,-0.0302034809407978,2.87981456176371e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0735801399730352,0.0100733561201053,-0.0933239179684416,-0.0538363619776287,2.93957153385549e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0632402319104574,0.00866937856889603,-0.0802322139054937,-0.0462482499154212,3.13778101138942e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.0665129948833987,0.00911914512739596,-0.0843865193330948,-0.0486394704337026,3.18595551680845e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0296479149974823,0.00406667798693502,-0.0376186038518749,-0.0216772261430896,3.23426042780016e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0458123529166326,0.00628692221697328,-0.0581347204619002,-0.0334899853713649,3.35168041813005e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40009,-0.0150668413642591,0.00207041838350557,-0.01912486139593,-0.0110088213325882,3.56496693478946e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,40030,-0.0373630958484751,0.00513629671586418,-0.0474302374115689,-0.0272959542853813,3.64113026355419e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0221708929450762,0.00305127465227826,-0.0281513912635415,-0.0161903946266108,3.87135447002205e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0250255866013763,0.00344719891468583,-0.0317820964741605,-0.018269076728592,4.06136303934389e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0247855595390999,0.00341521508555133,-0.0314793811067805,-0.0180917379714193,4.1305808121274e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0290474495166175,0.00400487777484348,-0.0368970099553108,-0.0211978890779243,4.26024968237508e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0421668702323765,0.00581471204034191,-0.0535637058314466,-0.0307700346333063,4.34351861109629e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0464154869078167,0.00640977349728762,-0.0589786429625004,-0.033852330853133,4.64222416157742e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0391141438861551,0.00540779489028872,-0.049713421871121,-0.0285148659011892,4.94279997823278e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.0164161477200646,0.00226959125422743,-0.0208645465783504,-0.0119677488617789,4.98205449010535e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37124,-0.0365656943765435,0.00505898362588144,-0.0464813022832711,-0.0266500864698159,5.17450946693605e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0457558580135127,0.0063454203774345,-0.0581928819532844,-0.0333188340737411,5.80611139342838e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,39788,-0.0197905976703052,0.00274509188356527,-0.0251709777620931,-0.0144102175785172,5.87017599643106e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0450277316298215,0.00624498593951364,-0.0572679040712683,-0.0327875591883748,5.88209596457199e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.024059984075424,0.00333873787843534,-0.0306039103171572,-0.0175160578336907,6.05215705026298e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0437888867071088,0.00607821335147228,-0.0557021848759945,-0.0318755885382231,6.15461499505457e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0151669693175966,0.00210946952924297,-0.0193015295949128,-0.0110324090402804,6.82886879616302e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0316833796689879,0.00442041989917382,-0.0403474026713686,-0.0230193566666072,8.04415887640689e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,39817,0.0426060601374601,0.00594839480961579,0.0309472063106131,0.054264913964307,8.26088312324286e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,40009,-0.0409493948330147,0.00572108259199507,-0.052162716713325,-0.0297360729527044,8.56144186551396e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.0175925158173606,0.00245986847282981,-0.022413858024107,-0.0127711736106141,8.93301826320394e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0164323084609689,0.00229746836099269,0.0119292704734232,0.0209353464485146,8.97746333415105e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.037353752835329,0.0052342923274329,-0.0476129657970975,-0.0270945398735606,9.99141997848069e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0307242870740949,0.00430547514561152,-0.0391630183594935,-0.0222855557886963,1.00907754130021e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0755140746610537,0.0105956134239329,-0.0962814769719622,-0.0547466723501452,1.07020104483224e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0224360747151628,0.00315100333362178,-0.0286120412490615,-0.0162601081812641,1.13271111891334e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,39858,-0.0174589798823331,0.0024527877867309,-0.0222664439443257,-0.0126515158203406,1.14143347426293e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,37437,-0.0501371786978733,0.00704574566368299,-0.063946840198692,-0.0363275171970547,1.16718960773372e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0504152608410991,0.00708862938132665,-0.0643089744284993,-0.0365215472536988,1.20005003732934e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0394408734215689,0.00554917356990064,-0.0503172536185742,-0.0285644932245637,1.2325765364079e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37368,-0.0215810406589416,0.00303739517514086,-0.0275343352022177,-0.0156277461156655,1.26247589671329e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0199570732448489,0.00280950470913574,-0.025463702474755,-0.0144504440149429,1.26840181681025e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37056,-0.0614683311337599,0.00867122758665284,-0.0784639372035994,-0.0444727250639203,1.4219082064916e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0559281936081656,0.00791097640235439,-0.0714337073567802,-0.0404226798595509,1.62876178500222e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0705643898601666,0.00998374494917679,-0.0901325299605531,-0.0509962497597801,1.64955926040431e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0415118134974008,0.00587563052383222,-0.0530280493241119,-0.0299955776706896,1.67134996643535e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0704200779451255,0.00996597185836152,-0.0899533827875141,-0.0508867731027369,1.67336213321739e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0510082342108835,0.00722660116429133,-0.0651723724928945,-0.0368440959288725,1.76859136338749e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0291552433205817,0.00413614601720721,-0.0372620895143078,-0.0210483971268556,1.87899252506627e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0311814759927599,0.00442386521534047,-0.0398522518148272,-0.0225107001706925,1.88462678176005e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0641859276252244,0.00910676447672309,-0.0820351859996017,-0.0463366692508472,1.88754484474501e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0167584318260096,0.00237852365612539,0.0120965254600039,0.0214203381920154,1.92034394180149e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37388,-0.0364841561414194,0.00517842875548468,-0.0466338765021693,-0.0263344357806694,1.93860199725526e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.049690265702184,0.00708136848081645,-0.0635697479245843,-0.0358107834797838,2.35864784675047e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0389788607768836,0.00556061846311652,-0.049877672964592,-0.0280800485891752,2.48106007541481e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40030,-0.0732158151172266,0.0104468650427596,-0.0936916706010354,-0.0527399596334178,2.50576515241362e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,37453,-0.0143123426666565,0.00204420943989473,-0.0183189931688502,-0.0103056921644628,2.65299276593485e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0379200089575268,0.00542827067616324,0.0272805984322468,0.0485594194828067,2.94657316691825e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0358447750567554,0.00513315583109707,-0.0459057604857056,-0.0257837896278051,3.02797331032791e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0194349111976202,0.0027894418075223,-0.0249022171403639,-0.0139676052548765,3.35606649982947e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0218269726455917,0.00313930816564652,0.0156739286409245,0.0279800166502588,3.71811804642889e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0512141928752061,0.00736919635472214,-0.0656578177304615,-0.0367705680199508,3.80114364547645e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,39913,-0.0252246408123128,0.00364237025571649,-0.0323636865135171,-0.0180855951111085,4.51436937388195e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0499362314418041,0.00721602785267562,-0.0640796460330483,-0.0357928168505598,4.71908852417074e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37411,-0.0330686379632602,0.00478055492457427,-0.0424385256154258,-0.0236987503110946,4.80910334704242e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37382,-0.0217175579221649,0.00314454852040498,-0.0278808730221587,-0.0155542428221711,5.19261652977991e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.032031914532629,0.00464237604488088,-0.0411309715805956,-0.0229328574846625,5.43472161230701e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,39985,-0.0462271087256774,0.00670290187927842,-0.0593647964090631,-0.0330894210422917,5.52470628436556e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0268436377510211,0.00389687684662306,-0.0344815163704023,-0.0192057591316399,5.89261656772932e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0485591006554682,0.00705983745928138,-0.0623963820756597,-0.0347218192352767,6.327078015791e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0609849236457516,0.00888195954380942,-0.0783935643516181,-0.0435762829398851,6.8391538121576e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0304219585481972,0.00443951918010662,-0.0391234161412061,-0.0217205009551882,7.56944865938772e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0320084201472973,0.0046712219483408,-0.0411640151660453,-0.0228528251285494,7.58915924990694e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39477,-0.0260469472957767,0.00381586055842229,-0.0335260339902844,-0.018567860601269,9.05493824993365e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0228500853928989,0.00335196751484618,-0.0294199417219975,-0.0162802290638004,9.69635479563655e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0202955364693,0.00298554693389642,-0.026147208459737,-0.0144438644788631,1.09851166731307e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0497927914555121,0.00732881935087414,-0.0641572773832254,-0.0354283055277988,1.12923517195035e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,39881,-0.0680775972822723,0.0100233488513178,-0.0877233610308551,-0.0484318335336894,1.14557370997954e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.0418130661293157,0.0061557632221596,0.0297477702138828,0.0538783620447485,1.14806193283075e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0316653537552675,0.00466515070369973,-0.040809049134519,-0.022521658376016,1.18967699380118e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0241654984847861,0.00356551781979204,0.0171770835579937,0.0311539134115785,1.26546715598194e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0611704711988325,0.00902647646495017,-0.0788623650701348,-0.0434785773275302,1.27169093379837e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0217906348917767,0.00322152437689941,-0.0281048226704995,-0.0154764471130539,1.38832548978615e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37043,-0.0572098742443429,0.00846575774285358,-0.073802759420336,-0.0406169890683499,1.45994207769167e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37021,-0.0247978416969545,0.00367217990589393,-0.0319953143125066,-0.0176003690814024,1.5100887913044e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0151845823416066,0.00224911816323749,0.0107763107416612,0.0195928539415521,1.51536646569953e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0284459956737219,0.00421351693462112,-0.0367044888655792,-0.0201875024818645,1.51877016080679e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.016022910105826,0.00237640928252884,-0.0206806722995825,-0.0113651479120694,1.60979879169347e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.022581043342694,0.00335005411994524,-0.0291471494177867,-0.0160149372676013,1.64419237352525e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0502651551114292,0.00748946748519921,-0.0649445113824197,-0.0355857988404388,2.00595826630737e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0290393411665932,0.00433417456809472,-0.0375343233200588,-0.0205443590131275,2.15331509231884e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0171868109449364,0.00257032732294002,-0.0222246524978988,-0.0121489693919739,2.35937708970135e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0272911287677689,0.00408356032657849,-0.0352949070078627,-0.019287350527675,2.43232560327342e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0424127675978158,0.00634671740361949,-0.05485233370891,-0.0299732014867216,2.44140391113652e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,39866,-0.0304986409324211,0.00456583579849866,-0.0394476790974784,-0.0215496027673637,2.47236506260705e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0261587461966889,0.00391891206147549,-0.0338398138371809,-0.018477678556197,2.5688117716087e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0389151140495741,0.00583100770496714,-0.0503438891513097,-0.0274863389478385,2.57398101909169e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0426426054716263,0.00639121838242785,-0.0551693935011849,-0.0301158174420678,2.62246301362863e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37021,-0.0418824634043733,0.00628624494898727,-0.0542035035043884,-0.0295614233043583,2.79810524597223e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0498796463768817,0.00748678177836204,-0.0645537386624713,-0.0352055540912921,2.80166463842064e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,36543,-0.0152407333903586,0.0022883372734679,-0.0197258744463557,-0.0107555923343615,2.84778478790406e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0253409739522065,0.00380904062400138,-0.0328066935752492,-0.0178752543291638,2.96819029524979e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0204379565144866,0.0030719451173256,0.0144169440845284,0.0264589689444448,2.97983288583221e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0225625197285257,0.00339251235533826,-0.0292118439449887,-0.0159131955120627,3.01306823487175e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,39489,-0.0444630555228082,0.00668745893553953,-0.0575704750364657,-0.0313556360091507,3.0544507761404e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0338188979085943,0.00508734764502456,-0.0437900992928425,-0.0238476965243462,3.07326891042838e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40030,0.0102959287924364,0.00154918447882202,0.00725952721394529,0.0133323303709276,3.10723939646601e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0282109164535974,0.00424695384650585,-0.0365349459927489,-0.0198868869144459,3.20244743215614e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0236652367442492,0.00356413370991337,-0.0306509388156794,-0.016679534672819,3.24174247304878e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0229688063943137,0.00346328843776827,-0.0297568517323395,-0.0161807610562879,3.43540157548491e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,39785,-0.0545033221662719,0.00822190597681109,-0.0706182578808216,-0.0383883864517221,3.48739033800745e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.049685531771106,0.00751136842581478,-0.0644078138857029,-0.034963249656509,3.84288365159562e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0419579705973564,0.00634512367337282,-0.0543944129971671,-0.0295215281975457,3.91695393190539e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,39866,-0.0327097200838748,0.0049665408792065,-0.0424441402071195,-0.02297529996063,4.65856220349321e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37039,-0.0303788191850104,0.00461329664704877,-0.039420880613226,-0.0213367577567948,4.71954622741461e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.0142993531558674,0.00217561157487844,-0.0185635518426291,-0.0100351544691056,5.09670067822595e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0365792627647782,0.00557558860247011,-0.0475074164256197,-0.0256511091039368,5.55386285280629e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,37021,-0.0365920020844025,0.00557981474230643,-0.0475284389793231,-0.0256555651894819,5.65999657901905e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,39818,-0.024593284845584,0.00375869188919781,-0.0319603209484117,-0.0172262487427563,6.21143030666496e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0179444813416502,0.00274386222756713,0.0125665113756186,0.0233224513076818,6.37886876674315e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0498198973519123,0.00762016308731374,-0.0647554170030472,-0.0348843777007773,6.42884304933952e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40030,-0.0264768138070316,0.00405457929944998,-0.0344237892339536,-0.0185298383801097,6.76840123874705e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,39908,-0.0533493165218945,0.00818101642758751,-0.069384108719966,-0.037314524323823,7.18730084680009e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0393006329578571,0.0060268090429151,-0.0511131786819706,-0.0274880872337435,7.199776790073e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,39931,-0.0565941263749615,0.00871247708134835,-0.0736705814544043,-0.0395176712955187,8.50437491836897e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0344554042092908,0.00530448212802962,-0.0448521891802288,-0.0240586192383527,8.51857032465674e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0409046066593243,0.00629878831867346,-0.0532502317639243,-0.0285589815547243,8.65306553533423e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0423146928146955,0.00651603627571593,-0.0550861239150987,-0.0295432617142922,8.66052296421716e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0273120086303192,0.00420614106394625,0.0190679721449846,0.0355560451156539,8.68663689049042e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.02038242599614,0.00314097523743835,-0.0265387374615192,-0.0142261145307608,8.93476583848673e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37124,-0.033667564884238,0.00519147281421554,-0.0438428516001004,-0.0234922781683755,9.17759498340186e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0170435566236664,0.00262931692207066,-0.0221970177909249,-0.0118900954564079,9.30852255443277e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0488963141078766,0.007548374505801,-0.0636911281392466,-0.0341015000765066,9.64205605226876e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0131125545104122,0.00203427609755168,0.00912537335921093,0.0170997356616135,1.18871332615731e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0543459401725982,0.00843381922545721,-0.0708762258544943,-0.0378156544907021,1.19854575741074e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0234059124619896,0.00363349629344719,0.0162842597268332,0.0305275651971461,1.21508825060053e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0311385947874596,0.0048376799595635,-0.040620447508204,-0.0216567420667151,1.2565140574781e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0170492839921024,0.00265020770858151,-0.0222436911009221,-0.0118548768832826,1.29254148177334e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0456212055840789,0.00709173095603169,-0.0595209982579011,-0.0317214129102568,1.29300357500731e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0350742713298292,0.00545591004179234,-0.0457678550117421,-0.0243806876479162,1.32364107769906e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0592277570226659,0.00921501575578584,-0.0772891879040061,-0.0411663261413256,1.33647654320027e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0280961534233969,0.00437107738524461,-0.0366634650984763,-0.0195288417483175,1.3384228395754e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.046950055626289,0.00730816574656652,-0.0612740604895594,-0.0326260507630187,1.36878747383338e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0262004105556983,0.00408203964374219,-0.034201208257433,-0.0181996128539635,1.42371996453586e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0291759221852709,0.00455328249196666,-0.0381003558695256,-0.0202514885010162,1.5189548027755e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0198003979127472,0.00309000763649844,-0.0258568128802842,-0.0137439829452103,1.52422127109439e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0456999128093878,0.00713300447927215,-0.0596806015887612,-0.0317192240300144,1.53582644953356e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0310414932694619,0.00484507932495569,-0.040537848746375,-0.0215451377925487,1.53643310134362e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0199388723639292,0.0031193894580737,-0.0260528757017537,-0.0138248690261048,1.68298762465688e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,37056,-0.0270630882665945,0.00423812333372449,-0.0353698100006945,-0.0187563665324945,1.76413245121692e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0350320056014837,0.00549084749780849,-0.0457940666971884,-0.0242699445057791,1.82915279076612e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0625755216570304,0.00981064896767007,-0.0818043936336637,-0.0433466496803971,1.83945099805415e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0225261306769673,0.00353307287830995,-0.0294509535184548,-0.0156013078354798,1.87009123594136e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0539659863537778,0.0084817301635937,-0.0705901774744215,-0.0373417952331342,2.04712930874071e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0311458279546012,0.004895804797854,-0.040741605358395,-0.0215500505508074,2.05036321437837e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0198914603052989,0.00313057940910915,-0.0260273959471528,-0.013755524663445,2.16795156490985e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,39858,-0.0533435789766799,0.00839708609058984,-0.069801867714236,-0.0368852902391238,2.17382314292702e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0266408517286512,0.00419514964558657,-0.0348633450340008,-0.0184183584233015,2.2070087955291e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0360049578794802,0.00566993484553332,-0.0471180301767255,-0.0248918855822349,2.20906785221646e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0283429056726444,0.00446621708921139,-0.0370966911674987,-0.0195891201777901,2.27921682673235e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,39771,-0.0333408468988994,0.00525503542412458,-0.0436407163301836,-0.0230409774676153,2.29101902410853e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.0151441660886081,0.00238867195492233,-0.0198259631202559,-0.0104623690569604,2.37076211305453e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0479864134578596,0.00758769545608806,-0.0628582965517922,-0.033114530363927,2.62698715971637e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.019929959566544,0.00315179727439899,0.013752436908722,0.026107482224366,2.63945439147097e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37021,-0.0278223170596757,0.00440769340743574,-0.0364613961382498,-0.0191832379811017,2.83894642210772e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,39868,-0.04533621772566,0.00718544608774586,-0.0594196920576419,-0.0312527433936781,2.87385831163309e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0496740049031221,0.00788837034689332,-0.065135210783033,-0.0342127990232111,3.11136486385272e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0596815502915481,0.00948106254958846,-0.0782644328887415,-0.0410986676943547,3.17230454321879e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.053243189653207,0.00846332629283718,-0.0698313091871679,-0.0366550701192462,3.25025961720854e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0194958799110327,0.00309945146614325,-0.0255708047846735,-0.013420955037392,3.25400472764391e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0309720076532832,0.00492812755775508,-0.0406311376664832,-0.0213128776400832,3.37050877450782e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0210528416210997,0.00335008932744636,-0.0276190167028946,-0.0144866665393049,3.38417319195383e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,39913,-0.0325276616737561,0.00517838268655418,-0.0426772917394023,-0.0223780316081099,3.44104062307185e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0159414349455893,0.00253803042053598,-0.0209159745698398,-0.0109668953213387,3.46644995896855e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,37445,-0.0405023877233491,0.00645286916318207,-0.0531500112831859,-0.0278547641635122,3.56464545382795e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40030,0.034762023754856,0.00553924511509187,0.023905103329276,0.0456189441804361,3.57183186088904e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0418669949645005,0.00668828154421651,-0.0549760267911649,-0.0287579631378362,3.953840043806e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0544967830420624,0.00870714586911205,-0.071562788945522,-0.0374307771386028,3.97859548955505e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0343632596505078,0.00549249154952622,0.0235979762134364,0.0451285430875792,4.03859853739949e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0393943615304422,0.00629762644927115,-0.0517377093710137,-0.0270510136898708,4.08340057426221e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0772463224253388,0.0123532108163417,-0.101458615625369,-0.053034029225309,4.14710586154801e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0184026981676902,0.00294421674034171,0.0126320333566205,0.02417336297876,4.1963357079739e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0232176521208561,0.00371465227313763,-0.0304983705762058,-0.0159369336655063,4.22238619343207e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.039804745139497,0.00637920397953009,-0.0523079849393759,-0.027301505339618,4.49172570810464e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,39857,0.0342895433290022,0.00549987067370901,0.0235097968085326,0.0450692898494719,4.64268589613887e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,39812,-0.0278128847090082,0.00446348611078223,-0.0365613174861414,-0.0190644519318751,4.74487695804047e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37388,-0.0417559355540561,0.00670713981029511,-0.0549019295822346,-0.0286099415258777,4.93908719245676e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0275005462884868,0.00441813200999801,-0.0361600850280829,-0.0188410075488907,4.95103163551937e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0494909864887681,0.0079541107305746,-0.0650810435206943,-0.0339009294568419,5.03227368067534e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,37388,-0.0798238813484274,0.0128393314497068,-0.104988970989853,-0.0546587917070021,5.21189713561511e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,39810,-0.0236174356306162,0.00380078552210571,-0.0310669752539434,-0.016167896007289,5.29923084557542e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0525029300992317,0.00845109189782326,-0.0690670702189653,-0.0359387899794981,5.36943371058861e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0257458858021839,0.00414710825986433,-0.033874217991518,-0.0176175536128498,5.49349033138583e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0367666532416913,0.00592911370020755,-0.0483877160940981,-0.0251455903892845,5.74709878761782e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0241567081421021,0.00389963960894569,-0.0318000017756356,-0.0165134145085685,5.98887022616948e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,37169,-0.0313462910980236,0.00506310825564438,-0.0412699832790865,-0.0214225989169606,6.14954718191071e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0682886056577862,0.0110320988827196,-0.0899115194679165,-0.0466656918476558,6.1951396909915e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0277917272578044,0.00449160640009914,-0.0365952758019987,-0.0189881787136101,6.28973816251274e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0261852790287898,0.00423502169289465,0.0178846365107163,0.0344859215468633,6.44030853845699e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0278786731248115,0.00451360527724422,-0.0367253394682102,-0.0190320067814128,6.73853560526205e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.054915430353885,0.00889723325656042,-0.0723540075367434,-0.0374768531710265,6.89844877435559e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0170198074089242,0.002759577531791,-0.0224285793712345,-0.0116110354466138,7.10939657762298e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,37437,-0.0175726551007564,0.002850541895158,-0.0231597172152661,-0.0119855929862467,7.26297262321901e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0231278648292295,0.00375556151816056,-0.0304887654048242,-0.0157669642536348,7.5605067151755e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0375954325191425,0.00610802502667665,-0.0495671615714287,-0.0256237034668562,7.72203593106535e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.024769940835154,0.00402664392519582,-0.0326621629285378,-0.0168777187417702,7.85547630269476e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0276672009766005,0.00449837835247052,-0.0364840225474427,-0.0188503794057583,7.94192049551838e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,39750,-0.0380759243564825,0.00619559375126264,-0.0502192881089573,-0.0259325606040077,8.15392000392919e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37043,-0.0399719787846209,0.00650899487140189,-0.0527296087325686,-0.0272143488366732,8.43404544789125e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0632245593052922,0.0103075540780605,-0.0834273652982908,-0.0430217533122937,8.78087201058329e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0230942891796706,0.00376572676167756,-0.0304751136325587,-0.0157134647267826,8.84343439047062e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,39856,0.0354521431466728,0.00578750990295941,0.0241086237368723,0.0467956625564732,9.24391626483063e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0450233010815059,0.00736742360213506,-0.0594634513416906,-0.0305831508213212,1.01271771460267e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0161009689000594,0.00263755795987293,0.0109313552987085,0.0212705825014104,1.05503974629999e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0246140598650676,0.00403263068567088,-0.0325180160089825,-0.0167101037211527,1.06058027017696e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,37437,-0.0159719886744058,0.00262213831962919,-0.021111379780879,-0.0108325975679326,1.15088964546531e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.022949323627891,0.00377456507740602,0.0155511760761752,0.0303474711796068,1.22946904474659e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0305258901293889,0.00502834032141509,-0.0403814371593624,-0.0206703430994153,1.30841143806803e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0679733271140164,0.0112112717407063,-0.0899474197258007,-0.0459992345022321,1.3720227381103e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39477,-0.0214237512274527,0.00353640538759641,-0.0283551057871416,-0.0144923966677637,1.40935741568433e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,39973,-0.0303744698324872,0.00501783577096354,-0.0402094279435757,-0.0205395117213986,1.45052904127423e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0211120999303058,0.00349106458436175,-0.0279545865156549,-0.0142696133449568,1.51119842676357e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,39908,-0.0290708351999327,0.00481808489026812,-0.0385142815848582,-0.0196273888150072,1.63777851100153e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.021231369538836,0.00352084755981112,-0.0281322307560657,-0.0143305083216062,1.67371707830908e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,39868,-0.0301443866178085,0.00500026090824851,-0.0399448979979756,-0.0203438752376414,1.69056151663133e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37333,-0.019647900680159,0.00326323645040046,-0.0260438441229439,-0.0132519572373741,1.77865743393262e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0150948143979183,0.0025089494145749,-0.0200123552504851,-0.0101772735453515,1.82251496831776e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0255217186322912,0.00424423301372051,-0.0338404153391833,-0.017203021925399,1.86621828458895e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0374915889318275,0.00624154207714309,-0.049725011403028,-0.025258166460627,1.93337121419043e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0380391418688068,0.00633385196989656,-0.050453491729804,-0.0256247920078095,1.94743430371074e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0128291934705672,0.0021380727016109,-0.0170198159657245,-0.00863857097540981,2.01163913538401e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0233221020762324,0.0038882419567039,-0.0309430563113721,-0.0157011478410928,2.03926696863164e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0521219385571677,0.00869338070727434,-0.0691609647434254,-0.03508291237091,2.07912801254848e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0143983496263,0.00240283197719552,0.00968879895099675,0.0191079003016032,2.12218732168607e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0452584655984005,0.00756322838828957,-0.060082393239448,-0.0304345379573529,2.22346704168893e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0375800479404876,0.00628060639069822,-0.0498900364662561,-0.0252700594147191,2.2399422937117e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0190343941382735,0.00318534937120249,-0.0252776789058304,-0.0127911093707167,2.34083318794979e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0508810183966224,0.00852451658750541,0.0341729658851118,0.067589070908133,2.4421284692925e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,37039,-0.023478672385747,0.00393390281898855,-0.0311891219109645,-0.0157682228605295,2.45910979085741e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.00983675537519596,0.00164842999258747,-0.0130676781606674,-0.00660583258972452,2.47139902940747e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,39777,-0.0158384019157867,0.00265484202013337,-0.0210418922752481,-0.0106349115563253,2.48513883464512e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0377960903340379,0.00634770907340157,-0.0502376001179049,-0.0253545805501708,2.67668501877937e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0180549847753142,0.00303242416559455,0.0121114334107489,0.0239985361398795,2.68164113240214e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0515702360687777,0.00867649657668752,-0.0685761693590853,-0.0345643027784702,2.84601144261619e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37257,0.059813583359406,0.0100752340106337,0.0400661246985639,0.0795610420202482,2.98021079842451e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0382680175682682,0.00644958742378718,-0.0509092089188911,-0.0256268262176454,3.03955060538797e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0442466309994892,0.0074670751084185,-0.0588820982119894,-0.0296111637869889,3.17660951474424e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0353851716172241,0.00597360693000016,-0.0470934412000244,-0.0236769020344238,3.21394033049692e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0295116576309195,0.00498778266786388,-0.0392877116599327,-0.0197356036019063,3.36227270413805e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0490405174835365,0.00829362796856778,-0.0652960283019293,-0.0327850066651436,3.44164560237764e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0317561751359315,0.00538065015724333,-0.0423022494441284,-0.0212101008277346,3.68110881418955e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,37056,-0.0319497169496007,0.00541944430465894,-0.0425718277867322,-0.0213276061124692,3.82941337104433e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.03309048164506,0.00561796594465221,-0.0441016948965783,-0.0220792683935417,3.95343595829596e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0281012777875395,0.00477492946916945,-0.0374601395471117,-0.0187424160279674,4.07068377380589e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0201644134662929,0.00342833104286444,0.0134448846222786,0.0268839423103072,4.15664400700952e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,37415,-0.0246019096110263,0.00418416816558723,-0.0328028792155772,-0.0164009400064753,4.20529353661006e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0367395343222161,0.00624964193845238,-0.0489888325215828,-0.0244902361228494,4.23617234411151e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0278167957616757,0.00473718356198781,-0.0371016755431718,-0.0185319159801795,4.40645370304252e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0363456964842521,0.00619072978850569,-0.0484795268697232,-0.0242118660987809,4.41932159649666e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,39559,-0.0298489205579099,0.00508626468024865,-0.0398179993311973,-0.0198798417846225,4.48519829613455e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0331849120128315,0.00565690878029775,-0.0442724532222151,-0.0220973708034479,4.54740183087598e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0374061938998007,0.00638104656934333,-0.0499130451757136,-0.0248993426238878,4.68048540374543e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.00936988504435107,0.00160025558428217,-0.0125063859895441,-0.00623338409915802,4.87310788113784e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0317551238996926,0.0054293985598891,-0.0423967450770752,-0.0211135027223099,5.05210062067636e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.0178497547987168,0.0030537127104976,-0.0238350317112921,-0.0118644778861415,5.15634287445884e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.050258289798626,0.00859724638397514,-0.0671088927112173,-0.0334076868860347,5.15886541540158e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0238134939661082,0.00407406924539364,-0.0317986696870797,-0.0158283182451367,5.16240745160638e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.0216409663857604,0.00370642336279532,-0.0289055561768392,-0.0143763765946816,5.36142146666723e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0305365557426295,0.00523252558285859,-0.0407923058850324,-0.0202808056002267,5.45497067346318e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0207426522908134,0.00355441271621222,-0.0277093012145894,-0.0137760033670375,5.45807793257838e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,39866,0.0233620740303161,0.00400926253618444,0.0155039194593946,0.0312202286012376,5.75080325153818e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0238541089575373,0.00409386332820682,0.0158301368342519,0.0318780810808226,5.76156602253113e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,37342,-0.0524550084375628,0.00901062532804904,-0.070115834080539,-0.0347941827945867,5.96627507262273e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0356816615644633,0.00613706888715394,-0.047710316583285,-0.0236530065456415,6.21037445430434e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,39555,-0.0206019974780199,0.00354472009875592,-0.0275496488715815,-0.0136543460844583,6.29193200638147e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37043,0.035573771839627,0.00614048453640915,0.0235384221482651,0.047609121530989,7.05858551727087e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0289985597634241,0.00500686124003211,-0.038812007793887,-0.0191851117329612,7.12301220673413e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37424,0.0078886119941093,0.00136355774621591,0.00521603881152611,0.0105611851766925,7.39736827444016e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,39489,-0.0366664164862243,0.00634162201370522,-0.0490959956330866,-0.0242368373393621,7.52860270670753e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.048041453181338,0.0083132879383877,-0.0643354975405779,-0.0317474088220981,7.66070081435644e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,39847,0.0277025317683845,0.00480372799068263,0.0182872249066465,0.0371178386301224,8.2242829559078e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0236008921001462,0.00409328304484422,0.0155780573322515,0.0316237268680409,8.27883643934054e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,39892,-0.0202983682781226,0.00352237925181764,-0.0272022316116852,-0.01339450494456,8.43054520790567e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,37124,-0.0422304147776847,0.00733271455815491,-0.0566025353116683,-0.0278582942437011,8.63985516712188e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0304795125140566,0.0052996228787828,-0.0408667733564709,-0.0200922516716423,9.05444105253318e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0152775277979626,0.00265664254943139,0.010070508401077,0.0204845471948481,9.08111037815161e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37422,-0.0249373908401407,0.00434389562925949,-0.0334514262734893,-0.0164233554067921,9.62541103662263e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0230014844101013,0.00400858176530196,-0.0308583046700932,-0.0151446641501095,9.78768448788981e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0465791356993353,0.00811902284311839,-0.0624924204718474,-0.0306658509268233,9.845747804539e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0406468317583026,0.00709772673964522,-0.0545583761680072,-0.026735287348598,1.04617370561724e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0459646665400484,0.00804190912305384,-0.061726808421234,-0.0302025246588629,1.1166375658631e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0316723007879012,0.00555492750957704,-0.0425599587066722,-0.0207846428691302,1.21122665945585e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0623813113540072,0.010961600267477,-0.0838660478782622,-0.0408965748297522,1.28599295677682e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37124,-0.035781640082079,0.00629748048438103,-0.0481247018314659,-0.0234385783326922,1.36009830934661e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,36991,-0.0230885223988705,0.00406358342806509,-0.0310531459178781,-0.0151238988798629,1.36105479184101e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0309215467971796,0.00546174636601778,-0.0416265696745745,-0.0202165239197847,1.53121906040938e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.0123285021284382,0.00217960102336347,-0.0166005201342306,-0.00805648412264576,1.57281411929551e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37437,-0.0121266440283815,0.00214389248037441,-0.0163286732899153,-0.00792461476684766,1.57730537722729e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0606421670822866,0.010730513142457,-0.0816739728415024,-0.0396103613230709,1.62375772238052e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37357,-0.0168541975133116,0.00298265180436397,-0.022700195049865,-0.0110081999767582,1.62987120969917e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,40009,-0.0400293682812461,0.00709494598700762,-0.053935462415781,-0.0261232741467112,1.70950422279409e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0276807393577795,0.00490744092952845,-0.0372993235796553,-0.0180621551359037,1.72883137406588e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0188346419501297,0.00334447982894487,-0.0253898224148616,-0.0122794614853977,1.82141540873201e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0433812790946106,0.00770649703665923,-0.0584860132864627,-0.0282765449027585,1.84664718393861e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0180683291358248,0.00321138359544627,-0.0243626409828995,-0.0117740172887501,1.8721348548969e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0252871787280036,0.00449577641591632,-0.0340989005031996,-0.0164754569528076,1.89658744534e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0374941925755855,0.00666746529954199,-0.0505624245626878,-0.0244259605884832,1.90886551956184e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,37162,-0.0119117198675511,0.00212115737333231,-0.0160691883192824,-0.00775425141581975,1.99723603180521e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0316318294703232,0.00563517957340699,-0.0426767814342009,-0.0205868775064455,2.01846956952684e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0341612707985905,0.00608591759987446,-0.0460896692943444,-0.0222328723028366,2.02563567441909e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00472144730159914,0.000843499528689527,0.00306818822536767,0.00637470637783061,2.21053558435252e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0149598728136294,0.00267332873210155,-0.0201995971285484,-0.00972014849871037,2.23634492060095e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.0163483093934276,0.00293620907980736,-0.0221032791898501,-0.0105933395970052,2.62974259718923e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.0175183441607904,0.00314964811046156,-0.023691654457295,-0.0113450338642857,2.70951721501566e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0252751346539681,0.00454677054555968,-0.034186804923265,-0.0163634643846711,2.75734720146817e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,37453,0.0117810927889405,0.00211973979349574,0.00762640279368888,0.0159357827841922,2.78334675827044e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.035214103743547,0.00634536219415612,-0.047651013644093,-0.022777193843001,2.9188894883182e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0143309856645384,0.00258863636426163,-0.0194047129384912,-0.00925725839058565,3.15177094639214e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0337236780340021,0.00609820283144606,-0.0456761555836363,-0.0217712004843678,3.25983284389131e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0259817581070807,0.0046989931673064,-0.0351917847150013,-0.0167717314991602,3.26638484136235e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0381053904882366,0.00690133313444975,-0.0516320034317581,-0.0245787775447151,3.41462891356568e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.0130974150983897,0.00237455951454368,-0.0177515517468953,-0.00844327844988411,3.52664543400214e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0413099017273012,0.00748873616565644,-0.0559878246119878,-0.0266319788426146,3.52803821421024e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0373878755435458,0.00677932775695107,-0.0506753579471699,-0.0241003931399217,3.55341366163632e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37037,-0.0221074739337249,0.00401103062812337,-0.0299690939648467,-0.0142458539026031,3.62126329190776e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0255903191416597,0.00464478392208915,-0.0346940956289544,-0.0164865426543649,3.66698327318564e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.076134030655091,0.0138190642822898,-0.103219396648379,-0.0490486646618029,3.66749397208987e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0270958555908898,0.00492580275321673,-0.0367504289871946,-0.017441282194585,3.83972490871711e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0349623635294059,0.00635661921920766,-0.0474213371990529,-0.0225033898597589,3.85298309429522e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0243610357135266,0.00443172460836654,0.0156748554811282,0.033047215945925,3.92307004893272e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,39587,-0.0246520478106093,0.00449478406847789,-0.033461824584826,-0.0158422710363926,4.20822442242444e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0385622712243413,0.00703629352210008,-0.0523534065276575,-0.0247711359210252,4.30581398611708e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0128525370380028,0.00234885363468029,-0.0174562901619762,-0.00824878391402945,4.52071580652993e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37382,-0.0156942092853682,0.0028702734405937,-0.0213199452289319,-0.0100684733418046,4.63625289109468e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0289299782209721,0.00529502895878325,-0.0393082349801873,-0.018551721461757,4.75066757519563e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40058,-0.0281156226970458,0.00515786035691101,-0.0382250289965914,-0.0180062163975002,5.08126799720787e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,36991,-0.0327942910266274,0.00601620015596458,-0.044586043332318,-0.0210025387209368,5.09927209652313e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37124,-0.0167328653454242,0.00307108275030722,-0.0227521875360263,-0.010713543154822,5.16961894462339e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37368,-0.0248132648693234,0.00455531770137706,-0.0337416875640224,-0.0158848421746244,5.20942162496532e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,39868,-0.0338847058955088,0.00622280654439412,-0.0460814067225212,-0.0216880050684963,5.24963746397689e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0312248295483486,0.00576423657669165,0.0199269258580329,0.0425227332386642,6.1484860283234e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.018508817778583,0.00341845681205917,-0.025208993130219,-0.0118086424269471,6.25799744697467e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37437,-0.0427362042595972,0.00791212177025698,-0.0582439629293009,-0.0272284455898936,6.72525944977067e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37340,-0.0238912528196701,0.00442738649768897,-0.0325689303551404,-0.0152135752841997,6.92014961332293e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37382,-0.0181447939683686,0.00336288368928489,-0.024736045999367,-0.0115535419373702,6.94434510154703e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0342894774225059,0.00636310668042071,-0.0467611665161305,-0.0218177883288813,7.21208707134018e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0151975874117478,0.0028231026454763,-0.0207308685968813,-0.00966430622661423,7.4350387122931e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37411,-0.0386229526102737,0.00717479127525353,-0.0526855435097706,-0.0245603617107767,7.44144217986556e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,39573,0.0171090438423324,0.0031801915708812,0.0108758683634052,0.0233422193212595,7.56036225043627e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37138,0.0106757839323028,0.00198453905420338,0.00678608738606412,0.0145654804785414,7.59691886461343e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40052,-0.0280594111100249,0.00522385834605452,-0.0382981734682917,-0.017820648751758,7.92084382012249e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0205417323304861,0.00382619066638783,0.0130423986243659,0.0280410660366062,8.04015277213905e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0185359646850895,0.00345380437018093,-0.0253054212506442,-0.0117665081195349,8.12703877284096e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0340825550047054,0.00637901452615586,-0.0465854234759709,-0.0215796865334399,9.27133504667671e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0402030031751859,0.00753206214306952,-0.0549658449756021,-0.0254401613747696,9.57533440866659e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0283740053412509,0.00531916185561197,-0.0387995625782503,-0.0179484481042514,9.72179802001382e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,37382,-0.0394791444278561,0.00740047483383624,-0.0539840751021752,-0.0249742137535371,9.72574156026123e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0383388685220697,0.00719409302830149,-0.0524392908575406,-0.0242384461865988,1.00269168492683e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0294869518795232,0.0055349710655247,-0.0403354951679516,-0.0186384085910948,1.00991925354158e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0188845914723961,0.0035451362255845,-0.0258330584745417,-0.0119361244702504,1.01547626006863e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,37208,-0.0137772761601758,0.00258753421910484,-0.0188488432296213,-0.00870570909073031,1.02882773746451e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,39843,-0.0168296264060739,0.00316446294096955,-0.0230319737703742,-0.0106272790417736,1.06139494409965e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40058,-0.0173042690216892,0.00325697199363781,-0.0236879341292193,-0.010920603914159,1.09265866894222e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0178043631131875,0.00335147379466968,-0.0243732517507401,-0.011235474475635,1.09642922578987e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0325548460639103,0.00615089512152554,-0.0446106005021004,-0.0204990916257203,1.22152773113975e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0260940261667495,0.00494523101096373,-0.0357866789482384,-0.0164013733852606,1.33346026154722e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,39788,-0.00930530400593248,0.00176680130844213,-0.012768234570479,-0.00584237344138591,1.40664505654668e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0125058501150451,0.00237621984171978,-0.0171632410048159,-0.00784845922527437,1.43617399508269e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.0124972650015508,0.00237593630320719,-0.0171541001558368,-0.00784042984726467,1.46296361952662e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0220983852228979,0.00420257492999229,-0.0303354320856827,-0.013861338360113,1.47274935289605e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0268727101257641,0.00511484449428079,-0.0368978053345545,-0.0168476149169738,1.50857351220926e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0250126999235069,0.00477207003855733,-0.0343659571990793,-0.0156594426479345,1.61695132160208e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0269776668109353,0.00515245387825028,-0.0370764764123058,-0.0168788572095648,1.6671856800902e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0629996326008302,0.0120347549942458,-0.0865877523895519,-0.0394115128121085,1.67243380504082e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0147379496942521,0.0028200271462845,0.00921069648753446,0.0202652029009697,1.75202449125372e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.023990155479573,0.0045920900772798,-0.0329906520310414,-0.0149896589281046,1.77063509820479e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.00796477082862943,0.00152615553947975,-0.0109560356860097,-0.00497350597124912,1.82691378195705e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.01453764649936,0.00278724888147004,-0.0200006543070413,-0.00907463869167873,1.85313797469075e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.022968797002012,0.0044054391099694,-0.031603457657552,-0.0143341363464719,1.87796931931085e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,39682,0.032666403910087,0.00627089277815614,0.020375454064901,0.0449573537552731,1.92024288390076e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0194704271885773,0.0037415942307485,-0.0268039518808443,-0.0121369024963102,1.98122382286334e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,39739,-0.0283075573694903,0.00545258780280791,-0.0389946294629938,-0.0176204852759868,2.11086708001887e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0372878347827187,0.0071916270402339,-0.0513834237815772,-0.0231922457838603,2.19253951456765e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37437,0.0146807493107262,0.00283166013961085,0.00913069543708897,0.0202308031843635,2.1970302324452e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,39749,-0.0162523961553564,0.00313540019716313,-0.0223977805417962,-0.0101070117689167,2.20409970518713e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0301786320088807,0.00582705018759554,-0.041599650376568,-0.0187576136411935,2.25777940686417e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0316069306833342,0.0061043345359527,-0.0435714263738015,-0.0196424349928669,2.27244352077714e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0108618003105677,0.00210024324565929,-0.0149782770720599,-0.00674532354907545,2.35288336195863e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0234022039803347,0.00452541672187572,-0.0322720207552111,-0.0145323872054582,2.3581228351605e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0144853185984631,0.00281021652046508,0.00897729421835154,0.0199933429785747,2.57363336081601e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0458790519777888,0.00890236799312798,-0.0633276932443197,-0.028430410711258,2.58627578141964e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37382,-0.0160287097240482,0.00311456065606985,-0.0221332486099451,-0.00992417083815131,2.69284031361088e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0403444564046378,0.00784382660819033,-0.0557183565566908,-0.0249705562525847,2.73490616538238e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0265835041725649,0.00517345198496083,-0.0367234700630881,-0.0164435382820416,2.80912330768471e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0140545241572836,0.00273553864047603,-0.0194161798926166,-0.00869286842195054,2.81333357547315e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0205107006251411,0.00399250104772181,0.0126853985716064,0.0283360026786759,2.82683834493868e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40009,0.010930851949962,0.00212810342902546,0.00675976922907206,0.0151019346708519,2.83266215131067e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0140261017614352,0.00273326219005591,-0.0193832956539448,-0.00866890786892563,2.90681302320211e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,37021,-0.0188681667717796,0.0036785102572519,-0.0260780468759933,-0.0116582866675659,2.94962442983349e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,39866,-0.0313233934784027,0.00610769980715055,-0.0432944851004178,-0.0193523018563876,2.95454008006906e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0236823290095982,0.0046191206437206,-0.0327358054712906,-0.0146288525479058,2.98418884289744e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,39843,-0.018665120059481,0.00364432466891375,-0.025807996410552,-0.0115222437084101,3.06321591191344e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0235753762272565,0.00460433119587041,-0.0325998653711625,-0.0145508870833505,3.08642602741772e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0373154230723599,0.00729842771209255,-0.0516203413880612,-0.0230105047566585,3.21073548678932e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,39788,0.0135702952352002,0.00265499356942568,0.00836650783912591,0.0187740826312746,3.23764609360672e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0209958220543342,0.004119101156802,-0.0290692603216661,-0.0129223837870022,3.48669239067106e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,37388,-0.0402421696595916,0.00789628448426732,-0.0557188872487556,-0.0247654520704277,3.50948280873063e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,39788,-0.0282341832583583,0.0055545462537546,-0.0391210939157173,-0.0173472726009992,3.7557739722846e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.0144989221336165,0.00285450594909195,-0.0200937537938367,-0.00890409047339623,3.83982225063052e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,39686,-0.023967252877236,0.00471976283473808,-0.0332179880333226,-0.0147165177211493,3.85633470784337e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0284904364028138,0.00561342466253371,-0.0394927487413799,-0.0174881240642477,3.91014531002164e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,37453,-0.0343699047411122,0.00679374955528498,-0.0476856538694708,-0.0210541556127536,4.26850821768709e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0511541383375285,0.0101117934202742,-0.0709732534412658,-0.0313350232337911,4.27307670889066e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0130766015301641,0.00258575846565577,-0.0181446881228494,-0.00800851493747876,4.3025526010573e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0185269770914459,0.00367405434893316,0.0113258305675369,0.0257281236153549,4.64144729319499e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39489,-0.0290819637284098,0.00577023575904185,-0.0403916258161318,-0.0177723016406878,4.70743127765754e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0349970677844346,0.00694394758223396,-0.0486072050456131,-0.021386930523256,4.71795737215272e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0266612548605548,0.00530248571016441,-0.037054126852477,-0.0162683828686326,5.0082911974413e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.03313647198616,0.00659117400088826,-0.046055173027901,-0.020217770944419,5.03710779055851e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0120269266653574,0.00239374834826105,0.00733517990276576,0.0167186734279491,5.10697701594431e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0290970573011209,0.00579871296518123,-0.0404625347128761,-0.0177315798893657,5.29356994201604e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,37043,-0.0132160930023535,0.00263626494178211,-0.0183831722882464,-0.00804901371646052,5.42305314954793e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0426943568123297,0.00851814354914491,-0.0593899181686537,-0.0259987954560057,5.45011744173844e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0223106821312651,0.00445354097595013,-0.0310396224441274,-0.0135817418184029,5.52141597885496e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0575134380714813,0.0114814637824154,-0.0800171070850155,-0.0350097690579471,5.52452491362818e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0170090676142991,0.00339769263904633,-0.0236685451868299,-0.0103495900417683,5.6270876692221e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0404540463115263,0.00808975212789798,-0.0563099604822064,-0.0245981321408463,5.78665491081153e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,39931,0.014074674237552,0.00281783036415376,0.00855172672381065,0.0195976217512934,5.94954994837996e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,37382,-0.0484339586786229,0.00969975772450379,-0.0674454838186503,-0.0294224335385954,6.00909603942072e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0413133788477673,0.00828418956419059,0.0250763673019537,0.0575503903935808,6.19615893451994e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,39587,-0.0533461376189338,0.0107113480005492,-0.0743403797000103,-0.0323518955378573,6.41460883043778e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0269054273270496,0.00540294670813985,-0.0374952028750037,-0.0163156517790955,6.44666274468169e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0473241704369511,0.00950430489759569,-0.0659526080362386,-0.0286957328376635,6.45052362249708e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,39713,0.022120426956951,0.00444324351872328,0.0134116696602533,0.0308291842536486,6.47714917487937e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0167725834979985,0.00337896164362778,-0.023395348319509,-0.010149818676488,6.99587847263894e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0463921327428699,0.0093686289271038,-0.0647546454399933,-0.0280296200457464,7.43943806319709e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0175014182025707,0.00353520187605148,-0.0244304138796316,-0.0105724225255098,7.48713681758114e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0259516087459385,0.00524367561862827,-0.0362292129584499,-0.0156740045334271,7.5459779139485e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0337005726331064,0.00681018200189211,-0.0470485293568149,-0.0203526159093978,7.55232072959402e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0408904573896213,0.00826764486125357,-0.0570950413176783,-0.0246858734615643,7.67289150596499e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0288240844697815,0.00582852629993842,0.0174001729219022,0.0402479960176608,7.69517939411403e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0324864042324973,0.00658036037151237,-0.0453839105606615,-0.0195888979043331,8.02054474325488e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0234191599489705,0.00475460923228342,-0.032738194044246,-0.014100125853695,8.49522645269472e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0320413333584676,0.00650669911079612,-0.044794463615628,-0.0192882031013072,8.56637005322679e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0410887864078991,0.00835056096106872,-0.0574558858915938,-0.0247216869242044,8.73477232194556e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,39985,-0.0321611429982301,0.00653682098956206,-0.0449733121377718,-0.0193489738586885,8.7398833872936e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,39829,-0.0308066533152999,0.00626172359867518,-0.0430796315687032,-0.0185336750618965,8.74792416547799e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0150321266492631,0.00305727212655833,-0.0210243800173174,-0.00903987328120874,8.88438962080243e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0320373642213806,0.00652340368658612,-0.0448232354470894,-0.0192514929956718,9.16262863772976e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.020976300282465,0.00427172877322571,-0.0293488886779874,-0.0126037118869426,9.1739313673314e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0152617271933551,0.00310845590901618,-0.0213543007750268,-0.00916915361168342,9.20905278969101e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0149480726780223,0.0030647264904302,0.00894120875677912,0.0209549365992655,1.08708960041851e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0336319904308131,0.00690451225553554,-0.0471648344516628,-0.0200991464099635,1.12315351117531e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0178315514610819,0.00366217303915052,0.0106536923043469,0.025009410617817,1.13186590680664e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0246548756794844,0.00506715001901135,-0.0345864897167466,-0.0147232616422221,1.15167825353449e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0238330530716783,0.00490335114136973,-0.033443621308763,-0.0142224848345937,1.18148079116866e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.0120016477932674,0.00247142353709075,0.00715765766056957,0.0168456379259653,1.20822013585814e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0244271941915277,0.00503144791120136,-0.0342888320974824,-0.014565556285573,1.21791149146996e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0300294466012777,0.006199207808615,-0.0421798939061631,-0.0178789992963923,1.28422651774457e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0131579526297038,0.00271990768284428,-0.0184889716880786,-0.00782693357132899,1.32835458896672e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0291509133244846,0.00603062536064592,-0.0409709390313506,-0.0173308876176186,1.35170790477816e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.0134596843660608,0.00278581351033516,0.00799948988580393,0.0189198788463178,1.36749362120945e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0130033170151642,0.00269143395969814,0.00772810645415586,0.0182785275761726,1.36837157544216e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0377734449982043,0.00781893773810093,-0.0530985629648821,-0.0224483270315264,1.37092863821843e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0108405214186805,0.00224716482643222,-0.0152449644784876,-0.00643607835887332,1.42172858438357e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,39885,-0.0134478268904443,0.00278808797054174,-0.0189124793127061,-0.00798317446818249,1.42489345663576e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0385303274469843,0.0079978822792095,-0.0542061767142349,-0.0228544781797337,1.46898191707075e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.012929575672031,0.00268607059997901,-0.0181942740479898,-0.00766487729607209,1.49863999454075e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,39858,-0.0290554236758611,0.00603793663429567,-0.0408897794790806,-0.0172210678726415,1.50681801034972e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0190347520785587,0.00396125334633926,-0.0267988086373837,-0.0112706955197338,1.56263019122695e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0182473340021071,0.00379847367433654,-0.0256923424038068,-0.0108023256004075,1.57080168204136e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0402283769187369,0.00837975295011819,-0.0566526927009685,-0.0238040611365052,1.59574502349651e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0472015978499574,0.00983412276225343,-0.0664764784639741,-0.0279267172359407,1.60574392479912e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,37287,-0.0448527040584165,0.00935124668987252,-0.0631811475705666,-0.0265242605462663,1.63244479661057e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,37043,-0.0233022110087192,0.0048634091966945,-0.0328344930342404,-0.013769928983198,1.67482703247098e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,39790,-0.018289766390209,0.00382136220674112,-0.0257796363154216,-0.0107998964649964,1.71502423004811e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0272843881860505,0.00570773464522308,-0.0384715480906877,-0.0160972282814133,1.76970448825583e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0347448440461388,0.00727389872076117,-0.0490016855388307,-0.0204880025534469,1.79823151791235e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0289030630671865,0.00605800329306407,-0.0407767495215921,-0.0170293766127809,1.84920180062416e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0197624241625664,0.0041425114640283,-0.0278817466320619,-0.0116431016930709,1.85614370710975e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,39868,-0.0191891907295726,0.00402386375257873,-0.0270759636846269,-0.0113024177745183,1.86914945770058e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,39858,-0.01106911787565,0.00232221477695136,-0.0156206588384747,-0.00651757691282537,1.88989035409949e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0306373226120814,0.006428758678238,-0.0432376896214279,-0.0180369556027349,1.90239742465005e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,39477,-0.0260107437348048,0.00546193966991454,-0.0367161454878372,-0.0153053419817723,1.9323165795506e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0118242455718377,0.00248333790575408,0.00695690327655966,0.0166915878671157,1.93914827541061e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0303738112085205,0.00638345713963778,-0.0428853872022106,-0.0178622352148305,1.97029834718924e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,39856,-0.0175507914213089,0.00369084212423896,-0.0247848419848173,-0.0103167408578006,1.99951523106614e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,39587,-0.0191952405960471,0.00403689674446255,-0.0271075582151937,-0.0112829229769005,2.00255371069063e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0396480016216917,0.00834479301396162,-0.0560037959290564,-0.0232922073143269,2.04257343593118e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.0221151265313183,0.00465583364353848,0.0129896925899829,0.0312405604726537,2.0519920073043e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,39489,-0.0468633443242002,0.00987465474019653,-0.0662176676149854,-0.027509021033415,2.09500851445225e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.0131174539981841,0.00276404339908022,-0.0185349790603813,-0.00769992893598686,2.09532470172238e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0378515291905665,0.00797682571365592,-0.0534861075893322,-0.0222169507918009,2.10158707041439e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0234462248672502,0.00494504043022273,-0.0331385041104867,-0.0137539456240137,2.14160830948733e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0462582564271603,0.00975660426229123,-0.0653812007812511,-0.0271353120730695,2.14645116225164e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,39585,-0.0375501213383665,0.00792055007993811,-0.0530743994950452,-0.0220258431816878,2.14691136106891e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,39858,0.0139963455578283,0.00295343442551562,0.0082076140838177,0.0197850770318389,2.16615645095639e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0487201761645102,0.010288974686223,-0.0688865665495073,-0.028553785779513,2.20739021655875e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0231596722158297,0.00489861975130185,-0.0327609669283813,-0.013558377503278,2.28883518546422e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0496728594571505,0.0105130297148888,-0.0702783976983326,-0.0290673212159685,2.32193960383441e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0155159242269359,0.00328793465669157,-0.0219602761540513,-0.00907157229982037,2.39389053062395e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,39809,-0.0121187783994569,0.0025682890963669,-0.017152625028336,-0.00708493177057779,2.394656246867e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0418438513703082,0.00887116833996569,-0.0592313413166409,-0.0244563614239754,2.41563217445189e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0270474084002225,0.00574841075319072,-0.0383142934764763,-0.0157805233239687,2.56197953515882e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.032431199626483,0.00689369895000004,-0.0459428495684831,-0.0189195496844829,2.57086405562558e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,39866,-0.0144530443671619,0.00307328665457412,-0.0204766862101271,-0.00842940252419661,2.58762944229762e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0286374008620578,0.00609378631038717,-0.0405812220304166,-0.0166935796936989,2.63442772125238e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.00962094139738351,0.00205151971055104,-0.0136419200300635,-0.00559996276470348,2.76326908793281e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.0181148256408899,0.00386475051431702,-0.0256897366489513,-0.0105399146328286,2.79750093331478e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0172749665112474,0.00368972197879616,-0.0245068215896879,-0.0100431114328069,2.8653682440076e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.00763865126178264,0.00163166526323425,0.0044405873458435,0.0108367151777218,2.87114806985383e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,39489,-0.0342620059160027,0.00733697537392409,-0.0486424776488939,-0.0198815341831115,3.04042062989753e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37124,-0.0478798496449203,0.0102606951083813,-0.0679908120573476,-0.0277688872324929,3.09617304833097e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0199514161277537,0.00427643375850714,-0.0283332262944277,-0.0115696059610797,3.10438014118214e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0377719562377639,0.00809995319626021,-0.0536478645024339,-0.0218960479730939,3.14334847956758e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0200506750850195,0.00430644145717628,-0.028491300341085,-0.011610049828954,3.25600445168247e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,39846,-0.0166760261716774,0.0035850451125245,-0.0237027145922254,-0.00964933775112935,3.32084493033946e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0182610933082805,0.00392930035321289,-0.0259625220005778,-0.0105596646159833,3.38783163197197e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0158897955460958,0.00342790673935898,-0.0226084927552393,-0.00917109833695216,3.59632011396556e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0315516640867507,0.00682189862879863,-0.0449225853991961,-0.0181807427743054,3.77419777552604e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0204658384079558,0.00443048361056953,-0.0291495862846721,-0.0117820905312395,3.88636481796543e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0252507047386513,0.00546649560704821,-0.0359650361284658,-0.0145363733488368,3.88821412389552e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0228844517118901,0.0049573459978031,-0.0326008498675841,-0.013168053556196,3.94362841157015e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0200315967612254,0.00435522757317303,-0.0285678428046445,-0.0114953507178063,4.26960435428786e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0247899504008237,0.00539940790591507,-0.0353727898964173,-0.0142071109052302,4.43985702796134e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0178613371332925,0.00389080633366189,-0.0254873175472698,-0.0102353567193152,4.45947030425052e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0179858029820821,0.00391912371913582,-0.0256672854715883,-0.0103043204925758,4.48330159178109e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,39344,-0.0328828384997867,0.00716800201610607,-0.0469321224513546,-0.0188335545482188,4.5221530196753e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0504724708297978,0.0110185897465736,-0.0720689067330822,-0.0288760349265135,4.6774237224051e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,-0.0424642824949306,0.00927519847612872,-0.0606436715081429,-0.0242848934817183,4.72375655213736e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0144886708766159,0.00316569866100587,-0.0206934402521874,-0.00828390150104437,4.76421701634987e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.00961756919490601,0.00210438794202826,-0.0137421695612814,-0.00549296882853063,4.90805122621034e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0115059614426549,0.0025215485626487,-0.0164481966254463,-0.00656372625986341,5.07862197804209e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0281817840260645,0.00617794283056959,-0.0402905519739809,-0.0160730160781481,5.11232048575234e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,39858,0.010968782973108,0.00240830019198837,0.00624851459681083,0.0156890513494052,5.28792108565319e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0322823688746886,0.00709118293156409,-0.0461810874205542,-0.0183836503288229,5.34132008846698e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0207360525669381,0.00455578617299645,-0.0296653934660112,-0.0118067116678651,5.37076246775821e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0417496728774914,0.00917516904837639,-0.0597330042123091,-0.0237663415426736,5.40384939090587e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,39970,-0.0256211915393239,0.0056328976708157,-0.0366616709741227,-0.0145807121045252,5.44257117699746e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0376362684234504,0.00827715449592038,-0.0538594912354544,-0.0214130456114465,5.4820645426804e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,39866,0.0179731713337932,0.00395716769104604,0.010217122659343,0.0257292200082435,5.61489863870427e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37388,-0.030096165187589,0.00662768934077521,-0.0430864362955084,-0.0171058940796696,5.64784594250415e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0179337337544407,0.00395342309975995,-0.0256824430299703,-0.0101850244789112,5.77552777848625e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.006656703669104,0.00146826301641089,0.00377890815693865,0.00953449918126935,5.83672376051383e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,39859,-0.01336589661027,0.00294897650430249,-0.0191458905587029,-0.00758590266183715,5.87439902488462e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0269264682787315,0.00595050602398297,-0.0385894600857381,-0.0152634764717248,6.08897755095363e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0214379222456696,0.00473866383129111,-0.0307257033550001,-0.012150141136339,6.12000679131014e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0401020317603135,0.00888223206080853,-0.0575112065994983,-0.0226928569211288,6.38115140201763e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0276966273071551,0.00614094599092533,-0.0397328814493688,-0.0156603731649415,6.5241826847675e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,39489,-0.0282120593547442,0.0062612510254548,-0.0404841113646357,-0.0159400073448528,6.65971012942773e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0162753033519222,0.00361250626428803,-0.0233558156299268,-0.0091947910739177,6.68440896317314e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0138210488230272,0.00306859305546081,-0.0198354912117304,-0.00780660643432405,6.7247451544928e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,0.0118338083310548,0.0026280899660961,0.0066827519975064,0.0169848646646031,6.75302604791604e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.015643754087264,0.00348037081042681,-0.0224652808757005,-0.00882222729882743,7.01182614918757e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,39858,0.0193254945127245,0.00430258419418658,0.0108924294921188,0.0277585595333302,7.11842409245839e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,39882,-0.0387915072123959,0.008637937115375,-0.0557218639585309,-0.0218611504662609,7.14415940295441e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,36991,-0.0231068588396358,0.00515558121469343,-0.0332117980204349,-0.0130019196588367,7.46033331322404e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0140556884677721,0.00313658006627173,0.00790799153787951,0.0202033853976647,7.47384453058928e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0230839034596864,0.00515136705820655,-0.0331805828937712,-0.0129872240256015,7.48619393496081e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.0430070942371549,0.00960171472514193,-0.0618264550984331,-0.0241877333758767,7.5570772473132e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0249947467720298,0.00558785364710109,-0.035946939920348,-0.0140425536237117,7.77412386184514e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.0392582270852218,0.00877749196440791,-0.0564621113354613,-0.0220543428349823,7.78054972915956e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0244816531761525,0.00547513597608224,-0.0352129196892737,-0.0137503866630313,7.82333529391165e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,39587,-0.0331467196387026,0.00741498066690844,-0.0476800817458431,-0.0186133575315621,7.86792040205604e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0160429467078448,0.00358926099583518,-0.0230778982596817,-0.00900799515600784,7.88773647509463e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.028443180495732,0.00636351031994537,-0.0409156607228249,-0.0159707002686391,7.89751814753281e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0387585400553281,0.00868594825395477,-0.0557829986330794,-0.0217340814775767,8.17901791746526e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,39563,-0.0205794483992273,0.00461627953599312,-0.0296273562897738,-0.0115315405086808,8.32947847772076e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0316900631406391,0.00711222663316353,-0.0456300273416397,-0.0177500989396386,8.42852503641405e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0349037253396151,0.0078456823436994,-0.050281262733266,-0.0195261879459643,8.69394437842828e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0394372677412887,0.00886628650925579,-0.0568151892994301,-0.0220593461831473,8.73647063904563e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0379412312113241,0.00855058548778104,-0.054700378767375,-0.0211820836552733,9.18463873880711e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0409653123529334,0.00924963402246328,-0.0590945950369614,-0.0228360296689054,9.54740385874593e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0117686633550529,0.00265820206077766,-0.0169787393941771,-0.00655858731592872,9.60547746256017e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,35640,-0.0417219085117257,0.00947699999184801,-0.0602968284957478,-0.0231469885277036,1.07983909995527e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.011413909893738,0.00259621842874755,-0.0165024980140832,-0.00632532177339276,1.10787901795269e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,39619,-0.0174073896450789,0.00397168347444139,-0.025191889254984,-0.00962289003517378,1.1788122382123e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.021145272357574,0.0048319908454693,-0.0306159744146938,-0.0116745703004541,1.21605863397264e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0340520600992316,0.00778165566779296,-0.0493041052081058,-0.0188000149903574,1.2183410295467e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.0234237540231631,0.00535481138063325,-0.0339191843292043,-0.0129283237171219,1.22590710701776e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0344696529387155,0.0078796422151921,0.019025554196939,0.049913751680492,1.22610998159708e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37056,0.0121854857889054,0.00278625450816646,0.0067244269528991,0.0176465446249116,1.23247555432375e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0170816477119176,0.00390612715679681,-0.0247376569392393,-0.00942563848459585,1.23442751224945e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37437,0.00935771279472528,0.0021414883202277,0.00516039568707899,0.0135550299023716,1.25327338116022e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.00950301890489268,0.00217716520996357,-0.0137702627164213,-0.00523577509336409,1.28009574578113e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0254748891653861,0.00583769130777699,-0.036916764128629,-0.0140330142021432,1.28729095691205e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0284562284430384,0.00652970117456204,0.0156580141408968,0.04125444274518,1.32093423850393e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40058,0.0160675449277761,0.00369147108765696,0.0088322615959685,0.0233028282595838,1.35348837654688e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0259332352907892,0.00596319371204472,-0.0376210949663969,-0.0142453756151816,1.37859704773317e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0213310653867058,0.0049146420823063,-0.0309637638680262,-0.0116983669053855,1.43155760347331e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0360586733679937,0.00830816386484079,-0.0523426745430817,-0.0197746721929058,1.43260801137311e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0267864385832536,0.00617497175904992,-0.0388893832309915,-0.0146834939355158,1.44914776400651e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0237508947702944,0.00548664054612623,-0.0345047102407018,-0.012997079299887,1.50810090188322e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0216156868612207,0.0049940508380432,-0.0314040265037854,-0.011827347218656,1.51380264678708e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0404165358009028,0.00933851325482734,-0.0587200217803644,-0.0221130498214412,1.51623480922815e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0196175624117793,0.0045387373542919,-0.0285134876261914,-0.0107216371973672,1.55401044785753e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37187,-0.0101228168981448,0.00234313008307075,-0.0147153518609635,-0.00553028193532614,1.57008715871585e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.0217815902000759,0.00504497121680777,-0.0316697337850192,-0.0118934466151327,1.58770234459436e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,39862,0.00878700608534188,0.00203647847877103,0.00479550826695066,0.0127785039037331,1.60702731046031e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0301129692193239,0.00697938660289854,-0.043792566961005,-0.0164333714776428,1.61080225153845e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00817228231247874,0.00189462621428937,0.00445881493247157,0.0118857496924859,1.61720320864338e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0284256976486318,0.0065962983370146,0.0154969529080832,0.0413544423891804,1.64899250332882e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0240966845569204,0.00559728139484227,-0.0350673560908113,-0.0131260130230296,1.67915994671949e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,39749,-0.058461800249616,0.0135827610745107,-0.0850840119556569,-0.0318395885435751,1.6865607345931e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0246830241631547,0.00573970902331083,-0.035932853848844,-0.0134331944774655,1.71693574670503e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,37039,-0.0176057062321199,0.00409500922942634,-0.0256319243217955,-0.00957948814244426,1.72563789557389e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.0142881596723655,0.00332514622571628,0.00777087306996156,0.0208054462747694,1.741463270238e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0108343572355529,0.00252324558123467,0.00588879589633297,0.0157799185747729,1.76657398937373e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,39913,-0.0253823154263906,0.00591756071966489,-0.0369807344369338,-0.0137838964158474,1.80268279109288e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37095,-0.0572151029641872,0.0133421533273734,-0.0833657234858391,-0.0310644824425352,1.81325254577823e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0128627390775091,0.00299996551289785,-0.0187426714827889,-0.00698280667222935,1.81635561990874e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39238,0.0123988600033956,0.00289684317268194,0.00672104738493898,0.0180766726218522,1.87916512887647e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0107543422218153,0.00251589182968325,-0.0156854902079945,-0.00582319423563615,1.92818213815694e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0525179657058778,0.0123077255297891,-0.0766411077442644,-0.0283948236674911,1.9919827918038e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0309002305905103,0.00724612064211764,-0.0451026270490609,-0.0166978341319597,2.01852058488114e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37382,-0.0227767823016791,0.0053651770783472,-0.0332925293752396,-0.0122610352281186,2.19759118990979e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0159941659232087,0.00377740476629293,-0.0233978792651428,-0.00859045258127453,2.30913916075457e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37411,-0.0115945552771532,0.00273968941656552,-0.0169643465336216,-0.00622476402068478,2.33075224113294e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0238715717662662,0.0056479652569335,-0.0349415836698558,-0.0128015598626765,2.38828305999907e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0275255298815976,0.00651871086193531,-0.0403022031709908,-0.0147488565922044,2.42917698369561e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.0098705535712799,0.00234086663294019,0.00528245497071714,0.0144586521718427,2.49593952363575e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0348855350427431,0.00827571134008854,-0.0511059292693167,-0.0186651408161696,2.50942371870084e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0360646619726909,0.00857134179608937,-0.052864491893026,-0.0192648320523557,2.59556040304667e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,40052,-0.0350482113727717,0.00833786335797199,-0.0513904235543968,-0.0187059991911466,2.6422906718233e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0161223853296028,0.00383629474496951,-0.023641523029743,-0.00860324762946256,2.65571393845103e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0136963170845406,0.00326077142759738,-0.0200874290826315,-0.00730520508644975,2.67969263818128e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0231838910455915,0.00553346010786261,-0.0340294728570022,-0.0123383092341808,2.8104612215608e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0198215143250451,0.0047390725778819,-0.0291100965776937,-0.0105329320723966,2.90093846093921e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.00899347195187571,0.00215431040109003,-0.0132159203380122,-0.00477102356573926,3.00046522052651e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,39885,0.0126748822928957,0.00303742283246965,0.00672153354125524,0.0186282310445363,3.02323893738213e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0289899546734764,0.00695173946852931,-0.0426153640317939,-0.015364545315159,3.06297285716814e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.014233894521788,0.0034191283004287,-0.0209353859906282,-0.00753240305294776,3.16066185257711e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0138339356969972,0.0033241588007813,-0.0203492869465285,-0.00731858444746584,3.17631398146925e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0259129626745486,0.0062434137063161,-0.0381500535389281,-0.013675871810169,3.3354147531535e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.00814973505128531,0.00196626561248699,0.00429585445081081,0.0120036156517598,3.42268384681311e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0176857928860877,0.00428092544260727,-0.026076406753598,-0.00929517901857748,3.62526757427933e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37437,0.0195977549812119,0.0047456724569552,0.0102962369655797,0.0288992729968441,3.6556066064546e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,37437,-0.0101103805414698,0.00245408205966433,-0.0149203813784119,-0.0053003797045277,3.81414116113071e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0338233821373768,0.00823012474046334,-0.049954426628685,-0.0176923376460687,3.98492807563305e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0129315172053475,0.00315026472944577,-0.0191060360750612,-0.00675699833563374,4.06499385114141e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0460771248572143,0.0112277060447242,-0.0680834287048737,-0.0240708210095548,4.08732644555797e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,39477,-0.0284576601728341,0.00693968032193655,-0.0420594336038298,-0.0148558867418385,4.13958818108638e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.014349583616563,0.00350398864483526,-0.0212174013604401,-0.0074817658726859,4.23851580067802e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0285295795341365,0.00697053540786481,-0.0421918289335515,-0.0148673301347214,4.28184430331278e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.00933752085675376,0.00228307753495875,0.00486268888823461,0.0138123528252729,4.33702055857849e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,39615,-0.0286197883703584,0.00701314027872003,-0.0423655433166496,-0.0148740334240671,4.50864658142471e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0277862817976618,0.00681542921534538,-0.0411445230597387,-0.0144280405355848,4.58473753148091e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,39489,-0.0148993919614913,0.0036583670538313,-0.0220697913870006,-0.00772899253598194,4.67025138144978e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0227349192802329,0.00558353056858717,-0.0336786391946637,-0.011791199365802,4.68799210769675e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39477,-0.022028035147083,0.00542492020078732,-0.0326608787406261,-0.0113951915535398,4.92008828092003e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0194280718663495,0.00478640217902488,-0.0288094201372383,-0.0100467235954608,4.9520458150005e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0101272411484497,0.00249508336411226,0.00523687775478966,0.0150176045421097,4.95931658734294e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,39788,-0.0158872364096523,0.00391479988462986,-0.0235602441835268,-0.00821422863577777,4.96777720872438e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,37056,-0.0122086925310136,0.00301027498466316,-0.0181088315009534,-0.00630855356107385,5.02773936652775e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.0214104257666402,0.00528112706598273,-0.0317614348159663,-0.0110594167173141,5.06087807375979e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,37056,-0.0199217952717692,0.00491646062866243,-0.0295580581039476,-0.0102855324395908,5.10593970038623e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,39585,-0.0190524219162349,0.00470255713693214,-0.0282694339046219,-0.00983540992784794,5.11342226867255e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,37453,-0.0116720431291219,0.00288568460984382,-0.0173279849644158,-0.00601610129382799,5.26550286977506e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0113187249714273,0.00280396152933888,-0.0168144895689315,-0.00582296037392307,5.45079980400425e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40030,-0.0101907174171855,0.0025264657344565,-0.0151425902567203,-0.00523884457765079,5.51843063061899e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37382,-0.0170592684332728,0.00423719206410744,-0.0253641648789234,-0.00875437198762223,5.70241310560095e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0371799238442123,0.00924114126045845,-0.0552925607147109,-0.0190672869737138,5.77080927912274e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0229717916642707,0.00571419152333119,0.0117719762785415,0.0341716070499998,5.84801600324843e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0111293075918749,0.00277133056241423,-0.0165611154942068,-0.00569749968954302,5.9495674442394e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0289179665814937,0.0072084414681081,-0.0430465118589856,-0.0147894213040018,6.05688232288891e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0361228826268608,0.00901795908005028,-0.0537980824237593,-0.0184476828299622,6.21244240219781e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0186934906518553,0.00466694052768472,-0.0278406940861173,-0.00954628721759322,6.22227797295235e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0172639459698724,0.00432016053999448,-0.0257314606282616,-0.00879643131148321,6.47351817520729e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0222234751916814,0.00556163120223416,-0.0331242723480603,-0.0113226780353024,6.47558252792789e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.041916535423085,0.0104918857392583,-0.0624806314720313,-0.0213524393741386,6.49509598731347e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.01806571904922,0.00452992287932428,-0.0269443678926955,-0.00918707020574437,6.6968380506437e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0171772859562375,0.00431053397409675,-0.0256259325454671,-0.00872863936700785,6.78467566543176e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0100510851559504,0.00252252489339212,0.00510693636490185,0.014995233946999,6.79689198270272e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0163159189987972,0.0040964170320164,-0.0243448963815493,-0.00828694161604505,6.84152497602719e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0122282469620105,0.00307341688376942,-0.0182521440541985,-0.00620434986982243,6.95942422169155e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0191977981360268,0.00483305387946426,-0.0286705837397767,-0.00972501253227684,7.15348130177511e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0140916719848568,0.00354938928907344,-0.0210484749914407,-0.00713486897827283,7.21927320280065e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0179156108018662,0.00452165669592703,-0.0267780579258831,-0.00905316367784918,7.45988158372809e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.00812759423965463,0.00205178110529476,-0.0121490852060324,-0.00410610327327689,7.49427170774187e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0208180432851192,0.00525597670848835,0.010516328936482,0.0311197576337564,7.50090819822357e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,39779,-0.0108013217538864,0.00272742486223584,-0.0161470744838686,-0.00545556902390413,7.51928539881841e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0325398358493302,0.0082320690715841,-0.048674691229635,-0.0164049804690253,7.76441545501689e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0197948035451724,0.00501557107194637,-0.0296253228461873,-0.00996428424415752,7.96449204052195e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,37039,-0.0163258153471017,0.00414429683477461,-0.02444863714326,-0.0082029935509435,8.21254444706993e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0235805452112719,0.00599103859928157,-0.0353229808658638,-0.01183810955668,8.32115552509626e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,39866,0.0217884254455707,0.00553822134422229,0.010933511610895,0.0326433392802464,8.3829465158992e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0216345808260065,0.00550182053239889,-0.0324181490695083,-0.0108510125825047,8.45093063858706e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,39866,-0.0250718927364816,0.00640260729986532,-0.0376210030442176,-0.0125227824287456,9.0445655545481e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0237761017846617,0.0060857986214623,0.0118479364865955,0.0357042670827278,9.39062838559084e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00895982154453793,0.00229621311407552,-0.0134603992481259,-0.00445924384094991,9.58613227189444e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,37445,-0.0335370976149697,0.00860596366788938,-0.0504047864040328,-0.0166694088259065,9.78751052023685e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0176456468654509,0.00453271448441679,-0.0265297672549078,-0.00876152647599401,9.95084871593464e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.011888210755847,0.00306093519381737,-0.017887643735729,-0.00588877777596493,0.000103229017846769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.0311131779415308,0.00801093257332368,-0.0468146057852452,-0.0154117500978164,0.000103308127556779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0186420488442392,0.00480325426956569,-0.028056427212588,-0.00922767047589043,0.000104400056012513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.0101949248409687,0.00262772030656777,-0.0153452566418416,-0.00504459304009589,0.000105068012014481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0218187184940211,0.00562412042704052,-0.0328419945310205,-0.0107954424570217,0.000105184715891975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0151862950635895,0.00392244473363458,-0.0228742867415132,-0.00749830338566568,0.000108529824288021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00857506216784148,0.00221519963539695,-0.0129168534532195,-0.00423327088246347,0.000108814693494723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.00819953996919892,0.00211837123197876,-0.0123515475838773,-0.00404753235452055,0.000108969771812462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,36654,-0.0447475164307933,0.0115604505380204,-0.0674059994853132,-0.0220890333762733,0.000109043818501975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.015099517845662,0.00390263197050152,-0.022748676507845,-0.00745035918347906,0.00010977833855892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0340187863118407,0.00880176772542923,-0.051270251053682,-0.0167673215699994,0.000111526075457694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0407555613141821,0.0105608122143966,-0.0614547532543994,-0.0200563693739648,0.000114248174387497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0230220970221863,0.00596852826329527,-0.034720412418245,-0.0113237816261275,0.000115115212762697
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0152959193028292,0.00396667636650558,-0.0230706049811801,-0.00752123362447827,0.000115741953624389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,37056,-0.0178451739561274,0.00463120673567758,-0.0269223391580554,-0.00876800875419932,0.000117114551625834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0288189704929974,0.00748940100915989,-0.0434981964709508,-0.014139744515044,0.000119566415128525
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,39788,-0.0299259592657758,0.00778301168517345,-0.0451806621687157,-0.0146712563628358,0.000121003669474891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0176835105502028,0.0046123401129175,0.00864332392888449,0.0267236971715211,0.000126682715517088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0119374215126589,0.0031155229624481,0.00583099650626062,0.0180438465190572,0.000127801916053469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.00935101945220105,0.00244478001313823,-0.014142788277952,-0.00455925062645012,0.000131323923672232
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,39858,-0.0276208839672066,0.00723900856230767,-0.0418093407493297,-0.0134324271850836,0.000136384650592262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0171242453217021,0.00448860156638212,-0.025921904391811,-0.00832658625159313,0.000136760486004393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37043,-0.0185819444356264,0.0048736421606588,-0.0281342830705176,-0.00902960580073516,0.000138058924964052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.00817771479740443,0.0021484598250051,-0.0123886960544144,-0.00396673354039443,0.000141574850121928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,40009,-0.012344703969113,0.00324337318580873,-0.0187017154132982,-0.00598769252492792,0.000141678688863781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.00890302483832717,0.00233966480872856,-0.0134887678634351,-0.00431728181321918,0.000142182400567778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0243306771521214,0.00639749197846646,-0.0368697614299156,-0.0117915928743271,0.000143406648337012
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0365616067388001,0.00961782007614074,-0.055412534088036,-0.0177106793895643,0.000144502924926223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.00950412427272035,0.00250301566369776,-0.014410034973568,-0.00459821357187275,0.000146950929208168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REN,Renin,39868,-0.0234562712927036,0.00617810517608295,-0.0355653574378261,-0.011347185147581,0.000147189659497411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0177448076968104,0.00469080748337525,-0.0269387903642259,-0.00855082502939492,0.00015568618128895
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00874444919630907,0.00231324937922175,0.00421048041303443,0.0132784179795837,0.000157297699366403
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,37249,0.0110864541580009,0.00293562975651919,0.00533261983522334,0.0168402884807785,0.000159724907224944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0107818322621772,0.00285595680744377,0.00518415691958744,0.016379507604767,0.000160579651744052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,39731,0.0101662695112228,0.00269347012505228,0.00488706806612033,0.0154454709563253,0.000160968512437128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.00862510112727306,0.00228546011324185,-0.0131046029492271,-0.00414559930531904,0.000161294112147535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37056,-0.0138165308501239,0.0036694242698911,-0.0210086024191104,-0.00662445928113731,0.000167062453679235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,39866,-0.0109893685866355,0.00291872940056378,-0.0167100782117405,-0.00526865896153045,0.000167063951548748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.010032416638445,0.00266586128223802,0.00480732852525852,0.0152575047516316,0.000168413180844871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.0163005069023787,0.00433800329274324,-0.0248029933561555,-0.00779802044860201,0.000172150955307349
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37043,-0.0303581519310376,0.00808373479618268,-0.0462022721315557,-0.0145140317305196,0.000173766828730866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0141442918851765,0.00376800112383582,-0.0215295740878947,-0.00675900968245834,0.000174929921701056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.025870784228197,0.00690434934800607,-0.0394033089502889,-0.0123382595061051,0.000179586359735426
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0420660186664539,0.0112479770230085,-0.0641120536315506,-0.0200199837013571,0.000184753514792005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0142225771060978,0.00380448198865108,-0.0216793618038539,-0.00676579240834172,0.000185978744928451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,40052,0.00936269435047896,0.00251205173948246,0.00443907294109335,0.0142863157598646,0.000194346618174928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0221332243904606,0.00594971282435676,-0.0337946615261998,-0.0104717872547213,0.000200012098168549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0218270328907057,0.00587042424148772,-0.0333330644040216,-0.0103210013773898,0.000201383121766867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0104183143715938,0.002804021626447,-0.0159141967594299,-0.00492243198375766,0.000203494114193868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,39868,-0.0241414405426334,0.00649959516710087,-0.0368806470701511,-0.0114022340151157,0.000204459962776882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0237340405860866,0.00639623017866128,-0.0362706517362627,-0.0111974294359105,0.000207569750217279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0158818275216462,0.00428499920683988,-0.0242804259670524,-0.00748322907624006,0.000211106381526762
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0349539105763916,0.00943742720204941,-0.0534512678924084,-0.0164565532603747,0.000213146257791736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.00956459828154464,0.00258395445573785,-0.0146291490147908,-0.00450004754829846,0.000215146021138185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,37453,0.00947341865262446,0.00256029834009855,0.00445523390603129,0.0144916033992176,0.000216345112661056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0116203380206672,0.00314307043697636,-0.0177807560771409,-0.00545991996419355,0.000218909795574091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37124,-0.0116534392818658,0.00316167915555982,-0.017850330426763,-0.00545654813696853,0.000228858972908424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0223558620489783,0.00606550919800838,-0.0342442600770747,-0.0104674640208818,0.00022895638051479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0151802794499564,0.00411911021241945,-0.0232537354662985,-0.00710682343361426,0.000229178508930394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,39419,-0.0237101393593934,0.00643739455000551,-0.0363274326774042,-0.0110928460413826,0.000231114563090504
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0282830128334099,0.00768159532081006,-0.0433389396621977,-0.0132270860046222,0.000232245936310392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0159990538150212,0.00435249174034174,-0.024529937626091,-0.00746817000395138,0.000237847740002652
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.00979478851017696,0.00266519323395009,-0.0150185672487191,-0.00457100977163479,0.000238556826892747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,37453,0.00763968871494901,0.00208286992253052,0.00355726366678919,0.0117221137631088,0.000245516461395588
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00703119283268322,0.00192021349595988,-0.0107948112847646,-0.00326757438060186,0.000251372901343054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.0108271781810668,0.00295909663851608,-0.0166270075925583,-0.0050273487695753,0.000254070885065893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0293261294937284,0.00801711091157666,-0.0450396668804187,-0.0136125921070382,0.000255063903093834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0340887735393062,0.0093297888965951,-0.0523751597766326,-0.0158023873019798,0.000259407021632986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0143634208613517,0.00394544254344583,-0.0220964882465056,-0.00663035347619792,0.000273110155537501
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.00947797155063845,0.00261012150185072,0.00436213340701104,0.0145938096942659,0.000283136202208451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,39703,-0.015453928916672,0.00425606504596675,-0.0237958164067668,-0.00711204142657713,0.000283174862558186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.011259995725228,0.00310301444434286,-0.01734190403614,-0.00517808741431596,0.0002857066585739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0130397253072175,0.00360048769923834,-0.0200966811977246,-0.00598276941671032,0.0002937945695017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.032686088505188,0.00903729828020985,-0.0503991931343993,-0.0149729838759767,0.000299354949055734
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0164113762557069,0.0045418998261496,-0.0253134999149601,-0.00750925259645367,0.000303239959103323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0149686479418949,0.0041436036607507,-0.0230901111169663,-0.00684718476682352,0.000304244652441227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.0217466056773249,0.00602948050703727,-0.033564387471118,-0.00992882388353184,0.000311041708775631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,0.00902522634403921,0.00250254653840765,0.00412023512876021,0.0139302175593182,0.000311396042156958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40009,-0.0390297365580651,0.0108313318506147,-0.0602591469852698,-0.0178003261308603,0.000315012714654372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.00927454629589797,0.00257500558681649,0.00422753534573766,0.0143215572460583,0.000317026890768842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.00804291967329741,0.0022333165855456,0.00366561916562802,0.0124202201809668,0.000317544995633249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.00792061616445919,0.00220179812240286,-0.0122361404843688,-0.00360509184454959,0.000322445933526414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0153110530358958,0.00425856517724647,-0.0236578407832989,-0.00696426528849271,0.000325102519745466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0140523156525169,0.00391454143926559,-0.0217248168734775,-0.00637981443155637,0.000331951389875452
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0272190238694839,0.00760161326268847,-0.0421181858643533,-0.0123198618746145,0.00034372765660765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0161549118391609,0.00451307020092995,-0.0250005294329836,-0.00730929424533824,0.00034534316747744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0256360816615251,0.00716522694476735,-0.0396799264732691,-0.0115922368497811,0.000347469698010945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,40030,-0.00833151135021972,0.00233432495589046,-0.012906788263765,-0.00375623443667442,0.000359204751947201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.014241277239755,0.00399699450873121,0.00640716800264185,0.0220753864768682,0.000367707207837407
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,39866,-0.0314469092818199,0.00882888257463105,-0.0487515191280968,-0.0141422994355431,0.000369359222929117
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0398446494913918,0.0112292505294883,-0.0618539805291888,-0.0178353184535947,0.000389079062020423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40052,0.00778483022913801,0.00219511086318094,0.00348241293730337,0.0120872475209726,0.000391575518550951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0229075352759547,0.00646789196998663,-0.0355846035371285,-0.0102304670147809,0.000398849436025427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,39587,-0.0112160170204937,0.00317444976369372,-0.0174379385573334,-0.00499409548365398,0.000411713885486994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0166344281435262,0.00470936382082846,-0.02586478123235,-0.0074040750547024,0.000413270488815213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40002,-0.00886506503540926,0.00252250860766426,-0.0138091819064312,-0.0039209481643873,0.000441981356956726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,39908,-0.00951809048867987,0.00271317729647731,-0.0148359179897754,-0.00420026298758435,0.000452558433748314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0085851360565288,0.00244805285670772,0.00378695245738167,0.0133833196556759,0.000454780771361944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0236380887177693,0.00674980119274927,-0.0368676990555578,-0.0104084783799807,0.000463190228929965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0137736665573058,0.00394933689603918,-0.0215143668735425,-0.00603296624106896,0.000488944069591157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0133949175276239,0.0038462334855296,-0.0209335351592619,-0.0058562998959859,0.000497908855100369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.0118699462089408,0.00340826207183394,-0.0185501398697353,-0.00518975254814626,0.00049795926971013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.013069637020013,0.00375639970650414,-0.0204321804447612,-0.00570709359526493,0.000504098333814131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00872211113027426,0.0025074503422188,-0.0136367138010231,-0.00380750845952542,0.000505616576706765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0225712356552763,0.00649704838191998,0.0098370208267131,0.0353054504838394,0.000514014362827439
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,39858,-0.0395180237298259,0.0114406612115668,-0.0619417197044969,-0.0170943277551549,0.000553412932528904
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.015867003177759,0.00459561301206446,-0.0248744046814054,-0.00685960167411269,0.000556818601816997
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.0131213430161262,0.00380497446443823,-0.0205790929664251,-0.00566359306582727,0.00056525749985208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.0116257485804712,0.00337258291443981,-0.0182360110927732,-0.00501548606816917,0.000568047084340352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0234473960899674,0.00682299603557702,-0.0368204683196984,-0.0100743238602365,0.000590762171790372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0168670130865906,0.00491344738958344,-0.0264973699701741,-0.007236656203007,0.000599159094028706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.019810054122153,0.00577286273297596,-0.0311248650787859,-0.00849524316552009,0.000601648023621387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.016141529104259,0.00471668063396694,-0.0253862231468342,-0.00689683506168381,0.000622954451974841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0277921408276093,0.00812845800793967,-0.0437239185231711,-0.0118603631320476,0.000630139414158045
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0102338729939861,0.00299851984525129,-0.0161109718906787,-0.00435677409729359,0.000644454528773615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0207011714199032,0.00606853423994649,-0.0325954985301984,-0.00880684430960814,0.000648625432538068
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.00655652285220579,0.00192238847098682,-0.01032440425534,-0.00278864144907163,0.000649779116505463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00592876902745005,0.00173863206733936,-0.00933648787943519,-0.00252105017546491,0.00065147072085232
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.00967342476183922,0.00283742143905605,-0.0152347707823891,-0.00411207874128936,0.000653085201604013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,39931,-0.0114734591374109,0.00336551305804033,-0.0180698647311699,-0.00487705354365184,0.000653313350583455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0122420781180816,0.00359586990801139,-0.0192899831377839,-0.00519417309837926,0.000664821368079164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.022534807844767,0.00662871504596211,-0.0355270893348527,-0.00954252635468124,0.00067654370441327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.022896159302063,0.00674067647364376,-0.0361078851904047,-0.0096844334137212,0.000683994076085734
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00659230507267268,0.00194165261871493,-0.0103979442053539,-0.00278666593999143,0.000687450482494189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0114901321746336,0.00338792547087655,-0.0181304660975516,-0.00484979825171556,0.000697118408997767
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,39799,0.011251089932304,0.00332423357876558,0.0047355921179235,0.0177665877466846,0.000714625578359472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,39585,-0.0237692505268093,0.00703144836127483,-0.037550889314908,-0.00998761173871067,0.000725510925980685
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0137596726797618,0.00407361661412208,-0.0217439612434411,-0.00577538411608252,0.000732594551838168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0162376296538036,0.00480998628509337,-0.0256652027725866,-0.00681005653502057,0.000737762500040645
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0194536139822341,0.00576294075225884,-0.0307489778566615,-0.00815825010780682,0.000738568009402714
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.0104715845509075,0.00310464362114462,-0.016556686048351,-0.00438648305346404,0.000745632259314243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.00834838668475573,0.00247761523248953,-0.0132045125404352,-0.00349226082907625,0.000755074343143576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0220685093214702,0.0065589024003234,-0.0349239580261041,-0.00921306061683636,0.000768174898697812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.026270828552228,0.00780988488920824,-0.0415782029350762,-0.0109634541693799,0.000770630111243162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.027796447698013,0.00826736395901537,-0.0440004810576832,-0.0115924143383429,0.000775072749200183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37420,0.0112221801570833,0.00334472879932527,0.00466651171040581,0.0177778486037609,0.000795298212758551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.0179464168553662,0.0053559247965495,-0.0284440294566033,-0.00744880425412922,0.000808165064725397
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0181406201434488,0.0054140951937721,-0.0287522467232421,-0.00752899356365549,0.000808195377757181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37021,0.0114731493926416,0.00342488315185085,0.00476037841501395,0.0181859203702693,0.000810565224304446
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37411,-0.0114765929514598,0.00342733052784378,-0.0181941607860336,-0.00475902511688594,0.000814565336425433
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,37252,-0.0165907051807714,0.00495561009366764,-0.0263037009643599,-0.00687770939718279,0.000816615521240768
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39478,-0.0175111556582177,0.00523117450970978,-0.0277642576972488,-0.00725805361918652,0.000817478658401168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,37169,0.0103447614601401,0.00309153437080666,0.00428535409335906,0.0164041688269211,0.000821665346564856
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0192461153380549,0.00575622074763178,-0.0305283080034131,-0.00796392267269657,0.000829425160674683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.00997948909406107,0.00298641042886472,-0.0158328535346359,-0.00412612465348622,0.000835121804263318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0119287943495751,0.00357130755786358,-0.0189285571629877,-0.00492903153616248,0.000839555890697691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0297285195504904,0.00890084778440504,-0.0471741812079243,-0.0122828578930566,0.000839813528667846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0252533390714897,0.00756121300075479,-0.0400733165529691,-0.0104333615900103,0.000840135424167054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.0110338306844749,0.0033049814451538,-0.0175115943169763,-0.00455606705197345,0.00084445220205792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.01466392313655,0.0043989564481208,-0.0232858777748668,-0.00604196849823328,0.00085959943463676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0184334974959984,0.00553197495239308,-0.0292761684026889,-0.00759082658930798,0.000864016504015779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00676457223523179,0.0020353847211392,-0.0107539262886646,-0.00277521818179896,0.00089100357386162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,36763,-0.00733925789110919,0.00220883360287351,-0.0116685717527413,-0.00300994402947711,0.000894035119680325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0167704325127746,0.00506001405723573,-0.0266880600649566,-0.00685280496059251,0.000920760615083172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.0119400067877389,0.00360285312392231,-0.0190015989106267,-0.00487841466485121,0.000921667301334259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,39477,-0.0211131196193719,0.00639505679965245,-0.0336474309466907,-0.00857880829205309,0.00096393694250333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,39490,-0.0130804480720182,0.00396410531331337,-0.0208500944861124,-0.00531080165792404,0.000969969297483383
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.00866316664054918,0.00263487387000687,0.00349881385533571,0.0138275194257626,0.00101158134861606
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0145549118817134,0.00443004405356993,-0.0232377982267104,-0.00587202553671631,0.00102021835904867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39123,-0.00863872265883671,0.00263102258813937,-0.0137955269315899,-0.00348191838608354,0.00102790513741113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0085969147405976,0.0026268515900286,-0.0137455438570536,-0.00344828562414155,0.00106747018008768
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0136002186125501,0.004157576725582,-0.0217490689946908,-0.00545136823040939,0.00107364447505858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0164630287747029,0.00503329245997017,-0.0263282819962444,-0.00659777555316135,0.00107500838961101
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,36962,0.014337171192683,0.00438938575609414,0.00573397511073852,0.0229403672746276,0.00109232236616735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0189645534821438,0.00581037888610979,-0.030352896098919,-0.00757621086536865,0.00110166032825328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.00823721637714152,0.00252887861467829,-0.013193818461911,-0.00328061429237207,0.0011272531565823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0107542207207547,0.00330167829635241,-0.0172255101816055,-0.004282931259904,0.00112757938449019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.016082896441724,0.00493959035787502,-0.025764493543159,-0.00640129934028897,0.00113312207613194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.0162917411025914,0.00500424595085831,-0.0261000631662737,-0.00648341903890911,0.00113400614317075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.00927565291986392,0.00285326447907985,-0.0148680512988604,-0.00368325454086741,0.00115326935907258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0130184377047002,0.0040062944120398,-0.0208707747522982,-0.0051661006571022,0.00115899450707027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0338131031209803,0.0104061590740691,-0.0542091749061558,-0.0134170313358049,0.00115919529744014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0345203649941104,0.0106294953421903,-0.0553541758648034,-0.0136865541234174,0.00116671425928512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,37437,0.0130499442857984,0.00402292837187931,0.00516500467691491,0.0209348838946818,0.0011819363948053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.00761656622822626,0.00234806355061525,-0.0122187707874322,-0.00301436166902037,0.00118200791263722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.0135950573871724,0.00420324964908129,-0.0218334266993717,-0.00535668807497307,0.00122185536270087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00949301842627584,0.00293593465370444,-0.0152474503475365,-0.00373858650501515,0.00122632030218634
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0185821965463004,0.0057603084508203,-0.0298724011099082,-0.0072919919826926,0.0012588415463771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,39564,0.0162560711059454,0.00505034926921586,0.00635738653828228,0.0261547556736085,0.00128989100489499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0102242082574332,0.00318258752824878,0.0039863367020656,0.0164620798128008,0.00131879757747663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.00870709773943434,0.00271411976826759,-0.0140267724852388,-0.00338742299362987,0.00133887014893017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,39862,-0.0074596869043616,0.00232890762213392,-0.0120243458437441,-0.00289502796497912,0.00136230462009126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.0158448110314475,0.00497486655977202,-0.0255955494886007,-0.00609407257429437,0.00145101729180845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0179210479659908,0.00563560911108782,-0.028966841823723,-0.00687525410825873,0.00147579781306261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0220741040338832,0.00694301695660828,-0.0356824172688355,-0.00846579079893101,0.00147950145529823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0178166089005083,0.00560413617058843,0.00683250200615504,0.0288007157948617,0.00148020411150184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0224180026732035,0.00706396315694483,-0.0362633704608154,-0.00857263488559165,0.00150918779878202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37043,-0.0216550534234871,0.00683933876176352,-0.0350601573965436,-0.00824994945043064,0.00154769923739558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0315966243507917,0.00998727617275528,-0.0511716856493921,-0.0120215630521914,0.00156128483762342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0193821844317829,0.00612710609438586,-0.0313913123767792,-0.00737305648678667,0.00156253322716888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00827506532073385,0.00262155749490769,-0.0134133180107529,-0.00313681263071479,0.00159999756666908
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37021,0.0122531513102481,0.00388290503076931,0.00464265744994022,0.0198636451705559,0.00160492953162742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0116696795611278,0.00369991307759726,-0.0189215091932184,-0.00441784992903713,0.00161323909673794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0349133805581697,0.0110733495474636,-0.0566171456711983,-0.013209615445141,0.00161948503954393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40058,-0.0179783568856556,0.00571199519602802,-0.0291738674698705,-0.00678284630144066,0.00164986309904275
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.0137387008355962,0.00436891839735756,0.00517562077677537,0.022301780894417,0.00166656957942896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,37072,-0.0128413491353781,0.00410960415494207,-0.0208961732790646,-0.00478652499169167,0.00178361582600224
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.00819155120192268,0.002624033418857,-0.0133346567028824,-0.00304844570096296,0.00180174408622508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0352404061166258,0.0113074562960152,-0.0574030204568156,-0.013077791776436,0.00183294712498974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.01022478068945,0.00328921598918761,0.0037779173506423,0.0166716440282577,0.00188390899690917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.0074307694205341,0.00239061945975083,0.00274515527942247,0.0121163835616457,0.00188493184478292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0105069576971105,0.00338272488462111,0.0038768169232531,0.0171370984709678,0.00189927647395474
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.00863346960264595,0.0027825205460087,-0.014087209872823,-0.0031797293324689,0.0019206448137197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,39788,-0.0205982015793779,0.00663964673597309,-0.0336119091818851,-0.00758449397687063,0.00192356517266584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00794606694264626,0.0025672596067287,0.00291423811345801,0.0129778957718345,0.00197045425757059
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0131565064203892,0.00425473529744907,0.00481722523738902,0.0214957876033894,0.0019901733851829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,39931,0.0136503808011796,0.00441624421061478,0.00499454214837459,0.0223062194539845,0.00199859774739466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0316030397982876,0.0102245448481833,0.0115629318958484,0.0516431477007268,0.00199955305002975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0178547335547413,0.00577970015386517,-0.0291829458563171,-0.00652652125316559,0.00201091853980449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00867327692505519,0.0028111774350511,-0.0141831846977554,-0.00316336915235503,0.00203768444168308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.014063478816177,0.00455945624237865,-0.0230000130512392,-0.00512694458111486,0.00204272822372045
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0105211503086953,0.00341142177349362,-0.0172075369847428,-0.00383476363264778,0.00204530842624332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00752229177710776,0.00244170924252405,-0.0123080418924549,-0.00273654166176062,0.00206832987494837
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0161038224614593,0.00523464233935274,-0.0263637214465906,-0.00584392347632791,0.00209874464178227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,39754,-0.0148907022991863,0.00484391023876037,-0.0243847663671566,-0.00539663823121598,0.00211490901042641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,37368,-0.0188412272464842,0.00612943420768086,-0.0308549182935386,-0.00682753619942967,0.00211706135813203
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0144877559301537,0.00472212130237817,-0.0237431136828149,-0.00523239817749246,0.00215889734457833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0251468225265884,0.00820740719460225,-0.0412333406280088,-0.00906030442516797,0.0021889975851873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.00738236682516889,0.00241049857453274,0.00265778961908471,0.0121069440312531,0.00219795284982694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0250392838784757,0.00817818376468245,-0.0410685240572533,-0.00901004369969814,0.00220436277617716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37411,-0.0197654864221325,0.00649269249347883,-0.032491163709351,-0.00703980913491399,0.00233695759874155
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0134332372220948,0.00442152217178465,-0.0220994206787927,-0.00476705376539684,0.00238430505414631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0120795721715619,0.00398206204319692,-0.0198844137762279,-0.00427473056689593,0.00242207323169045
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37437,-0.028048533834932,0.00925283680146715,-0.0461840939658076,-0.00991297370405641,0.00243926343636248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,39782,0.0117174308892959,0.00386739755670883,0.00413733167814664,0.0192975301004452,0.00245110407662875
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.00668762775310493,0.00221003860484314,-0.0110193034185975,-0.00235595208761238,0.00248190796846316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0144957140499904,0.00479466474465832,-0.0238932569495207,-0.00509817115046014,0.00250439774545927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37124,-0.0105537246005601,0.00349282782849743,-0.017399667144415,-0.00370778205670514,0.00251970547150544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,36962,0.00878771418076089,0.00291066774863176,0.00308280539344263,0.0144926229680791,0.00253980989929108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0106637333861308,0.00353434223069068,-0.0175910441582845,-0.00373642261397708,0.00255614378942724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37043,-0.00862620558606352,0.00286132114999598,-0.0142343950400556,-0.0030180161320714,0.00257669293720909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.00991792243330303,0.00329029398476365,-0.0163668986434398,-0.00346894622316627,0.00258060873348317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.0270942418412362,0.00900404508296966,-0.0447421702038567,-0.00944631347861563,0.00262498647225567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0118157920649104,0.0039367226467935,0.00409981567719518,0.0195317684526257,0.0026921855702162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0132409449346333,0.00441177353905035,-0.021888021071172,-0.00459386879809462,0.00269341302758178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.0210632036714706,0.00701938790240494,-0.0348212039601843,-0.00730520338275694,0.00269758704478797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37021,-0.0173968928235799,0.00580183490014254,-0.0287684892278593,-0.00602529641930051,0.00271805124847263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0252689632334981,0.00842856136000684,0.00874898296788472,0.0417889434991115,0.00272251853224811
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,40030,0.00813168733903048,0.00271903864557675,0.00280237159370006,0.0134610030843609,0.00278805524427592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0186301694957261,0.00623771572913084,-0.0308560923248225,-0.00640424666662964,0.00282512149337725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,36962,0.00999612476292781,0.00334741311794378,0.003435195051758,0.0165570544740976,0.00282968073859683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,39587,-0.0185838393240374,0.00622501437362974,-0.0307848674963516,-0.00638281115172307,0.00283690922857665
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0309123085566939,0.0103694409475016,0.0105882042995907,0.0512364128137971,0.00287653000211515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37100,0.0159016943497897,0.0053382915841678,0.0054386428448208,0.0263647458547586,0.00289905806821302
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0198926888725382,0.00668480613803948,-0.0329949089030956,-0.00679046884198084,0.00292744433061121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,39858,0.0132868365890549,0.00446636816903417,0.00453275497774792,0.0220409182003619,0.00293556434449517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.0187960941513762,0.0063195150128333,-0.0311823435765295,-0.00640984472622293,0.00294109529926563
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.035355917675091,0.0119152960033014,-0.0587098978415618,-0.0120019375086202,0.00300980350870877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37124,-0.0100872641170618,0.00340196638225555,-0.0167551182262827,-0.00341941000784096,0.00303095970888075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00638347566175358,0.00215314924479487,-0.0106036481815515,-0.00216330314195564,0.003035048743557
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0196420504968338,0.00666459317427038,-0.0327046531184037,-0.00657944787526384,0.0032118896636579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.0107592068657191,0.00366246160291139,0.00358078212401276,0.0179376316074254,0.00331130085907278
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00714430086551681,0.00243237420697849,0.00237684741983897,0.0119117543111946,0.00331797127417674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0138782106553617,0.00474250514761157,-0.0231735207446804,-0.00458290056604304,0.00343540649872688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0160441586285617,0.00548622930791167,-0.0267971680720686,-0.00529114918505486,0.00345662323607398
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0201229173826944,0.00688801337668026,-0.0336234236009877,-0.00662241116440104,0.00348908946491451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0264767332713953,0.00906521162671959,-0.0442445480597657,-0.0087089184830249,0.00349741919625498
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0227598944275961,0.00779318001145895,-0.0380345272500556,-0.00748526160513657,0.00349970543625395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37382,-0.0167940585640821,0.00575424644227637,-0.0280723815909438,-0.00551573553722037,0.00352242504277468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,36991,-0.0116364419406287,0.00399473344654034,-0.0194661194958478,-0.00380676438540967,0.00358640154131337
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.00876054115205643,0.00300851989977356,0.00286384214850024,0.0146572401556126,0.00359827781572758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.00943717910207341,0.00324386007193225,-0.0157951448430606,-0.00307921336108619,0.00362804800824609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,39489,0.00873002069521074,0.00300573430593613,0.00283878145557593,0.0146212599348456,0.00368408203573582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0178015677271551,0.00613186913368153,-0.0298200312291709,-0.00578310422513927,0.00369975490662298
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0132871194162076,0.00457904712764162,-0.0222620517863851,-0.00431218704602997,0.00371636454344814
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39489,-0.019300212166242,0.00665312801775287,-0.0323403430810376,-0.00626008125144637,0.00372584202624487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,39749,0.00902354116560367,0.0031126417621421,0.00292276331180516,0.0151243190194022,0.00374870033852606
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,39868,-0.0123282366077814,0.00425307587472915,-0.0206642653222505,-0.00399220789331227,0.00375265489606722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.0123901469835574,0.00427595783718174,-0.0207710243444336,-0.00400926962268116,0.00376611530803981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0344807008129338,0.0119020170903773,-0.0578086543100733,-0.0111527473157943,0.0037730962400006
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0138424704934531,0.00478945492735958,-0.0232298021510779,-0.00445513883582836,0.00385610972628106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,37039,-0.0113211017633331,0.00392424685578087,-0.0190126256006636,-0.00362957792600265,0.00392159435566163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0163267494909016,0.00566033022041259,-0.0274209967229103,-0.00523250225889291,0.00392775260472366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0195353830623248,0.00678088666906925,-0.0328259209337006,-0.0062448451909491,0.00397016749976624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00708774973842057,0.00246264436029613,0.00226096679224016,0.011914532684601,0.00400718440113663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0213782001927077,0.0074336901126855,-0.0359482328135712,-0.0068081675718441,0.00403566728785065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,39836,0.0186361369742612,0.0064843521890725,0.0059268066836791,0.0313454672648433,0.00405822028094593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0177364701436806,0.00617837207950458,-0.0298460794195096,-0.0056268608678516,0.00410055295643544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,39587,0.00766982573492035,0.00267406279333002,0.00242866265999352,0.0129109888098472,0.00413325089712743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0149759355516693,0.00522516376905303,-0.0252172565390132,-0.00473461456432536,0.00416188397201809
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0146727752358472,0.00512445820565471,-0.0247167133189304,-0.00462883715276394,0.00419833306889513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00620521103639785,0.00216796077160958,0.00195600792404306,0.0104544141487526,0.0042121566391441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.00855381195338878,0.00299149504270207,-0.0144171422370848,-0.00269048166969273,0.00425029054467909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0322510176721878,0.0113687783976447,-0.0545338233315715,-0.00996821201280417,0.00456369063773422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,39585,-0.0123159600718161,0.0043468054235716,-0.0208356987020165,-0.00379622144161581,0.00461235716766569
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0271407595963429,0.00959536074507236,-0.0459476666566847,-0.00833385253600103,0.00468209501460635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37411,0.0093025962228979,0.00330078945362903,0.00283304889378501,0.0157721435520108,0.00483494760939414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39489,-0.00989103668119845,0.00351715747548622,-0.0167846653331514,-0.00299740802924546,0.00492614600160292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.0129830511821528,0.00462122526777946,-0.0220406527070005,-0.00392544965730503,0.00496895801661847
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.0181366440503109,0.00646120057062191,-0.0308005971687298,-0.00547269093189192,0.00500658491965701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00936336128673211,0.00333816197124137,-0.0159061587503652,-0.00282056382309902,0.00503873264852878
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0101071166234659,0.00360683920971796,-0.0171765214745131,-0.00303771177241865,0.00508145144621405
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.012053931656619,0.00431042337362987,0.00360550184430448,0.0205023614689336,0.00517272297397409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.00865569080313504,0.00309690810790376,0.00258575091164366,0.0147256306946264,0.00519812300789196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.0113487587304472,0.00406430289829009,-0.0193147924110958,-0.00338272504979864,0.00523977589794585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0122688780179193,0.00440131965926985,-0.0208954645500882,-0.00364229148575041,0.00531732931050118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0211506278782241,0.00758905016161129,-0.0360251661949822,-0.00627608956146599,0.00532638997441753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.025854722605833,0.00928418200531614,-0.0440517193362527,-0.0076577258754134,0.00536328678448891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0154491708002429,0.00555553513520825,-0.026338019665251,-0.00456032193523469,0.00542896520420449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0121758879455832,0.00438447333783137,-0.0207694556877326,-0.00358232020343368,0.00549190625878844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.00886457366035913,0.00319751983232081,0.00259743478901034,0.0151317125317079,0.0055732772997112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0171966905270909,0.00620535220162486,-0.0293591808422756,-0.00503420021190618,0.00559146753368174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0151658789010646,0.00547492080162214,-0.025896723672244,-0.00443503412988525,0.00561119107304638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0157259095646966,0.00570449615085008,-0.0269067220203628,-0.00454509710903048,0.00584575151630892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,37453,0.00823181232741892,0.00298662170866329,0.00237803377843887,0.014085590876399,0.00585500400130458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0217530441540675,0.0078958436894564,-0.037228897785402,-0.00627719052273292,0.00587577921212304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,39788,0.00751173650537198,0.00272678874090074,0.00216723057320652,0.0128562424375374,0.00587960861789306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,39830,0.0203143562113861,0.00739548140956983,0.00581921264862923,0.034809499774143,0.00602361342210795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0143238532093585,0.00522331187061425,-0.0245615444757624,-0.00408616194295454,0.00610946830327632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00576115297810036,0.00210687258386172,-0.00989062324246933,-0.00163168271373139,0.00625522815437551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,37149,0.00823012032079749,0.00301100268325136,0.00232855506162483,0.0141316855799701,0.00627768653903708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0121664422184536,0.00445467299690103,-0.0208976012923796,-0.00343528314452757,0.00631820259436732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0107075593716907,0.00392216998447705,0.00302010620211574,0.0183950125412658,0.00634145479085195
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,39489,-0.00744398174434406,0.00273305695653958,-0.0128007733791616,-0.00208719010952648,0.00646300743228273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00779386915304155,0.00286336658845468,-0.0134060676664127,-0.00218167063967037,0.00649748430441055
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,39901,-0.00750626929227208,0.00276160633279381,-0.0129190177045479,-0.00209352087999621,0.00657323247758965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0244570328233878,0.00901948297647757,-0.0421352194572839,-0.00677884618949177,0.00670483253773647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0130708430984159,0.00482121100711726,0.00362126952446602,0.0225204166723657,0.00671427283098093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37021,0.0137671065578703,0.0050785613366773,0.0038131263379828,0.0237210867777578,0.00672024575746475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,-0.0091842980401906,0.00339056870595558,-0.0158298127038635,-0.00253878337651766,0.00676186964825142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,39931,0.00689401169224564,0.00254963228887329,0.001896732406054,0.0118912909784373,0.00685980892871263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0145636596024699,0.00540095990126825,0.00397777819598415,0.0251495410089557,0.00701626806637558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,39868,-0.0193903245814916,0.00720873611505522,-0.0335194473669998,-0.00526120179598336,0.00715610632008729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.00789956404994259,0.00293891208941563,-0.0136598317451972,-0.00213929635468795,0.007198857190852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0111631745829953,0.00415562233473278,-0.0193081943590716,-0.00301815480691908,0.00723403841859747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.0218831863583614,0.00816647120955978,-0.0378894699290986,-0.00587690278762424,0.00737935179646835
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.00869925284518803,0.00325041063057289,-0.0150700576811109,-0.00232844800926517,0.00745041172170019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,39684,-0.00966275619000646,0.0036146515588921,-0.016747473245435,-0.00257803913457794,0.0075204198395419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,39866,-0.00843248517156878,0.00315460091885265,-0.01461550297252,-0.00224946737061758,0.0075235634356346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,39903,0.0136930579620693,0.00512824405920862,0.00364169960602044,0.0237444163181182,0.00758991860860415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0115439425873159,0.0043283956855738,0.00306028704359131,0.0200275981310406,0.00766194315020021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37169,-0.0181628535070064,0.00682174442420108,-0.0315334725784405,-0.00479223443557232,0.00776572156057001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40030,0.0113591707781467,0.00426680338548764,0.00299623614259095,0.0197221054137025,0.00777038342266723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.022010980607593,0.00827657734660118,-0.0382330722069313,-0.00578888900825469,0.00783652811379314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,37388,-0.00944247546406951,0.00355914573824846,-0.0164184011110365,-0.00246654981710253,0.00798689365027548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37380,0.00782804867333344,0.00296798202759885,0.00201080389923969,0.0136452934474272,0.00836155286861744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0172055013413142,0.00652447043793789,-0.0299934633996725,-0.00441753928295596,0.00837205511814499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,40052,0.0180544415407141,0.0068500078126881,0.00462842622784538,0.0314804568535827,0.00840484428560696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.023483983662654,0.00891312458813366,-0.040953707855396,-0.00601425946991205,0.00842767698602732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37411,-0.0153062671537371,0.00580980085478083,-0.0266934768291075,-0.00391905747836667,0.00843422952973682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,39585,-0.0110563314583024,0.0041970772184434,-0.0192826028064515,-0.00283006011015335,0.00843952703962149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0217762250584918,0.0082963305694182,-0.0380370329745515,-0.00551541714243211,0.00867987733393763
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0155154390508439,0.00591984472015096,-0.0271183347023398,-0.00391254339934798,0.00877917718185472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,39587,-0.0121752372755119,0.00465227683216029,-0.0212936998665461,-0.00305677468447777,0.00887784234447264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,39866,-0.0137935660130607,0.00527195313768789,-0.0241265941629289,-0.0034605378631924,0.00889444827383724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.0102654249034992,0.00393691366897927,-0.0179817756946986,-0.00254907411229984,0.0091311607584981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0103782663609124,0.00398897316691856,-0.0181966537680727,-0.00255987895375198,0.00928375082678503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.0174698639126594,0.00671582856510065,0.00430683992506213,0.0306328879002567,0.00929759735614108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0180516095055799,0.00694243938943164,-0.0316587907088659,-0.00444442830229385,0.00932787687722973
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00696986882568978,0.00268177632711737,-0.0122261504268398,-0.00171358722453973,0.00935899465938507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00490317504303108,0.00189040181579832,0.00119798748406638,0.00860836260199577,0.00950486262385206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0139484744128143,0.00540290927540905,-0.024538176592616,-0.0033587722330125,0.00984144688561206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37106,0.00875287759031056,0.0033980357597285,0.00209272750124271,0.0154130276793784,0.0100097358944323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.00669330592375078,0.00260610788981333,-0.0118012773877849,-0.00158533445971664,0.0102283608653136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.00897136035289549,0.00349617041803684,-0.0158238543722477,-0.00211886633354329,0.0102953170638852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,39594,-0.0127238567359139,0.00495895926702364,-0.0224434168992802,-0.00300429657254756,0.0103020400301713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0120265068942106,0.00470610883224127,-0.0212504802054035,-0.00280253358301766,0.0106125915558434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00620762369523691,0.00242934855459637,0.00144610052822802,0.0109691468622458,0.0106219130215952
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,39858,0.00807452110683657,0.00316078579617861,0.00187938094632649,0.0142696612673467,0.0106403807056051
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.00712028245556641,0.00279348953216772,0.00164504297251767,0.0125955219386151,0.0108180252039819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.0156619310818382,0.00615004200618792,-0.0277160134139666,-0.00360784874970992,0.0108879047134071
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0145303117194876,0.00571184399086995,-0.0257255259415927,-0.00333509749738253,0.0109736509500686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0110074739676459,0.0043356158769872,-0.0195052810865409,-0.00250966684875103,0.0111312150774779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0091128315771137,0.00359082418785289,-0.0161508469853054,-0.00207481616892202,0.0111642820316894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0185484800617213,0.00731071068066019,-0.0328774729958153,-0.00421948712762732,0.0111850681568546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37411,-0.0191647248676081,0.00755886148848051,-0.0339800933850299,-0.00434935635018628,0.0112430966541611
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.00627106602124645,0.00247924963759705,-0.0111303953109367,-0.00141173673155623,0.0114346094973237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.0109578881329406,0.00433365941473359,-0.0194518605858184,-0.00246391568006273,0.0114648349389067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.0103461841581989,0.00409347306975597,-0.0183693913749206,-0.0023229769414772,0.0114996430634395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,39585,-0.00899952608352667,0.00356081759324206,-0.0159787285662811,-0.00202032360077222,0.0115015448913395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0180448064590735,0.0071631562187344,-0.0320845926477929,-0.00400502027035404,0.0117749731218573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.00499130624843417,0.00198229012156452,0.00110601761016771,0.00887659488670063,0.0118157036670589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0143994101200453,0.00573018247214514,-0.0256305677654498,-0.00316825247464088,0.0119859555333706
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,36991,-0.0262178334441154,0.0104478308751145,-0.0466955819593398,-0.00574008492889096,0.0121054318459936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.00847810213982479,0.00338161452996108,-0.0151060666185485,-0.00185013766110108,0.0121840578556796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0074609299793468,0.00297921606596313,0.00162166649005906,0.0133001934686345,0.0122785150584984
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.00848402298104061,0.00338920487252426,-0.0151268645311882,-0.00184118143089306,0.0123177757990989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.0109244623687953,0.00436720279303756,-0.0194841798431489,-0.00236474489444169,0.0123792850132628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37368,-0.0188711162662049,0.00754661537646006,-0.0336624824040666,-0.00407975012834321,0.0124098329926583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.0085547020826652,0.0034283966412106,-0.015274359499438,-0.00183504466589244,0.0125990424410046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0686856068659417,0.0275724398038726,-0.122727588881532,-0.0146436248503514,0.0127450077451675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.0300832713461081,0.012083113582823,0.00640036872377503,0.0537661739684411,0.0127952458376376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0179258933099915,0.0072110995703164,-0.0320596484678117,-0.00379213815217138,0.0129337055552981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0157238979391383,0.00632836444114449,-0.0281274922437815,-0.00332030363449516,0.0129794709097243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0268321805982334,0.0107995248279517,-0.0479992492610187,-0.00566511193544812,0.0129809242250097
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,39587,-0.00690710078744216,0.00278029720832146,-0.0123564833157522,-0.00145771825913209,0.0129908559124132
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37083,-0.019241147695988,0.007749111078829,-0.0344294054104929,-0.00405288998148318,0.0130399179491241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,40052,0.0120647898988254,0.00486058203094107,0.00253804911818089,0.0215915306794699,0.0130685629943732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0275924249464561,0.0111176748017428,-0.0493830675578719,-0.0058017823350403,0.0130822013535036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.00738320946674675,0.00298131730727934,0.00153982754447924,0.0132265913890143,0.0132781998542368
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37021,-0.0139490917619979,0.00564252975478106,-0.0250084500813687,-0.00288973344262699,0.0134434512970162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.0102171376172762,0.00413652420872424,-0.0183247250663758,-0.00210955016817672,0.0135223573623772
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0248388088252976,0.0100760394867637,-0.0445878462193545,-0.00508977143124069,0.0137065876683201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.00895317663073864,0.00363580803684616,-0.0160793603829571,-0.00182699287852017,0.0138076778330105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,39749,-0.00814709753026901,0.00331034918997207,-0.0146353819426143,-0.00165881311792375,0.0138617606245237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0164584852122468,0.00669100575296939,-0.0295728564880668,-0.00334411393642682,0.0139141106765505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0144342888350395,0.00587575935715787,-0.025950777175069,-0.00291780049501009,0.0140390393131454
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,37021,0.0109879698042555,0.00447875521430824,0.00220960958421131,0.0197663300242996,0.0141659909944493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,40030,0.0101882168004878,0.00415574127719868,0.00204296389717843,0.0183334697037972,0.0142327544759562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,39831,-0.00607349495769804,0.00247926622381132,-0.0109328567563682,-0.00121413315902785,0.0143076041298175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00569700993734791,0.00232738116338944,-0.0102586770175912,-0.00113534285710461,0.0143849121356391
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37021,-0.00976737360411622,0.00400826101748869,-0.0176235651983941,-0.00191118200983838,0.014830592230939
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00988554416997422,0.00406048670620964,0.00192699022580334,0.0178440981141451,0.0149222645554475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.0099095524865904,0.00408527579579666,-0.0179166930463519,-0.00190241192682895,0.0152931421195864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,39788,-0.00641522038946029,0.00265622052602797,-0.0116214126204751,-0.00120902815844546,0.0157391146912559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0080392178950278,0.00332983203329151,0.00151274710977644,0.0145656886802792,0.0157764540088226
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40009,-0.0149465349052044,0.00619948883450963,-0.0270975330208432,-0.00279553678956548,0.015922987213517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.0160105275889036,0.00666461229958835,-0.0290731676960968,-0.00294788748171047,0.0163052213590969
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.0105981887021201,0.00441714749271431,-0.0192557977878402,-0.00194057961640011,0.0164368073188938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0105826225218399,0.00441201892863051,-0.0192301796219557,-0.00193506542172412,0.016469622143145
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37169,0.00758192215475642,0.00316345585273154,0.0013815486834026,0.0137822956261102,0.0165562075891377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.0193861096897417,0.00809647606828026,-0.035255202783571,-0.00351701659591241,0.0166595898117728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.00804805365780531,0.00336825005804631,-0.0146498237715761,-0.00144628354403455,0.016890459078552
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37368,-0.0180395279392967,0.00755064585583647,-0.0328387938167362,-0.00324026206185723,0.0169016368864466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00610975589428361,0.00255777016204359,0.00109652637667818,0.011122985411889,0.0169193851186918
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00566907189317195,0.00237406269642559,0.00101590900817778,0.0103222347781661,0.0169554212083773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0125586796388033,0.00528548628099521,-0.0229182327495539,-0.00219912652805271,0.017512059702331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0108728799575451,0.00457788963881705,-0.0198455436496265,-0.00190021626546365,0.0175565796973715
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,39749,-0.00785114209017026,0.00331436861617456,-0.0143473045778724,-0.00135497960246811,0.0178568339340886
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.00533788445877056,0.002255612809237,-0.00975888556487509,-0.000916883352666034,0.0179695936745313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.00628937111236595,0.00265820102833662,0.00107929709682617,0.0114994451279057,0.0179945034949181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.00898708255294746,0.00381592231925802,-0.0164662902986932,-0.00150787480720174,0.0185296161023861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0270471118306816,0.0114859117210114,-0.049559498803864,-0.00453472485749914,0.0185443063192162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.0062035896423127,0.00264004383155243,0.00102910373246995,0.0113780755521555,0.0187952982542797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.00617659291646922,0.00263067947979139,0.00102046113607809,0.0113327246968604,0.0188912981089535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39315,-0.00559038192679118,0.00238106432209201,-0.0102572679980915,-0.000923495855490843,0.0188946616061106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,40052,0.00372610451435522,0.00158827821491073,0.000613079213130183,0.00683912981558025,0.0189879798167656
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,39868,0.00678521689335975,0.00289741092001571,0.00110629149012896,0.0124641422965905,0.0192021245439211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00806966798175188,0.00344609646073164,0.00131531891871786,0.0148240170447859,0.019211788908689
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.00582704479506369,0.00249030648641714,-0.0107080455084413,-0.000946044081686088,0.0193014842609849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0144265117859395,0.0061747739182914,-0.0265290686657906,-0.00232395490608831,0.0194872512198299
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.00831009503746129,0.00355725262520694,0.00133787989205568,0.0152823101828669,0.0195010384983303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0124722091795002,0.00534126675987829,-0.0229410920288617,-0.00200332633013879,0.0195524965498989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,36991,-0.0161992939930666,0.00693846917397675,-0.029798693574061,-0.00259989441207214,0.0195737130077271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.013509591459493,0.00579056206879126,-0.0248590931143238,-0.00216008980466208,0.019658782025782
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,37437,-0.00804101217797037,0.00344657171918787,-0.0147962927475786,-0.00128573160836215,0.0196602310052986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40018,-0.00454462068286791,0.00194970802173794,-0.00836604840547427,-0.000723192960261542,0.0197696193455996
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.00748915220388768,0.00321437206103616,-0.0137893214435186,-0.00118898296425681,0.0198242430195462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.0059807770966403,0.00256832572744892,-0.0110146955224402,-0.000946858670840423,0.0198913084813123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37021,0.00684969885057313,0.00294433928036293,0.00107879386106179,0.0126206038400845,0.0200125441092695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0213171109308741,0.00918318016459347,-0.0393161440534773,-0.00331807780827086,0.0202847661103417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0175172776626957,0.00757873133239089,-0.0323715910741819,-0.00266296425120956,0.0208277849073575
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,39766,-0.0113681885818685,0.00492399911806332,-0.0210192268532726,-0.00171715031046441,0.020971278076169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.0199354600597602,0.00868013629762191,-0.0369485272030992,-0.00292239291642129,0.0216501149016803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00575952839336544,0.00251170261923378,-0.0106824655270637,-0.000836591259667225,0.0218566858398809
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.00619530478600503,0.00270279417488917,0.000897828203222254,0.0114927813687878,0.0219107035235655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,37453,-0.00570964040541609,0.00249748926378884,-0.0106047193624422,-0.000814561448389971,0.0222606722952833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00593298230207451,0.00259727397495473,0.000842325311163234,0.0110236392929858,0.0223689131154536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.008360886471933,0.00368150312181735,-0.015576632590695,-0.00114514035317099,0.0231571402812009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.00718146809510512,0.00316940172174908,0.000969440720476925,0.0133934954697333,0.0234752468201558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00171660534663153,0.000757991208556294,0.000230942577861197,0.00320226811540187,0.023548419784413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,39585,-0.0267276589111508,0.0118236375027428,-0.0499019884165268,-0.00355332940577483,0.0238021384996527
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40012,0.00619315409715966,0.00274155666417234,0.000819703035381881,0.0115666051589374,0.023897168376589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00789610959598115,0.00349770375593829,0.0010406102343421,0.0147516089576202,0.023992393867204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.0097146824101087,0.00430490981617201,0.00127705917041155,0.0181523056498058,0.0240461319593387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,37368,0.0229474938388492,0.0101761165762032,0.00300230534949101,0.0428926823282075,0.024147105366582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0121708225611973,0.00539845718351442,-0.0227517986408856,-0.00158984648150907,0.0241783340179389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,37453,-0.00545015387860927,0.0024241350423488,-0.0102014585616129,-0.000698849195605622,0.0245737832619206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.0076740928601451,0.00342729297230247,-0.0143915870858579,-0.000956598634432272,0.0251648412728718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,36962,0.00754209500348514,0.00339554337620962,0.000886829986114287,0.014197360020856,0.0263561597177151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,39868,-0.00565123939057702,0.00254953568257621,-0.0106483293284264,-0.000654149452727652,0.0266660868541058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.00859438586657908,0.00387909071524262,0.000991368064703543,0.0161974036684546,0.0267378981464118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37056,0.00558719228332446,0.00252336458243794,0.000641397701746097,0.0105329868649028,0.0268331840240813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0150972749096253,0.00682194263487177,-0.028468282473974,-0.00172626734527664,0.0269085348909988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0176474566362858,0.00797775527949802,-0.033283856984102,-0.00201105628846969,0.0269779081434499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37021,0.0107744930369896,0.00487122476035355,0.00122689250669662,0.0203220935672826,0.0269930857608134
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.00502546167269212,0.00227608451140048,-0.00948658731503706,-0.00056433603034718,0.0272624894666381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0126801716502725,0.00574754038862335,0.00141499248857077,0.0239453508119743,0.0273878816518348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00967325721666976,0.00438843091577989,0.00107193262174118,0.0182745818115983,0.0275225376271651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,36816,-0.00952989309629248,0.0043285580859728,-0.0180138669447992,-0.0010459192477858,0.027708858047965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,39891,0.00575166560289065,0.00262061304502999,0.000615264034631875,0.0108880671711494,0.0281937685456424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,-0.00973448002859813,0.00443786883310314,-0.0184327029414803,-0.00103625711571599,0.0282886035862747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.00522447230098989,0.00238229210399409,-0.00989376482481831,-0.000555179777161465,0.028321482729463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0144239211597146,0.0065792705681401,-0.0273192914732692,-0.00152855084616004,0.0283727911502287
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0133313196729094,0.00608998147970851,-0.0252676833731381,-0.00139495597268076,0.0286101184294986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.0100167317049046,0.00457929088971247,-0.018992141848741,-0.00104132156106817,0.0287278968107393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.0128554645548713,0.00588156462390477,0.00132759789201792,0.0243833312177246,0.0288535596568733
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0109060805613188,0.00499224133430365,-0.020690873576554,-0.00112128754608368,0.0289352957924198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.00640475284654475,0.00293571978858314,-0.0121587636321677,-0.000650742060921796,0.029148703105458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.00803139004098339,0.00368596526787942,-0.0152558819660271,-0.000806898115939734,0.0293559153585988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.00711162887694515,0.00326870967685172,0.000704957910315775,0.0135182998435745,0.0295944654636262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.0122765873066266,0.00564271732919363,0.00121686134140705,0.0233363132718461,0.0295990031275248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00941551881765319,0.00433246880878618,0.000923879952432281,0.0179071576828741,0.0297796901122029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0149118132404871,0.0068705008682723,-0.0283779949423008,-0.00144563153867341,0.0299935974178091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0135968823748835,0.0062868030617287,-0.0259190163758717,-0.00127474837389525,0.0305770117108829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,37220,0.00669484876088382,0.00309552268664949,0.000627624295050818,0.0127620732267168,0.0305779206336579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.0106206047377562,0.00492699197675391,-0.0202775090121939,-0.000963700463318532,0.0311328232639335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.00624747826070239,0.00290088524972757,0.000561743171236349,0.0119332133501684,0.0312848125947618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.00631668584484144,0.00293863432206177,-0.0120764091160825,-0.000556962573600376,0.0316104483197772
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00820520574425556,0.00382133872617795,0.000715381840946778,0.0156950296475643,0.0317950484611503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,36962,0.00679057660422048,0.00316301316784521,0.000591070795243874,0.0129900824131971,0.0318219685858618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37445,0.00479473811383099,0.0022407745458716,0.000402820003922662,0.00918665622373932,0.0323912671119718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.00883945368545513,0.00413268376304404,-0.0169395138610215,-0.000739393509888806,0.0324610120089934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.0103595155950571,0.0048446945939053,-0.0198551169991115,-0.000863914191002731,0.0325089761611267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,39587,-0.00896175297594925,0.00419956042643733,-0.0171928914117664,-0.000730614540132091,0.0328603285925778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.00383844554089501,0.00180381813141239,-0.0073739290784633,-0.000302962003326731,0.0333587042617384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,39585,-0.0232600113496588,0.0109473351698665,-0.0447167882825972,-0.00180323441672042,0.0336256178237693
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00764055051123346,0.00359773335580309,-0.0146921078886075,-0.000588993133859405,0.033712809699866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.0122745778263699,0.00579328261662045,-0.0236294117549459,-0.00091974389779379,0.0341263552938842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,36962,0.00970949453434203,0.004588994151302,0.000715065997790117,0.0187039230708939,0.0343787671096623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,37056,-0.0125439280404683,0.00594318131874869,-0.0241925634252157,-0.000895292655720845,0.0348218589200772
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.00983707961093688,0.00466204406074809,0.000699473251870617,0.0189746859700031,0.0348735975625054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.00710001201132003,0.00336918278644777,-0.0137036102727577,-0.000496413749882399,0.0351035068584467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00782656906252043,0.00371409598809507,-0.0151061971991868,-0.000546940925854099,0.0351105368109274
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00720724956014477,0.00344704263783769,0.000451045989982898,0.0139634531303066,0.0365600814284585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00857348411157274,0.00411225860335663,-0.0166335109741517,-0.000513457248993753,0.0371010095003627
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37391,0.00463989342282014,0.00222612902504052,0.000276680533740716,0.00900310631189957,0.0371527123599665
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.00847598580575172,0.00406805188313862,0.000502604114800013,0.0164493674967034,0.0372203985309728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39520,-0.0174792242280308,0.00839010371807813,-0.0339238275154639,-0.00103462094059765,0.0372387505958738
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,39587,0.00645791061331355,0.00310358660995062,0.000374880857810325,0.0125409403688168,0.0374693159846972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0290809625550562,0.0139899476935731,-0.0565012600344595,-0.00166066507565295,0.0376604392068477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.00841595574142611,0.00405268723716216,0.000472688756588279,0.016359222726264,0.0378544839660162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0109350494228294,0.00526935094634965,0.000607121567984066,0.0212629772776747,0.0379858457523263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00542505994495257,0.00262014298676429,-0.0105605401990106,-0.000289579690894564,0.0384225471129263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0093491698036156,0.00451691803080431,-0.018202329143992,-0.000496010463239147,0.0384861141841319
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,37039,0.00672039206628812,0.00324866814244147,0.000353002507102839,0.0130877816254734,0.0385973942482642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40030,0.0116715742531458,0.0056431589576918,0.000610982696069854,0.0227321658102217,0.0386305379625562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00741403144230555,0.00360318161237904,-0.0144762674025685,-0.000351795482042642,0.0396448159929573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00644632819097331,0.00313604009025529,0.000299689614072943,0.0125929667678737,0.0398443356978259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.00815336017156439,0.00398576584019686,0.000341259124778545,0.0159654612183502,0.0408103187375445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.016067756847906,0.00787450442074204,-0.0315017855125604,-0.00063372818325164,0.0413223856562427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0159077642825735,0.00782687567630783,-0.0312484406081368,-0.000567087957010123,0.0421241971726982
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.00742034675124083,0.00365748270931341,0.000251680640986539,0.0145890128614951,0.0424973230935968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0054365117198582,0.0026798538631738,0.000183998148037541,0.0106890252916789,0.0425094291994075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00817245082947103,0.00403111450466705,0.000271466400323613,0.0160734352586184,0.0426474299426893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37124,0.00939507213167847,0.00465252921347567,0.000276114873266148,0.0185140293900908,0.0434712126402639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00515406999998752,0.0025540654305954,-0.0101600382439545,-0.000148101756020542,0.0436097023839535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00741139316371569,0.00367446531100914,-0.0146133451732936,-0.000209441154137772,0.0437152535568469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37437,-0.0147980029246736,0.00733802618400503,-0.0291805342453235,-0.00041547160402376,0.0437549400951063
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0058706679953207,0.00291783899819205,0.000151703558864279,0.0115896324317771,0.0442411176347526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0079393540116709,0.00395380841357502,-0.0156888185022779,-0.000189889521063858,0.0446574921561583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0112854259664737,0.00562477100154687,0.000260874803441847,0.0223099771295056,0.0448323802444982
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0153075820718849,0.0076379458192018,-0.0302779558775205,-0.000337208266249419,0.0450746383007749
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0131952597976752,0.00661816664660403,-0.0261668664250191,-0.000223653170331302,0.0461916912208371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.00504245505341641,0.00253292115929075,7.79295812065465e-05,0.0100069805256263,0.0465234687543901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.011213667139537,0.00565204611628555,-0.0222916775274567,-0.000135656751617322,0.0472728677284449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.0112565083467282,0.00567426256539187,-0.0223780629748962,-0.00013495371856009,0.047297340472138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.00681082896413228,0.00343799816309839,7.23525644594318e-05,0.0135493053638051,0.0476070116295834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,39585,0.00993778462871359,0.00501660268925195,0.000105243357779762,0.0197703258996474,0.0476110206675206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.00250364419552477,0.00126417951239335,2.5852351233807e-05,0.00498143603981573,0.0476734703272676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.011120515540117,0.00561751220284858,-0.0221308394577002,-0.000110191622533774,0.0477669257712333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,36962,0.0110959152214568,0.00560990165376662,0.000100507980074212,0.0220913224628394,0.0479590820377965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.00723598593632112,0.00367574854798932,-0.0144404530903802,-3.15187822620532e-05,0.0490228640654549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.0104701053756442,0.0053199701976285,-0.0208972469629961,-4.29637882923394e-05,0.0490768423980584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00901042618227741,0.00457992744972242,-0.0179870839837334,-3.37683808214698e-05,0.0491577605616959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.00797588931792778,0.00406703903907828,4.49280133435134e-06,0.0159472858345212,0.0498878381278316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00468519432682213,0.00238955199606873,1.67241452742398e-06,0.00936871623911683,0.0499344572013523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0164501921862507,0.00842272327654264,-0.0329587298082743,5.83454357728566e-05,0.050831961191858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.00533773951425707,0.00273389148901701,-0.0106961668327304,2.06878042162796e-05,0.0509040913842214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,39858,0.00429126093357464,0.00220602615977539,-3.2550339585131e-05,0.0086150722067344,0.0517630160130867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00486661928518898,0.00250195297886925,-0.00977044712377272,3.72085533947557e-05,0.0517770175746993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,37056,0.00623134988276242,0.0032141038653263,-6.82936932771168e-05,0.012530993458802,0.0525528533314936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37380,-0.00849189829429872,0.00438246119747722,-0.0170815222413541,9.77256527566299e-05,0.052680541044221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00409215111736379,0.00211340207813715,-5.01169557850208e-05,0.0082344191905126,0.0528539933945225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,39749,-0.0101399249451173,0.00524723993960486,-0.0204245152267429,0.000144665336508188,0.0533241816351623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00556528445578545,0.00288142442327986,-8.2307413843072e-05,0.011212876325414,0.0534468910472035
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.00730713758268993,0.00379371243189367,-0.0147428139492015,0.000128538783821661,0.0541111616069143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,39780,0.0120462240360859,0.00628659266368866,-0.000275497584743824,0.0243679456569157,0.0553604622341579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39344,-0.0107529207906476,0.00561718532591361,-0.0217626040294382,0.000256762448143094,0.0556015432406926
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00497856213750672,0.00260454221358218,-0.000126340601114342,0.0100834648761278,0.055962995513278
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.0101799501668724,0.00533870732427794,-0.0206438165224572,0.000283916188712334,0.0565623086457441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.00459942921327909,0.00241209096073711,-0.000128269069765649,0.00932712749632383,0.0565646558070985
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00891503431785547,0.00468729846280644,-0.0181021393049561,0.000272070669245159,0.0571987199635193
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0151390753033988,0.00796127529610896,-0.0307431748837724,0.000465024276974721,0.0572434124705497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.00606088902906441,0.00318795752533788,-0.00018750772059782,0.0123092857787266,0.0572960535681905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.00656117026152191,0.00345627426170803,-0.000213127291425822,0.0133354678144697,0.0576734309709846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,39841,0.011831748627288,0.00624660735887989,-0.000411601796116622,0.0240750990506926,0.0582287231278829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00425774207944847,0.00225081565215056,-0.000153856598766616,0.00866934075766356,0.0585563669214192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.00816825728427073,0.00432880835211343,-0.016652721654413,0.000316207085871587,0.0591884114899064
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39315,-0.00614807679967514,0.00325994536781586,-0.0125375697205942,0.000241416121243948,0.0593211376881549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.0051769517741317,0.00274892929193348,-0.000210949638057924,0.0105648531863213,0.0596828916043535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.00727003409241839,0.00387193503847715,-0.0148590267678336,0.000318958582996825,0.0604548234596494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.0199530733971114,0.01063103608055,-0.000883757320766631,0.0407899041149894,0.0605541030682291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.0115223758981803,0.00616502802825738,-0.0236058308335647,0.000561079037204195,0.0616427745771782
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.0044685389124381,0.00239125367861926,-0.00915539612253185,0.00021831829765564,0.0616859842615036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00602158553741514,0.00322709247495533,-0.000303515713497315,0.0123466867883276,0.0620708621943705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37021,0.00591964962230688,0.0031729495078492,-0.000299331413077543,0.0121386306576913,0.062110975156705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.00609194626731824,0.00326711368493619,-0.0124954890897932,0.000311596555156694,0.0622553445572599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00621526241081849,0.00333404329306437,-0.000319462443587664,0.0127499872652247,0.0623177611933279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00603083145881908,0.00324239430244631,-0.000324261373975686,0.0123859242916138,0.0629088272309229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37056,0.00828454007186503,0.00446597790482743,-0.00046877662159673,0.0170378567653268,0.063613683749645
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.00492233266864683,0.00265777786892985,-0.0101315772917493,0.000286911954455677,0.0640373605052147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0249138729286989,0.013465130084926,-0.00147778203775608,0.051305527895154,0.0642990528059277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,37311,0.0124826621822849,0.00675243011495183,-0.00075210084302073,0.0257174252075904,0.0645349589144944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,37169,0.00503113583099335,0.00272302540796451,-0.000305993968617088,0.0103682656306038,0.0646784667027666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,39858,-0.00681438219592475,0.00369956212841409,-0.0140655239676164,0.000436759575766853,0.065501999687189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.0075643238982731,0.00410767138261419,-0.000486712011650698,0.0156153598081969,0.0655685549141782
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0116386911898589,0.00632660097395707,-0.0240388290988148,0.000761446719096916,0.0658425042080831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00594680198327268,0.00324119697999345,-0.000405944097514483,0.0122995480640598,0.066564653594174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.011441002632585,0.00623680120706272,-0.0236651329984279,0.000783127733257958,0.0666120687973583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,37453,0.00261620745076943,0.00142682148572658,-0.000180362661254661,0.00541277756279352,0.0667365384242991
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00519278362548888,0.00283703603959618,-0.000367807012119624,0.0107533742630974,0.0672188335372108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,39868,-0.00575008363055378,0.00314309557384859,-0.011910550955297,0.000410383694189461,0.0673533166451628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,37169,0.00724022563911198,0.00395913113246285,-0.000519671380515194,0.0150001226587392,0.0674607761500011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.00848561435730689,0.00464064735985185,-0.000610054468002738,0.0175812831826165,0.067487122199724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.00802886877219557,0.00439100426437167,-0.0166352371303641,0.000577499585972906,0.0674964126643594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,39868,-0.00677481183555863,0.00372484106667404,-0.0140755003262397,0.00052587665512249,0.0689577189799134
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00799307958392971,0.00440323695993526,-0.0166234240254028,0.000637264857543398,0.0695045934639126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.0108992245965421,0.00603867158768719,-0.022735020908409,0.00093657171532479,0.0711124983156514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00736234982626341,0.00408205183559701,-0.000638471771506739,0.0153631714240336,0.0713184915256372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.00558271417602342,0.0030981496256238,-0.000489659090199229,0.0116550874422461,0.0715718289408208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.00908216123683513,0.00505694667356456,-0.0189937767170217,0.000829454243351407,0.0725174406191676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0202952368030454,0.0113259724917488,-0.042494142886873,0.00190366928078229,0.0731646611940297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37056,-0.00716809293263312,0.00401184275022161,-0.0150313047230675,0.00069511885780124,0.0740035561708445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,36931,0.00677708484277182,0.00379885055412585,-0.000668662243314841,0.0142228319288585,0.0744496170390387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37411,-0.00422791827309177,0.00237194778826903,-0.00887693593809907,0.000421099391915518,0.0746955164757817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.00892960008580701,0.00501040809229382,-0.0187499999467029,0.000890799775088878,0.074737425922624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00507007457477996,0.00285569600308538,-0.0106672387408273,0.000527089591267378,0.0758471660305096
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00650053379559952,0.003664101083193,-0.000681104327458752,0.0136821719186578,0.0760632056728509
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,36991,0.00794497401560549,0.004480304898989,-0.000836423586412954,0.0167263716176239,0.076200359600296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,39788,-0.0308598188418751,0.0174482509241884,-0.0650583906532844,0.00333875296953414,0.0769717257783822
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0044239404167101,0.0025025280016569,-0.00932889529995762,0.00048101446653741,0.0771186982508024
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00484513829242964,0.00274115173836734,-0.000527519114770353,0.0102177956996296,0.0771583213477235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0138720104211163,0.00787913709949221,-0.0293151191361211,0.00157109829388841,0.0783256488546724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.00878480671876626,0.00499182392355608,-0.0185687816089362,0.000999168171403662,0.0784576151884896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.00673427237147512,0.00382783177957415,-0.000768277916490219,0.0142368226594405,0.0785471020810105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37388,0.0118898215194589,0.00678835214818363,-0.00141534869098103,0.0251949917298988,0.0798819048517231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0115373701663504,0.00659387206071841,-0.00138661907265769,0.0244613594053585,0.080191468908161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,37347,0.00458203078809792,0.00261974868282535,-0.00055267663023976,0.00971673820643561,0.0803078052114591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37021,0.00807090978648823,0.00462852971117631,-0.00100100844741734,0.0171428280203938,0.0812293916709795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,40058,-0.0073265366224122,0.0042042633557368,-0.0155668927996563,0.000913819554831924,0.0814147002600344
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00696960861209491,0.00400143710636457,-0.0148124253405695,0.000873208116379648,0.0815710501118941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00561912818974468,0.00323488733770415,-0.0119595073716448,0.000721250992155464,0.0824028609793493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00760341685206497,0.00437743089420559,-0.0161831814047079,0.000976347700577987,0.082417850155096
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37235,0.0055771796335101,0.00321204601216061,-0.000718430550324703,0.0118727898173449,0.0825280997319961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00668480716633596,0.00385077718484585,-0.000862716115961904,0.0142323304486338,0.0825893785333305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,39866,-0.0104195215992163,0.00600575382055358,-0.0221907990875013,0.00135175588906872,0.0827736595934359
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00492182230337019,0.00283861475159688,-0.0104855072165001,0.000641862609759698,0.082958786784783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,39866,-0.00937231360013791,0.00540844940915961,-0.0199728744420907,0.00122824724181492,0.0831323229590812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00361731497487702,0.00208783529561774,-0.0077094721542878,0.000474842204533755,0.0831953300010097
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37056,-0.00757173936347909,0.00437537509905324,-0.0161474745576234,0.00100399583066526,0.0835581271129288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.00840459872489433,0.00485877483529358,-0.00111859995228109,0.0179277974020697,0.0836935054379946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.0113357989564857,0.0065624971767369,-0.02419829342289,0.0015266955099186,0.0841226812634103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.00535377885645767,0.00310318254806609,-0.000728458937751859,0.0114360166506672,0.0845010611631638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.00678403858940366,0.0039321744363962,-0.0144911004847402,0.00092302330593289,0.0845027245580859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37021,0.00564467837288379,0.00327591280453243,-0.000776110723999778,0.0120654674697674,0.0848965249333582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.0161921459882002,0.00941594912473577,-0.0346474062726823,0.00226311429628194,0.0855193852023573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00473961221386801,0.00275644057516588,-0.0101422357411931,0.00066301131345711,0.0855526063365459
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0109608330675311,0.00637853962641302,-0.00154110460023843,0.0234627707353006,0.0857485493424068
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00350551615619038,0.00204811036669901,-0.000508780162539686,0.00751981247492044,0.0869965671748581
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00673695372953794,0.00393909013135118,-0.0144575703869862,0.000983662927910368,0.0872370726965421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.0092370277496623,0.00540295003811847,-0.0198268098243745,0.00135275432504989,0.0873586001919717
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0124982522084196,0.00731176023514593,-0.00183279785246641,0.0268293022693056,0.087412333997171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00851163914715078,0.00498173863810581,-0.0182758468778382,0.0012525685835366,0.0875545498379419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,39558,-0.00677936006592584,0.00396932450669328,-0.0145592360990447,0.001000515967193,0.0876676229999406
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,37056,0.0065040817837897,0.00382116799551341,-0.000985407487416587,0.013993571054996,0.0887566589305217
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,39858,0.00809359014074206,0.00477449895467871,-0.00126442781042821,0.0174516080919123,0.090062527217053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00718742419436429,0.00424412324773412,-0.0155059057599232,0.00113105737119457,0.0903833249609615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37021,0.0112597474847252,0.00665869694975286,-0.00179129853679037,0.0243107935062408,0.0908636082407257
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,39524,0.00742944035661875,0.00439493388332912,-0.00118463005470633,0.0160435107679438,0.0909607324023297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.0120839431501881,0.00718235104168948,-0.00199346489152332,0.0261613511918995,0.0925048152763455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.00751909985597916,0.00446940772109935,-0.0162791389893339,0.00124093927737557,0.0925250691881276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.00654557436014106,0.00389204871936736,-0.00108284112981896,0.0141739898501011,0.0926350003936546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,39788,-0.00502145958689113,0.00298791337718061,-0.0108777698061651,0.00083485063238287,0.0928620415319962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.00865638233291595,0.00517855190411996,-0.0188063440649911,0.00149357939915918,0.0946295929356983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00745497282382135,0.00446148137716012,-0.00128953067541248,0.0161994763230552,0.0947519664703933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,39489,-0.00950089714653356,0.00568726598831409,-0.0206479384836292,0.00164614419056205,0.0948294038093796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00439913367081358,0.00264213902127206,-0.000779458810879649,0.00957772615250681,0.0959387117441636
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00468013193300173,0.00281365922038768,-0.0101949040049616,0.000834640138958118,0.0962601946220414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00598539443813164,0.00362433882969121,-0.0130890985443264,0.00111830966806314,0.0986710644769466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37056,0.00829329133231808,0.00503722617484047,-0.00157967197036925,0.0181662546350054,0.0997051578105357
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,36962,0.00462675867298647,0.00281409138435787,-0.000888860440354943,0.0101423777863279,0.100171391681843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00659757711162646,0.00401542274519174,-0.0144678056922023,0.00127265146894935,0.100394549617093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,36991,0.0118870089501641,0.00726454712508807,-0.00235150341500853,0.0261255213153367,0.101799903560602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,37056,-0.00255403892322277,0.00156149991459876,-0.00561457875583634,0.000506500909390807,0.101940519356556
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00519527770864456,0.00318779868437179,-0.00105280771272414,0.0114433631300133,0.10317634588017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.00518941954246284,0.00318627396252755,-0.0114345165090168,0.00105567742409115,0.103400630718934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.00974927765620516,0.0060427048959935,-0.0215929792523524,0.00209442393994209,0.106682227376329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,37289,-0.00654548892872033,0.00405900727615664,-0.0145011431899873,0.00141016533254669,0.106858482536694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,39673,-0.00502335904030805,0.0031194048638716,-0.0111373925734964,0.00109067449288029,0.107339651393495
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.00518114608793994,0.00321917434517525,-0.0114907278044834,0.00112843562860355,0.107534348617148
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.00497911089096214,0.0030983965556783,-0.0110519681400916,0.00109374635816734,0.108078592710574
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0040835642100528,0.0025444544095217,-0.00907069485271533,0.00090356643260972,0.108538137695424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,37039,-0.00900421877820605,0.00562092351963308,-0.0200212288766869,0.00201279132027478,0.109199275268636
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37021,-0.00714292957029556,0.00447571244335495,-0.0159153259592713,0.00162946681868014,0.110528142614564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.00621516467590822,0.00389711512327764,-0.0138535103175324,0.00142318096571595,0.110774245801451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.00662508506513628,0.0041553041633684,-0.00151931109506579,0.0147694812253383,0.110873418299373
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.00795924745872182,0.00500664697099913,-0.0177722755218801,0.00185378060443647,0.111917703840734
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.00934247117746429,0.00588861382515562,-0.00219921191984072,0.0208841542747693,0.112642788957699
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00701390464678484,0.00443490165648561,-0.00167850259992696,0.0157063118934966,0.113782241707286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00426411660135006,0.00270548424466789,-0.001038632518199,0.00956686572089913,0.115026515762022
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.0107736869085483,0.00685171178105007,-0.0242030419994065,0.00265566818230982,0.115879231411691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,39725,0.00723834382299743,0.00460790204516555,-0.00179314418552705,0.0162698318315219,0.116236383376698
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.00415452422341244,0.00265780171226158,-0.00936381557944514,0.00105476713262025,0.118038934457523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.00790656235196253,0.00506198349649859,-0.0178280500050998,0.00201492530117469,0.118323204125876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.00900302807023508,0.00578198375834519,-0.00232966009612149,0.0203357162365916,0.119474902775888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.00880140207258608,0.00565390053541331,-0.002280242976824,0.0198830471219962,0.1195668741398
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0106405267350338,0.00684131325217562,-0.024049500709298,0.00276844723923041,0.119886424656423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00679819309149924,0.00440620939271908,-0.0154343635012286,0.00183797731823016,0.122883403920125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.00884073173694079,0.00573200464238622,-0.0200754608360178,0.00239399736213619,0.123009772739766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.00843200813198369,0.00549205475810125,-0.0191964354578621,0.00233241919389475,0.124727462469327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40011,-0.00443203073046363,0.00288787079447963,-0.0100922574876437,0.00122819602671644,0.124875811182377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.00974049497778135,0.00635491250901311,-0.022196123495447,0.00271513353988435,0.125357116087735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,37437,0.00673587994006687,0.00439512058202796,-0.00187855640070793,0.0153503162808417,0.125402333223172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00666869954053191,0.00435157226719179,-0.0151977811842278,0.00186038210316399,0.12542800264799
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00664117690664683,0.00435134074604519,-0.0151698047688954,0.00188745095560174,0.126974901193036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40009,-0.00364175560906444,0.00238738901610806,-0.00832103808063623,0.00103752686250735,0.127175558406747
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37169,0.00568640670819873,0.00373072472362801,-0.00162581375011217,0.0129986271665096,0.127480102937485
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.00889301924269565,0.00584022827762338,-0.00255382818144617,0.0203398666668375,0.12785336176439
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00586740115943411,0.00385911873946679,-0.0016964715699208,0.013431273888789,0.128434690623634
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.00392611836721578,0.00258544432963575,-0.00899358925330186,0.0011413525188703,0.128899880075187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.00437724110325023,0.00288510147114209,-0.0100320399866887,0.00127755778018826,0.129239090893449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00582313614701627,0.00384475179442175,-0.00171257737005037,0.0133588496640829,0.129905916131249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37056,0.0083608962190209,0.0055205344468468,-0.00245935129679882,0.0191811437348406,0.129920875831179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.00567768870629304,0.00375692134207096,-0.0130412545367521,0.00168587712416604,0.130741709941877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37039,-0.00958448471300766,0.00636372206007734,-0.0220573799507592,0.00288841052474392,0.132062127025855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00533589073551113,0.00355078632381701,-0.00162365045917021,0.0122954319301925,0.132931397223631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.009878456530392,0.00657759650144021,-0.00301363261243082,0.0227705456732148,0.133159917362653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.00687934062887189,0.00459003130384244,-0.0158758019844031,0.00211712072665929,0.13396136741493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0335354727790686,0.0223862074363096,-0.0774124393542355,0.0103414937960983,0.134145742589976
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,39397,0.00909922197412355,0.00607417284633337,-0.00280615680468987,0.021004600752937,0.134148815765038
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37368,0.00549325248382354,0.0036764159426058,-0.00171252276368382,0.0126990277313309,0.135150137698738
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0064777963669984,0.00433680212105032,-0.00202233579026023,0.014977928524257,0.135278883104061
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.00419769043339917,0.00281206432508457,-0.0013139556437666,0.00970933651056493,0.135528449145005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.00442144690561917,0.00296391269912386,-0.0102307157959019,0.00138782198466359,0.135781762025917
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,36962,0.00832632951642765,0.00559360262327272,-0.00263713162518688,0.0192897906580422,0.13663127751721
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.0084482575459727,0.00568258917820246,-0.0195861323352495,0.00268961724330413,0.137120206842359
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39405,-0.00935205019774121,0.00630778373182777,-0.0217153063121236,0.00301120591664121,0.138195508407626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00258888318123103,0.00174675656631691,-0.000834759688750127,0.00601252605121218,0.138334543712384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.00390678861522703,0.00263953892806184,-0.00126670768377417,0.00908028491422823,0.138865451307657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00566204700041852,0.00383030869208998,-0.00184535803607785,0.0131694520369149,0.13937237597676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,36962,0.00623228181385518,0.00421932501242993,-0.00203759521050749,0.0145021588382178,0.139678151162115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,37453,-0.00267368650242407,0.00181361610402205,-0.00622837406630728,0.000881001061459148,0.140442946976381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0115832143425569,0.00785728848309706,-0.0269834997694272,0.0038170710843133,0.140447779825082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.00961492428828528,0.00654140233734889,-0.00320622429291854,0.0224360728694891,0.141619988556462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00421946589035822,0.00287410179526637,-0.00985270540908029,0.00141377362836386,0.142097339741644
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00554424450870536,0.00377761489274124,-0.0129483696984782,0.00185988068106747,0.142221200153801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00519194421668745,0.00354076553860045,-0.00174795623896943,0.0121318446723443,0.142577848779254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.00676579275093997,0.00461685644848419,-0.00228324588808905,0.015814831389969,0.142816599946366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00742672706580746,0.00507532612900758,-0.0025209121470474,0.0173743662786623,0.143408797081485
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37039,-0.010946311341552,0.00748382923065475,-0.0256146166336353,0.00372199395053131,0.143583782263153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0108051879556688,0.00744844379094502,-0.0254041377859211,0.0037937618745834,0.146893562227854
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.00956772690601936,0.00660054139200536,-0.0225047880343499,0.00336933422231114,0.147211324853239
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.00618922116044197,0.00427199935012095,-0.014562339886679,0.0021838975657951,0.147416748454222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.00720694877526521,0.00497774042591996,-0.0169633200100683,0.00254942245953792,0.147686168046757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.00433331859840392,0.00299471178140681,-0.0102029536899613,0.00153631649315342,0.147923300116148
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00714600394113802,0.00494083616867206,-0.00253803494945922,0.0168300428317353,0.148112934488959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.00522285378772816,0.00362072168799567,-0.0123194682961997,0.00187376072074336,0.14918364037658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.00460063627882412,0.00319213720832702,-0.0108572252071451,0.00165595264949684,0.149536510190169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,36991,-0.00512761091138536,0.00355795993844714,-0.0121012123907417,0.00184599056797103,0.149561635203999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.00527620769014048,0.00366461498744068,-0.0124588530655242,0.00190643768524325,0.149955271361893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.00600148367589917,0.00417046116090059,-0.00217262019946599,0.0141755875512643,0.150156992014111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.00488912216810629,0.00341077359739291,-0.0115742384189964,0.00179599408278382,0.151756713891215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37021,-0.00692628945922732,0.00483377657823661,-0.0164004915525711,0.00254791263411643,0.151911884434114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.00681513903852783,0.00476159236186685,-0.0161478600677868,0.00251758199073119,0.152375813041922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.00235565553930069,0.00164811024764981,-0.00558595162469432,0.000874640546092939,0.152935524141461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERVV_1,,37021,0.0064328918865267,0.0045099146614109,-0.00240654084983867,0.0152723246228921,0.153779856924159
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,37453,-0.00279507044031577,0.00196334776789545,-0.00664323206539086,0.00105309118475932,0.154578084964612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00579978193045072,0.00407604982834915,-0.0137888395940151,0.00218927573311361,0.154790991561241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.00879119244500919,0.00618150973707134,-0.00332456663965063,0.020906951529669,0.154999079342959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.00531357788289353,0.00373654251982699,-0.0126372012217544,0.00201004545596738,0.155029423998863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,40009,0.00393563047742208,0.00276921601905532,-0.00149203291992635,0.00936329387477051,0.155275764602989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.0122754110650478,0.00869247560758263,-0.0293126632559097,0.00476184112581419,0.157914006927498
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37437,-0.00382962841884063,0.0027225211837128,-0.00916576993891772,0.00150651310123645,0.159554741534349
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0114062052612771,0.00811109152671718,-0.0273039446536428,0.00449153413108861,0.159674246809847
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.00398568898228709,0.00283886327966528,-0.00954986101043103,0.00157848304585685,0.160345960600142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39421,0.00607544315844985,0.00433512491832615,-0.00242140168146942,0.0145722879983691,0.161100710576947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,39456,-0.00468903289944074,0.00335082202845836,-0.0112566440752191,0.00187857827633765,0.161722565873237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00470113900475013,0.00335975533314025,-0.00188398144820476,0.011286259457705,0.161757628838874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,39858,-0.00592977533166725,0.00424719700198138,-0.0142542814555508,0.00239473079221626,0.162685069953106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0189289156830593,0.0136597983653665,-0.00784428911305901,0.0457021204791776,0.165849460451765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.00398612622556847,0.00288297596939872,-0.00166450667445302,0.00963675912558995,0.166797850709154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,39885,-0.00305073367804705,0.0022130028832,-0.00738821932911905,0.00128675197302496,0.168052987064998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00383804875153765,0.00278969182865688,-0.00930584473570513,0.00162974723262983,0.168907328320487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,36991,-0.00603643315205833,0.004393444520329,-0.0146475844119032,0.00257471810778651,0.169476414150318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00466151404010617,0.00339613500851713,-0.0113179386567997,0.0019949105765874,0.169902138061829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.00794901432333479,0.0057922783288131,-0.0193018798478085,0.00340385120113888,0.169978960261376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,36991,-0.0116394579015126,0.00848688187387538,-0.0282737463743084,0.0049948305712831,0.17025361152894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,39868,-0.0045363022481904,0.00330869191716755,-0.0110213384058388,0.001948733909458,0.170386108628423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.00486215202231956,0.0035483398236565,-0.0118168980766863,0.00209259403204718,0.170628722307339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.00601245265098442,0.00438874403995768,-0.00258948566733263,0.0146143909693015,0.170714966826572
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00334480393701064,0.00244187560739555,-0.00144127225348463,0.00813088012750592,0.170782552506704
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0125182548677923,0.00914039903890051,-0.0304334369840373,0.00539692724845265,0.170849453402419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0124018662522195,0.00907598965516428,-0.0301908059763415,0.00538707347190248,0.171821754226505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0108441339448227,0.00794622769674671,-0.0264187402304463,0.00473047234080085,0.172373942828546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,37453,-0.00296220954584073,0.00217102058401119,-0.00721740989050266,0.0012929907988212,0.172454289561711
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00556462700518101,0.00407896156587136,-0.00243013766392687,0.0135593916742889,0.172519706236795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00763835135621845,0.00560768893592806,-0.0186294216706374,0.00335271895820054,0.173179184744279
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.00602406483570634,0.00444152541080145,-0.0147294546408772,0.0026813249694645,0.175021630371757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0131381716760459,0.00969040362436385,-0.00585501942770721,0.0321313627797991,0.17518800023944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,39587,0.0061902903558336,0.00456876165255136,-0.00276448248316706,0.0151450631948343,0.175463636917416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00695166485710814,0.00513418912878169,-0.00311134583530397,0.0170146755495202,0.175761422623538
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00948918402323971,0.00701505540213183,-0.0232386926114181,0.00426032456493868,0.176178491145097
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.00295537302100884,0.00218745116954512,-0.00724277731331726,0.00133203127129959,0.176696100457285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.00322491996102624,0.00238876279876243,-0.0079068950466006,0.00145705512454811,0.177026460437056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.00557225393532997,0.00412900020974856,-0.0136650943464372,0.00252058647577721,0.177182445306509
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37388,0.00381071215666821,0.00283255663096697,-0.00174109884002704,0.00936252315336347,0.178542522055437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,39585,-0.00894587357842093,0.00665742770282675,-0.0219944318759614,0.00410268471911949,0.179050812743758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,37437,-0.0113264581565375,0.0084466981998945,-0.0278819866283308,0.00522907031525567,0.179964570531396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00422898194968411,0.00315506134229097,-0.0019549382812062,0.0104129021805744,0.180144855018442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,39892,-0.00560884724282667,0.00419478747982425,-0.0138306307032822,0.00261293621762886,0.181209209224802
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00983677233462306,0.00735987622164164,-0.0242621297290407,0.00458858505979455,0.18139553362829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,39788,-0.00525075339855981,0.00393047618899784,-0.0129544867289956,0.00245297993187595,0.181598530976103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.0078655772755197,0.00589040211874571,-0.0194107654282613,0.00367961087722189,0.181794384697843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.00729023143798174,0.00547594110824481,-0.0180230760101416,0.00344261313417808,0.183102945858453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00776142777505239,0.00583155409391169,-0.0191912737991193,0.00366841824901452,0.183228741923074
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,39868,0.00474526285450374,0.00356636255199391,-0.00224480774740433,0.0117353334564118,0.183352461587213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0115422815911028,0.00867778128359689,-0.0285507329069527,0.00546616972474712,0.18350968261502
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,36991,0.0119976794029443,0.00902573069455743,-0.00569275275838822,0.0296881115642769,0.18378030804118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.0107808183310335,0.00812948002825154,-0.00515296252433951,0.0267145991864065,0.184816506618328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00366020116604501,0.00276432189576907,-0.00907827208175239,0.00175786974966238,0.185497298738212
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00628772819495617,0.00475866710590101,-0.0030392593326098,0.0156147157225221,0.186417028232032
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37039,-0.00334958053532089,0.00253608225144865,-0.00832030174816025,0.00162114067751847,0.186601106888222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.010475545391237,0.0079319543792377,-0.0260221759745429,0.00507108519206891,0.186632284452491
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,39587,-0.0111557627892976,0.00846084732915768,-0.0277390235544467,0.00542749797585143,0.18735016478712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,39783,-0.00895140463709239,0.00679589389314759,-0.0222713566676617,0.00436854739347689,0.187797786806623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00420505792779452,0.00319457622195464,-0.00205631146723657,0.0104664273228256,0.188091680371404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.0134513177944675,0.0103180826572463,-0.0336747598026703,0.00677212421373529,0.19237136393147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.0133992260255616,0.0102820625856802,-0.0335520686934949,0.00675361664237165,0.19254110950333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37056,0.00723093577077275,0.00557680628172665,-0.00369960454141147,0.018161476082957,0.194788515939958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.0101090009458015,0.00779869559421807,-0.0253944443104689,0.00517644241886596,0.194914701574042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,39585,0.00262942532967243,0.0020293416844711,-0.00134808437189093,0.00660693503123578,0.195096638635141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37021,0.00490358731560809,0.0037922310969411,-0.00252918563439647,0.0123363602656126,0.19601255158928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00818164391684019,0.00633219386589137,-0.0042294560603069,0.0205927438939873,0.196355252480067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,37411,-0.00261560791879421,0.0020251449468907,-0.00658489201469998,0.00135367617711155,0.196529589066054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00341048749892606,0.00264083513066449,-0.00176554935717633,0.00858652435502846,0.196568966169058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.00658163905077872,0.00510501831162002,-0.00342419683999652,0.016587474941554,0.197330260118297
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00597361084820525,0.00463795440482435,-0.015064001481661,0.00311677978525048,0.197774163119063
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37388,0.00444980957900712,0.00346779320002018,-0.00234706509303244,0.0112466842510467,0.199450326146467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,39931,0.00544996170165418,0.00425528958356929,-0.00289040588214164,0.01379032928545,0.200300009535632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.00606590227980282,0.00474012321058175,-0.0153565437725431,0.00322473921293742,0.200675700941395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0126433860309919,0.00989567750753057,-0.0320389139457518,0.00675214188376802,0.201385447444146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00298166018623341,0.00233876006538345,-0.00756562991438497,0.00160230954191815,0.202370331669537
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.0119664869968845,0.00938858110884524,-0.0303681059702211,0.0064351319764522,0.202480847098245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37368,-0.00625614361076308,0.00492188805624199,-0.0159030442009974,0.00339075697947121,0.203719899052347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00496710852850387,0.00390797813365769,-0.0026925286134652,0.0126267456704729,0.203744833724943
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37368,0.00472363683835533,0.00372206110635722,-0.00257160293010482,0.0120188766068155,0.204430228378639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39489,-0.00823086002076116,0.00648991557931775,-0.020951094556224,0.00448937451470163,0.204726225157303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,0.00696180039818108,0.00550209938791515,-0.00382231440213261,0.0177459151984948,0.205782402225346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,37169,-0.00510776812415187,0.00404652773830622,-0.0130389624912321,0.00282342624292832,0.206877538917178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00429363659209807,0.00340606745721655,-0.0109695288082425,0.00238225562404636,0.207480817220617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.00739484191877809,0.00587017536097171,-0.00411070178872645,0.0189003856262826,0.207788505623828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37021,0.00505941547986833,0.00402420501121808,-0.00282802634211911,0.0129468573018558,0.208686896555593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00287548898040072,0.00228724918446051,-0.00735849738194333,0.00160751942114189,0.208709313819996
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37031,0.00822766863159518,0.00656817381083932,-0.00464595203764988,0.0211012893008402,0.210352816343821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00347484171723325,0.00278104662483018,-0.00892569310190041,0.00197600966743391,0.211514568057175
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,37411,-0.00410470990534438,0.00329987618366879,-0.0105724672253352,0.00236304741464644,0.213558564136957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.00542110460949916,0.00436184576129125,-0.00312811308263168,0.01397032230163,0.213945964965719
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37021,-0.012809990732991,0.0103452543383351,-0.0330866892361278,0.00746670777014586,0.215646196386521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.00428705621614667,0.00347962092125091,-0.0111071132217985,0.00253300078950511,0.21795340010562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00502189398536143,0.00408133427470678,-0.0130213091637867,0.00297752119306386,0.218545670265575
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00649358862916294,0.00529021257653515,-0.0168624052791718,0.00387522802084595,0.219667234632906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00998772884738964,0.00813778615384705,-0.00596233201415059,0.0259377897089299,0.219721569905093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.00900944510497855,0.00735825239079781,-0.0234316197909423,0.00541272958098516,0.2208192921831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00694390328982723,0.00567570380363433,-0.0180682827449505,0.00418047616529605,0.221180537967194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,36962,0.00472528617419887,0.00386854867499236,-0.00285706922878615,0.0123076415771839,0.22193302729027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.00259444465185023,0.00212754328197326,-0.00157554018081736,0.00676442948451783,0.222689066202311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.00346419240207474,0.00285708251607384,-0.00213568932942998,0.00906407413357946,0.225342082160353
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,0.00410847198710866,0.00338998458207416,-0.00253589779375671,0.010752841767974,0.225551597513008
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,36962,0.0104813761904001,0.00865185472200876,-0.00647625906473705,0.0274390114455373,0.225740993046987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,39749,0.00138729007086483,0.00115353892112389,-0.000873646214537991,0.00364822635626765,0.229134246091258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,39455,0.00979180078013116,0.0081570980812172,-0.00619611145905455,0.0257797130193169,0.23000129919073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.00679556636601781,0.00567213929235576,-0.0179129593790351,0.00432182664699948,0.230914959561391
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00437621697073301,0.00365358902495436,-0.00278481751817754,0.0115372514596436,0.231021994652855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_A,,37411,-0.00362195048151939,0.00302639125123317,-0.00955367733393639,0.00230977637089762,0.231409908416578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.0080917690233849,0.00679793344179731,-0.00523218052253784,0.0214157185693076,0.233938817401737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37351,-0.00561802832053244,0.00472091824324765,-0.0148710280772978,0.00363497143623294,0.234056042788866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.00298249153274933,0.00250701015828548,-0.00789623144298887,0.00193124837749022,0.2342005697088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00394896672187024,0.0033246122615474,-0.0104652067545031,0.00256727331076266,0.234931180345951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37348,0.00643398127350608,0.00543300182269947,-0.00421470229898489,0.017082664845997,0.236338707542355
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00383646236565236,0.00324860038609036,-0.00253079439108475,0.0102037191223895,0.237639987155027
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00441013651713873,0.00373742689087642,-0.0117354932232565,0.00291522018897905,0.238024487207554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.00384110056378672,0.00327645185478112,-0.0102629461991577,0.00258074507158427,0.241080285011523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00574403319007967,0.00491748066103639,-0.00389422890555165,0.015382295285711,0.242793211646085
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.00547466190284165,0.00469989939077466,-0.00373714090307669,0.01468646470876,0.244102293361192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00426877743588532,0.00368585350545289,-0.00295549543480235,0.011493050306573,0.246822588040804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.00828233664487028,0.00715334838547485,-0.00573822619066043,0.022302899480401,0.246955234754445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00608128874565587,0.00528319260895279,-0.00427376876789159,0.0164363462592033,0.24972713554606
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00604397916989094,0.00526418026436432,-0.00427381414826312,0.016361772488045,0.250934571576394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.00358933334521571,0.00313360752077342,-0.00973120408593161,0.00255253739550019,0.252051151460185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00286358722711841,0.00251029625431787,-0.00205659343134461,0.00778376788558143,0.253996399035336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,37368,-0.00401013462091478,0.00352601750230347,-0.0109211289254296,0.00290085968360002,0.255433670581853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.00463215320076673,0.00407296364358591,-0.0126151619421951,0.00335085554066166,0.255436453770385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00637672132873192,0.00562824523885495,-0.0174080819968876,0.00465463933942379,0.257237535831868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00299373155709574,0.00266309941665038,-0.00821340641373048,0.00222594329953901,0.260968043528395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.00893726882405277,0.00799849587466278,-0.0246143207383918,0.00673978309028628,0.263857081242095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00486781139666404,0.004358070241188,-0.0134096290693925,0.00367400627606444,0.264026526330103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00349263846874788,0.00312825036764287,-0.00962400918932791,0.00263873225183215,0.264232486973672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00484360484350186,0.00434182099398282,-0.0133535739917082,0.00366636430470447,0.264626647751189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,39587,0.0032574803393258,0.00292060786435798,-0.00246691107481584,0.00898187175346744,0.264720390038969
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,39985,0.00313493772655496,0.00281806788140785,-0.00238847532100442,0.00865835077411434,0.265964638821675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.00936854863672442,0.00843282721969137,-0.0258968899873195,0.00715979271387067,0.266605047853321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,39587,-0.0051333068113496,0.00463997676662496,-0.0142276612739345,0.00396104765123532,0.268604240917016
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39477,0.00973543912901142,0.00881823058867067,-0.0075482928247831,0.0270191710828059,0.269604610819671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.00575696273158499,0.00524062675194077,-0.0160285911653889,0.00451466570221892,0.271995224533375
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.00296794922154729,0.00270409167051161,-0.00233207045265547,0.00826796889575005,0.27240549179839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.00827914572433782,0.00754388969157903,-0.00650687807115708,0.0230651695198327,0.272458872964519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-0.00414809987716284,0.0038049087264477,-0.0116057209810003,0.00330952122667466,0.275646330361385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00405378434542323,0.00372538563393065,-0.0113555401879273,0.00324797149708085,0.276548202319293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00391821143976139,0.00360127947307327,-0.010976719206985,0.00314029632746222,0.276612629111774
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37039,-0.00613053371504353,0.0056411079167616,-0.0171871052318963,0.00492603780180921,0.277162508915146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,39866,0.00393333895428863,0.00362238718045464,-0.00316653991940247,0.0110332178279797,0.277565398940337
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37039,-0.00612098561431882,0.00565371035112902,-0.0172022579025317,0.00496028667389406,0.278983919035067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00562149423602292,0.00522971154938273,-0.0158717288728131,0.00462874040076724,0.282429478441541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.00387996085947389,0.00361641797581826,-0.0109681400920777,0.00320821837312989,0.283343942080539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40030,-0.00382689350297059,0.0035733338501645,-0.010830627849293,0.00317684084335183,0.284203918217816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.00544538728360616,0.00508683746768001,-0.015415588720259,0.00452481415304665,0.284416838405843
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.00793250233705239,0.00741609448332364,-0.00660304285026194,0.0224680475243667,0.284804107915469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00645688870005808,0.00605691018610922,-0.0183284326648322,0.005414655264716,0.28642642249712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40052,-0.00193921443940833,0.00181972012548736,-0.00550586588536355,0.00162743700654689,0.286590400148518
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,39587,0.00473903000427221,0.00444788517233802,-0.0039788249335103,0.0134568849420547,0.28668557055791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.00619176781754463,0.00581517811523971,-0.0175895169234145,0.0052059812883252,0.287003570660759
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,37039,-0.00746700278318532,0.00703766619078262,-0.0212608285171192,0.00632682295074861,0.288706828781233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.00475037249037683,0.00447839521550264,-0.00402728213200834,0.013528027112762,0.288831647272539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00294694561242505,0.00278662392174465,-0.00840872849904456,0.00251483727419445,0.290287947851052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,39984,-0.00611093936448681,0.00578615887176764,-0.0174518107531514,0.00522993202417775,0.290924381529575
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,39587,-0.00512752674351314,0.00486529035962113,-0.0146634958483705,0.00440844236134427,0.291945154032893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00559620965276559,0.00531745281974431,-0.0160184171794644,0.00482599787393327,0.292624318246119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,37169,0.00566020599093196,0.00538063166198963,-0.00488583206656772,0.0162062440484316,0.292837281763745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,39866,0.00637553558073587,0.00606940231784502,-0.00552049296224037,0.0182715641237121,0.293532281982718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37021,0.00348306071040776,0.00331985017807277,-0.00302384563861487,0.0099899670594304,0.294122821966694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.00319857819452463,0.00304958742203219,-0.00277861315265847,0.00917576954170773,0.294263607263642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37039,-0.00417942954611361,0.00398898160808385,-0.011997833497958,0.00363897440573074,0.294776014888308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,38832,0.0047053528376514,0.00449560226521345,-0.00410602760216696,0.0135167332774698,0.295274775394829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.00508664566149452,0.00489267644028107,-0.0146762914844454,0.00450300016145638,0.298523837283413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00318890454090315,0.00306907230806328,-0.00282647718290088,0.00920428626470718,0.298802850315769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.00872758840352096,0.00840671368719348,-0.00774957042337825,0.0252047472304202,0.299207086961696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,39908,-0.00797026581983703,0.007730775813719,-0.0231225864147263,0.00718205477505221,0.302566307974349
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37021,-0.00522713520735205,0.00508319045436644,-0.0151901884979103,0.00473591808320616,0.303819260395144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00854888220772754,0.0083176686602691,-0.024851512781855,0.00775374836639989,0.304063802950198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,37021,0.00797289337083165,0.00776965726547431,-0.007255634869498,0.0232014216111613,0.304836131488388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.00751631993902162,0.00733159704559823,-0.0218862501483941,0.00685361027035091,0.305289274287056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37445,0.00246649391736364,0.00240728631434521,-0.00225178725875297,0.00718477509348025,0.305572490836385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00250149520342259,0.00244709622283282,-0.00229481339332975,0.00729780380017492,0.306690788191106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00549996464125478,0.00538138971109548,-0.0160474884750019,0.00504755919249236,0.306782962394181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,36962,-0.00687128983658106,0.00672349024816061,-0.0200493307229759,0.00630675104981373,0.306808019754403
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37056,0.00365240634982966,0.00358241731477595,-0.00336913158713121,0.0106739442867905,0.307966874107243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,39788,0.00143726668245656,0.00141036147180414,-0.00132704180227956,0.00420157516719268,0.308181976528035
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,36991,-0.00554740113920494,0.00545354940334148,-0.0162363579697542,0.00514155569134436,0.309072617002964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00260195798652458,0.00255829836925356,-0.0024123068172124,0.00761622279026156,0.309137285954469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.00464062346416808,0.00457406143480171,-0.0136057838763794,0.00432453694804327,0.31033755275184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37021,-0.00719045037202298,0.00709307268627774,-0.0210928728371273,0.0067119720930814,0.310730927177202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00647022482848305,0.00638733955270698,-0.00604896069482263,0.0189894103517887,0.311089803541854
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.00878615363319963,0.00869715367319336,-0.0258325748326586,0.00826026756625936,0.312402218841839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.00585645931327327,0.00579976039007577,-0.00551107105127525,0.0172239896778218,0.312621146530291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.0109600541716019,0.0109363510978755,-0.0323953023234378,0.0104751939802341,0.316281233334949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00324678103311492,0.0032399117157519,-0.0031034459297588,0.00959700799598864,0.316303958517686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00277306931645962,0.00277255113032414,-0.00266113089897569,0.00820726953189494,0.317237893406827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,37453,0.00137334410657239,0.00137723572558516,-0.00132603791557453,0.00407272612871931,0.318697651000621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00638958545876114,0.00641406509886446,-0.0189611530525355,0.00618198213501321,0.31917928838712
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.0038068265178612,0.0038400204737799,-0.00371961361074741,0.0113332666464698,0.32152686740093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00505360703520418,0.00509979826214878,-0.00494199755860744,0.0150492116290158,0.321731939241462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00448362677166339,0.00453594181643759,-0.0133740727318811,0.00440681918855429,0.322942354292946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTN,Titin,37021,-0.00632640366754544,0.00641231009160036,-0.0188945314470821,0.00624172411199126,0.323855490104289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.00510083948396557,0.00517260249958962,-0.00503746141523009,0.0152391403831612,0.324089208114561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,-0.00504894566951623,0.00512664445981248,-0.0150971688107487,0.00499927747171622,0.324715793918069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00310735655433586,0.0031611269163041,-0.00930316531029191,0.00308845220162018,0.325630342092311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,39913,0.00261560476739666,0.002664093690912,-0.00260601886679086,0.00783722840158418,0.326213631701578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00486049818117087,0.00496295680988853,-0.0145878935285524,0.00486689716621064,0.327422525620131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,39868,-0.00217923673798195,0.00223970908496332,-0.00656906654451006,0.00221059306854617,0.330568048807933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.0038175193701084,0.00392712032543427,-0.0115146752079596,0.00387963646774277,0.331023011752131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.0047470255398451,0.00488722664085271,-0.0143259897559164,0.0048319386762262,0.331407500414865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00300900846885369,0.0030983888391829,-0.0030638336559448,0.00908185059365217,0.331487089169122
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.00297063542149831,0.00306117560939128,-0.00897053961590522,0.00302926877290861,0.331853005529725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.00334464282358015,0.00344876263627825,-0.0101042175906855,0.00341493194352522,0.332158810204617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,36991,-0.00581116796570099,0.00602071892550866,-0.017611777059698,0.00598944112829599,0.334464912444898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,36991,0.00425748115689533,0.00442472393698447,-0.00441497775959423,0.0129299400733849,0.335965529632468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0127348303930013,0.0132531709213066,-0.0387110453987622,0.0132413846127596,0.336622686556021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.0062043220480692,0.006458177181804,-0.018862349324405,0.00645370522826664,0.336724282107493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00520771629673347,0.00542219372521183,-0.0158352159981487,0.00541978340468172,0.336846405900121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,39587,-0.00555698068293218,0.00583246113890084,-0.0169886045151778,0.00587464314931347,0.340722417262486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.0046981033757998,0.00495322482573394,-0.0144064240342383,0.00501021728263872,0.342895314646873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00352256890357362,0.00372146528704607,-0.0108166408661839,0.00377150305903667,0.34388332762379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.00232465636580734,0.0024620720341364,-0.00715031755271468,0.0025010048211,0.345091516415663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00325905836017753,0.00345349509904633,-0.00350979203395328,0.0100279087543083,0.345341031923837
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.00361740846691049,0.00383517123557006,-0.0111343440886278,0.00389952715480683,0.345585908475805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.00523719827385248,0.00556193878194894,-0.0161385982864724,0.00566420173876743,0.346407495927267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,37056,0.00505728375296163,0.00539012002793283,-0.00550735150178673,0.01562191900771,0.348132773836626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00176993063268866,0.00188996193359695,-0.00547425602253868,0.00193439475716135,0.349038047445858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00294846762454298,0.00315160112146997,-0.00322867057353815,0.00912560582262411,0.349524263623276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,39913,-0.00332284727416638,0.00355772830076481,-0.0102959947436654,0.00365030019533265,0.350328229346129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,36962,0.00366012956022183,0.00392915195940929,-0.00404100828022038,0.011361267400664,0.351595764629503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.00467822978441924,0.00503262657915085,-0.0145421778795549,0.00518571831071642,0.352605101469897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.00555464207626001,0.00597614814314736,-0.00615860828430882,0.0172678924368288,0.352663412011826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00419233507200351,0.0045234660103956,-0.00467365830837186,0.0130583284523789,0.354048937063138
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00374028970196465,0.00405403206564744,-0.00420561314670434,0.0116861925506336,0.356227049630062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,39587,-0.0124648897908969,0.0135236112894504,-0.0389711679182198,0.0140413883364259,0.356692380320209
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40009,0.00248303671737864,0.00269989191944569,-0.00280875144473491,0.00777482487949218,0.357753721274672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.00625259920416345,0.00688121274032282,-0.00723457776686928,0.0197397761751962,0.363552713095367
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.00331370187757996,0.00365622681543775,-0.010479906435838,0.00385250268067803,0.364784485582335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37169,-0.00380542659654794,0.00420827838620348,-0.0120536522335068,0.00444279904041088,0.365867773945283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,39585,0.00273435742798151,0.0030299946079902,-0.00320443200367929,0.0086731468596423,0.366842419352859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00456292995935781,0.00506101552304977,-0.00535666046581974,0.0144825203845354,0.367294499002912
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,-0.00493133756459669,0.00548199560551242,-0.015676048951401,0.00581337382220765,0.368375454157593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00271833166116125,0.0030240994254456,-0.00320890321271212,0.00864556653503462,0.368727926264535
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.0063353987902198,0.00705084707474533,-0.00748426147628105,0.0201550590567206,0.368919445872387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00214735279907472,0.00240443539629707,-0.00256534057766755,0.00686004617581698,0.371830816682815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37169,-0.00442691033071408,0.00496753946455469,-0.0141632876812413,0.00530946701981311,0.372855361856959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,39858,0.00159452805146649,0.0017938492354357,-0.00192141644998748,0.00511047255292046,0.374077541303227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.00347493832581075,0.00391026051706571,-0.0111390489392595,0.00418917228763803,0.374195305050911
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,37368,-0.00910477484914532,0.0102838289682697,-0.029261079626954,0.0110515299286634,0.375984338427342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00727438143133058,0.00825127149133992,-0.0234468735543568,0.00889811069169567,0.378002757869963
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00327007574069424,0.0037102645908838,-0.0105421943388265,0.00400204285743802,0.378137000170554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,39546,-0.00591224961734657,0.00675886227851786,-0.0191596196832416,0.00733512044854844,0.381728587745536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00256930536074241,0.00294295219389141,-0.00833749166076958,0.00319888093928476,0.382656387014342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.0021777856869723,0.00249581194706014,-0.00271400572926558,0.00706957710321018,0.382910101132877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00174529658999523,0.00200404829189046,-0.00567323124210054,0.00218263806211008,0.383832137748067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00680397051094683,0.00787861271873816,-0.0222460514396736,0.00863811041777996,0.387823340870268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.00180074002810668,0.00208606483231193,-0.00588942709943807,0.0022879470432247,0.388027589009852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.00520707992791171,0.00604939760659596,-0.00664973938101638,0.0170638992368398,0.389385858179842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00312978957869555,0.00364218544427515,-0.0102684730494748,0.00400889389208374,0.390179174170601
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.0039442565975057,0.00459054313031327,-0.0129417211329197,0.0050532079379083,0.390235918434314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00469927690242623,0.00548449647931344,-0.00605033619702811,0.0154488900018806,0.39155469552177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37039,-0.00281795662897918,0.00329301655823216,-0.00927226908311422,0.00363635582515585,0.392158739694864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,39699,-0.00542495726970151,0.00634090526254738,-0.0178531315842944,0.00700321704489135,0.39226004707628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37411,0.00357904193592018,0.00419485020816222,-0.00464286447207776,0.0118009483439181,0.393564047009494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,39913,-0.00235169454088842,0.00275716154579924,-0.00775573117065493,0.00305234208887809,0.393705068054227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00270683242310014,0.00317793962978423,-0.00352192925127695,0.00893559409747723,0.394364493175322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.00449476316501514,0.0052952969618364,-0.00588401888018421,0.0148735452102145,0.39599596646432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.00487457662432452,0.00575638950319544,-0.0161571000505876,0.00640794680193854,0.397112971048822
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00408926430039773,0.00487532815970103,-0.0136449074934118,0.00546637889261629,0.401615145154497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00294818509481454,0.00351637480022297,-0.00984027970325155,0.00394390951362248,0.401812260640251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00466592168628259,0.00559163555796348,-0.015625527379891,0.00629368400732583,0.404044539760579
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00267416041123205,0.00322694026465393,-0.00899896332995376,0.00365064250748965,0.407287725105202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,39587,-0.00366133271102438,0.00442561930868278,-0.0123355465560426,0.00501288113399388,0.408077309712014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.00495299989080202,0.00599777499774586,-0.00680263910477986,0.0167086388863839,0.408929062327661
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00509097463001165,0.00616493854215907,-0.00699230491262013,0.0171742541726434,0.408935266206676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00497129294002025,0.00602788946065568,-0.0167859562829054,0.00684337040286488,0.409548143605632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.00498269441488524,0.00605710840913127,-0.00688923806701205,0.0168546268967825,0.410739410836628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.00255492297671847,0.00311089693458559,-0.00865228096850623,0.00354243501506929,0.411498014703135
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00296129314748158,0.003606265158505,-0.0100295728581514,0.00410698656318823,0.41157395849511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00281003489380278,0.00342619185687451,-0.00390530114567126,0.00952537093327681,0.412138194340473
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.00929816980644517,0.0113575666888995,-0.0315590005166882,0.0129626609037978,0.412983569946467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00212036412391077,0.0025951929452569,-0.00296621404879275,0.0072069422966143,0.413920563351439
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37056,-0.00198714594344246,0.00244818745187663,-0.00678559334912066,0.00281130146223574,0.416989643627159
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.00158177912827365,0.00195241005942817,-0.00224494458820556,0.00540850284475287,0.417856031631621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.00181283295304017,0.00223876801129639,-0.00257515234910075,0.0062008182551811,0.418100518050741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.00170751742035774,0.00211476725625343,-0.00585246124261446,0.00243742640189899,0.419435448862887
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,39585,-0.00365574590570329,0.00454295218423208,-0.0125599321867982,0.0052484403753916,0.421000883855758
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,36991,0.00400189165534647,0.00497351815144396,-0.00574620392148369,0.0137499872321766,0.421042019306393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0063002566078124,0.00783195458680452,-0.0216508875979493,0.00905037438232446,0.421163470111868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37388,-0.00278192135691428,0.00349312186544899,-0.00962844021319431,0.00406459749936575,0.425813702789066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37388,-0.00203493387697436,0.00256168072135884,-0.00705582809083768,0.00298596033688897,0.426991371607258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.00292338069118514,0.00370605433383179,-0.0101872471854954,0.00434048580312516,0.430235571735923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.00774528376483119,0.00988553947291721,-0.0116303736020865,0.0271209411317489,0.43334938289141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.00351366230001136,0.00449420442462334,-0.00529497837225039,0.0123223029722731,0.434333948390254
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00225667300510867,0.00288779880706054,-0.00340341265673,0.00791675866694733,0.434551357971658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00242226258631199,0.00309970557916949,-0.00365316034886021,0.00849768552148419,0.43455237370008
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,39477,0.00613956100430913,0.00787345751628859,-0.0092924157276165,0.0215715377362348,0.435532474111983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,37453,0.00133060552007431,0.00171221809805961,-0.00202534195212253,0.00468655299227115,0.437099227727702
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,39885,0.00231676123075985,0.00298635981040573,-0.00353650399763537,0.00817002645915508,0.437889746616615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.00469391163917559,0.00607714581822805,-0.0166051174429026,0.00721729416455138,0.439898408626061
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.0055929378071683,0.00724339490089773,-0.00860411619859125,0.0197899918129278,0.440043109275949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00261728721096509,0.00340255092590605,-0.00405171260381077,0.00928628702574096,0.441778285536128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,39862,0.00159927490987051,0.00208020849917245,-0.0024779337485075,0.00567648356824853,0.442020365289045
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.00396381347089102,0.00515825159557724,-0.0140739865982224,0.00614635965644036,0.442236682071441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37368,-0.0024568831479844,0.00320041698561167,-0.00872970043978327,0.00381593414381447,0.442693146585259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-0.00415675529404439,0.00541597943931725,-0.0147720749951062,0.00645856440701742,0.442799072694793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,0.00241917720250936,0.00315642372847823,-0.00376741330530797,0.0086057677103267,0.443431954228327
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00339481712416308,0.00443053496449235,-0.0120786656545681,0.00528903140624192,0.443552067571514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,37056,0.00731562381892349,0.00957350005825257,-0.0114484362952516,0.0260796839330985,0.444789421392496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.0039926761909566,0.00522605000979239,-0.0142357342101497,0.00625038182823648,0.444881354035153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,36868,0.00312114089123722,0.00409768720229753,-0.00491032602526594,0.0111526078077404,0.446262710857414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37039,0.00422979931857164,0.00555461485582273,-0.00665724579884092,0.0151168444359842,0.446376392855252
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.0020136301104107,0.00264725953938224,-0.00720225880759989,0.00317499858677849,0.446881441315394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.00284940611039371,0.00376228719095329,-0.00452467678387474,0.0102234890046622,0.448845320072992
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.00447463530515272,0.0059138457414009,-0.00711650234799305,0.0160657729582985,0.449278539055075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,39889,-0.00209721030987175,0.00277333654717503,-0.00753294994233482,0.00333852932259131,0.449537550056863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00237014773022998,0.00314463704418276,-0.00853363633682819,0.00379334087636823,0.45103622073624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.00836046686823049,0.0111159688162798,-0.0301477657481388,0.0134268320116778,0.451994052190906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37039,-0.00338974893032934,0.00452443389657029,-0.0122576393676071,0.00547814150694842,0.453744306450679
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.00590072955511314,0.0078932080636684,-0.0213714173599032,0.00956995824967692,0.454730295845229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,39477,-0.0114993063330762,0.0154126118534028,-0.0417080255657457,0.0187094128995933,0.455619939313934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0104941104696362,0.0141287035170572,-0.0381863693630683,0.0171981484237959,0.457643242419961
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00352019494578611,0.00478201985680825,-0.00585256397355806,0.0128929538651303,0.461663712371479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.00361465602777151,0.00491575647254444,-0.00602022665841558,0.0132495387139586,0.462155419364163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00409117449635269,0.00556625012273282,-0.015001024736909,0.00681867574420363,0.462354736718034
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00285527368057338,0.0038994172765139,-0.0104981315425406,0.00478758418139385,0.464040563237494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.00516024987509523,0.00705460361431702,-0.00866677320896613,0.0189872729591566,0.464503533474926
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.0037072297443934,0.00510543321096329,-0.0137138788378814,0.00629941934909464,0.467769390066018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.00207051554157911,0.00285812912927057,-0.00767244863494943,0.00353141755179122,0.468812338640857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,36903,0.00232811258484252,0.00321904579538535,-0.00398121717411277,0.00863744234379781,0.469551160005334
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.00322592578271926,0.00447733548816675,-0.0120015033395261,0.00554965177408756,0.471226962071924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.00710750957310961,0.00987166123479119,-0.0264559655933003,0.0122409464470811,0.471543206655646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37124,0.00632109391591063,0.00880703852982369,-0.0109407016025438,0.0235828894343651,0.472935150955447
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.00652032226066689,0.0091307607512829,-0.0244166133331814,0.0113759688118476,0.475174894527463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.00370149099716811,0.00520132402742152,-0.0138960860909143,0.00649310409657807,0.476697837625807
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00529545032841001,0.00746664145668103,-0.0199300675835048,0.0093391669266848,0.478204001222204
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00249983463567839,0.0035286833896992,-0.00441638480813203,0.00941605407948882,0.478689052720433
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37056,0.00173269514463172,0.00245598743913113,-0.00308104023606529,0.00654643052532873,0.480512596717667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37056,0.00359503962324221,0.00510009564669601,-0.00640114784428196,0.0135912270907664,0.480887082848196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.00488365584430203,0.00695447971152338,-0.0185144360788878,0.00874712439028379,0.482544793745092
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,37169,0.00233215035447613,0.00332725702082041,-0.00418927340633187,0.00885357411528414,0.483363439944512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.00302324553657771,0.00433087076350942,-0.0115117522330562,0.00546526115990074,0.485146516727039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,39964,-0.00217777290748015,0.00312688372186309,-0.00830646500233181,0.00395091918737152,0.486146151992698
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00475158244658693,0.00684555770783811,-0.0181688755539496,0.00866571066077576,0.48762431199529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37186,0.0114257913641539,0.0165052555063978,-0.0209245094283859,0.0437760921566937,0.488791331292214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,36991,-0.00416087530315176,0.00602951829454356,-0.0159787311604571,0.00765698055415361,0.490153435218637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37169,-0.00270143221608644,0.00393490403809002,-0.0104138441307429,0.00501097969856999,0.492390505639787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39477,-0.00256012251723286,0.00372945837914804,-0.00986986094036302,0.00474961590589729,0.492433522015291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,39749,0.00270682513467901,0.00394590210233456,-0.00502714298589674,0.0104407932552547,0.49273329869438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37056,-0.00223507823315904,0.00326204802317629,-0.00862869235858457,0.00415853589226648,0.493244666363194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00320040242521032,0.00470186384356017,-0.00601525070816762,0.0124160555585882,0.496094348356466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.0044113306816045,0.00648868277137777,-0.0171291489135049,0.00830648755029592,0.496609188510082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.00657598424804414,0.00970711319999085,-0.0256019261200262,0.0124499576239379,0.498138882677851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.00200983290226674,0.00297242347109048,-0.00783578290560408,0.0038161171010706,0.498949037466539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37124,0.00278165539926217,0.00411996164157532,-0.00529346941822545,0.0108567802167498,0.499582478705009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37437,0.00496298116792227,0.00736959977162787,-0.00948143438446836,0.0194073967203129,0.500679052892662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00370099972396251,0.00551874751421412,-0.00711574540389717,0.0145177448518222,0.502472439307858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00199768770667074,0.00299551815082148,-0.00786890328228084,0.00387352786893936,0.504852707819597
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00371994486303366,0.00560438664118475,-0.0147045426797558,0.00726465295368844,0.506858215605192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.0035586304968119,0.00536840987126972,-0.00696345285087676,0.0140807138445006,0.507416460175357
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00306055566354359,0.00464198319903972,-0.00603773140657426,0.0121588427336614,0.50970102789573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00165096844563455,0.0025106870234134,-0.00326997812025571,0.00657191501152482,0.510821574258754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00289691944824628,0.00443297766686049,-0.0115855556752928,0.00579171677880027,0.513448176423292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.00340596043073063,0.00522662977977296,-0.00683823393762437,0.0136501547990856,0.51463472133362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,39775,0.0020494407665993,0.00314546118938971,-0.00411566316460453,0.00821454469780314,0.514697734350019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37056,-0.00133096752454739,0.00204297054009123,-0.00533518978312619,0.00267325473403141,0.514743898021036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,37368,-0.00304098150535067,0.00467437681494594,-0.0122027600626447,0.00612079705194337,0.515339009055497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.00365425021523115,0.00562544124717981,-0.00737161462924127,0.0146801150597036,0.515966133821164
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00219953497935064,0.00338956838417669,-0.00884308901233696,0.00444401905363568,0.516403985045245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00171681878673719,0.00265250282421555,-0.00348208674872528,0.00691572432219966,0.517483023467998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37039,0.00408233615344557,0.00631468674644997,-0.00829444986959637,0.0164591221764875,0.517978012528789
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,-0.00465590000915375,0.00721688306213698,-0.0188009908109422,0.00948919079263474,0.518847688342345
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,39587,0.00322709760419867,0.0050047192327208,-0.00658215209193409,0.0130363473003314,0.519059130861249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.00216976133346281,0.00336742220462509,-0.00876990885452799,0.00443038618760237,0.519366759092166
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,39720,-0.00275764017220535,0.00431185734715123,-0.0112088805726218,0.00569360022821105,0.522475670684137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00308015031785329,0.00481814060130905,-0.012523705896419,0.00636340526071246,0.522650639690637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,-0.00428924284038962,0.00671440747095398,-0.0174494814834594,0.00887099580268018,0.522956476134988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00289088329565923,0.0045319111532618,-0.0117734291560524,0.0059916625647339,0.52355313984942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00225367683067106,0.00353582440624346,-0.00918389266690824,0.00467653900556613,0.523884223769296
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37056,0.00164587701778357,0.00258667546182635,-0.00342400688739607,0.00671576092296321,0.524598132931618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.00189779145321284,0.00299188501525512,-0.00396630317668719,0.00776188608311288,0.52588582472247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00188395823934462,0.00297178987098546,-0.00394074990778688,0.00770866638647612,0.526124420185222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00404212600540685,0.00638383805003235,-0.0165544485834703,0.00847019657265655,0.526626224428872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.00435276695156025,0.00687602209291769,-0.0178297702536789,0.00912423635055843,0.526721040273546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00149869238524087,0.00237369000762257,-0.00315374002969937,0.00615112480018112,0.527805327657242
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00356440711247469,0.00564645786007357,-0.0146314645182189,0.00750265029326951,0.527876673481462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.00241178669237758,0.0038425618368598,-0.00994320789262278,0.00511963450786762,0.530243402087994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.00419310615723009,0.00668770486907527,-0.0173010077006176,0.00891479538615745,0.530678301512875
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37056,0.00373939329470073,0.00598119183045329,-0.00798374269298772,0.0154625292823892,0.531855861281128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.00210771986487823,0.00338047665109944,-0.00451801437127667,0.00873345410103312,0.532966376118847
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00463871286265654,0.00748254836980583,-0.019304507667476,0.0100270819421629,0.535309670068925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00290827925924732,0.00470280669826562,-0.0063092218693533,0.0121257803878479,0.536313535961162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.00354938071059952,0.00575820103016361,-0.0148354547297202,0.00773669330852116,0.537637979398248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,39858,0.0109318400618922,0.0177439430901014,-0.0238462883947064,0.0457099685184909,0.537844848060604
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,0.00273496385475285,0.00449538526647036,-0.00607599126752906,0.0115459189770348,0.54293520764955
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0065549790861238,0.0108412765031223,-0.0278038810322435,0.0146939228599959,0.545433884120794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00263355405969884,0.00437425856302552,-0.0112071008432289,0.00593999272383118,0.547146404439061
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00230636888130951,0.00383226779999323,-0.00520487600667722,0.00981761376929624,0.547298495333113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,37169,0.0093088380387326,0.0154895997418282,-0.0210507774552507,0.0396684535327159,0.547867911375547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.00524278315165835,0.00873548577481312,-0.0118787689669754,0.0223643352702921,0.54840274339042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00223039495823754,0.00371767765038209,-0.00505625323651135,0.00951704315298644,0.548554186777379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00182362566618753,0.00304288150753161,-0.00414042208857442,0.00778767342094949,0.548977320099542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,39587,0.00226422011474235,0.00378206755890179,-0.00514863230070516,0.00967707253018985,0.549399872929395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,39764,0.00379380901940357,0.0063519858362077,-0.00865608321956352,0.0162437012583707,0.5503400010453
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,-0.00220330169291179,0.00371775154026466,-0.00949009471183052,0.00508349132600694,0.553429852445292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.00401731293771338,0.00681310559111975,-0.0173709998963081,0.00933637402088134,0.555438890639942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,39415,-0.00165324010594092,0.00283361215216821,-0.00720711992419061,0.00390063971230878,0.559606205989258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,39720,0.00170381901928256,0.00293936214240239,-0.00405733077982612,0.00746496881839124,0.562154827391184
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,36962,0.0023835744336434,0.00412777438681391,-0.00570686336451187,0.0104740122317987,0.563646882230513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37445,0.00332673090472938,0.00576158959597886,-0.00796598470338919,0.014619446512848,0.563680123886484
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00247143762107519,0.00428639929560754,-0.010872780240466,0.0059299049983156,0.564235330779058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37437,0.0026953035615342,0.00467827314280278,-0.00647411179835925,0.0118647189214276,0.564535412271403
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00315093838468768,0.00551884207982645,-0.0139678688611475,0.00766599209177218,0.568048750764701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00188489377839078,0.00330306404274916,-0.00458911174539757,0.00835889930217913,0.568246589384861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.0018880445600933,0.00332276439407142,-0.00462457365228669,0.00840066277247328,0.569898657751291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,36991,-0.00330171166032548,0.00581664994172307,-0.0147023455461027,0.00809892222545173,0.57029515970993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,36991,-0.00251669550632429,0.00444915981530635,-0.0112370487443247,0.00620365773167615,0.571637078065402
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.00251916950830372,0.00445464533006705,-0.00621193533862769,0.0112502743552351,0.57173310802499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.00456063484790268,0.00821374470875959,-0.0206595744770715,0.0115383047812661,0.578736763578253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.00263960623852981,0.00475965928270863,-0.00668932595557911,0.0119685384326387,0.579192201702293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37424,-0.00116157804315,0.00211698331048381,-0.00531086533169826,0.00298770924539826,0.583223846297062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00241310509696604,0.00440295555704911,-0.00621668779485021,0.0110428979887823,0.583655338466729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,36962,-0.00371399008751872,0.00678485655316862,-0.0170123089317292,0.00958432875669177,0.584117367981441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39489,-0.00374465125655695,0.00685520308083491,-0.0171808492949934,0.00969154678187947,0.584902241585641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.00956529259656455,0.0175145354567229,-0.0438937820917413,0.0247631968986122,0.584981108235809
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,-0.0017582130531491,0.00321976501630812,-0.00806895248511301,0.00455252637881482,0.585027833831421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,39858,0.00140677958638562,0.00259708461471034,-0.00368350625844665,0.00649706543121789,0.588048956196104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.00361660257839105,0.00670258780163603,-0.00952046951281558,0.0167536746695977,0.589493777467864
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00283476789049879,0.00526979341041459,-0.0131635629749114,0.00749402719391381,0.590636075346534
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,37021,-0.00188765940832842,0.00351973043698537,-0.00878633106481974,0.0050110122481629,0.591754802708053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.00117005918983373,0.0021995819993565,-0.00314112152890501,0.00548123990857247,0.59477064956357
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.0023853011750738,0.00449687239569806,-0.011199171070642,0.0064285687204944,0.595818673210334
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,-0.00197124980169877,0.00375022946902437,-0.00932169956098654,0.005379199957589,0.599151076250791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.00173745234953045,0.0033065581999751,-0.00474340172242075,0.00821830642148165,0.599273183837832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,39908,-0.0011627104205244,0.00221857771508473,-0.00551112274209046,0.00318570190104167,0.600230696938399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,-0.00841390292059262,0.0161027802668013,-0.0399753522435232,0.023147546402338,0.601320926772523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00567166896286852,0.0108605351444225,-0.0269583178459366,0.0156149799201996,0.601520804406208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39477,-0.004971301207029,0.00952421330081631,-0.023638759276629,0.013696156862571,0.601702452772399
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.00160911454781143,0.00308379693583576,-0.00765335654204952,0.00443512744642666,0.601820770615566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00147107040369672,0.00282480364734521,-0.0040655447450999,0.00700768555249334,0.602534974925013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00363945041192179,0.00703821815873911,-0.0174343580030504,0.0101554571792069,0.605096272977078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40030,0.00150138319366769,0.00290861135232915,-0.00419949505689744,0.00720226144423282,0.605731869587076
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37382,-0.012270532300705,0.0237902576686236,-0.0588994373312072,0.0343583727297972,0.606016705185509
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,39787,0.00117785456466482,0.00231416819755374,-0.00335791510254051,0.00571362423187015,0.610776554186346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37424,0.00178044268782065,0.00351110326952971,-0.00510131972045758,0.00866220509609889,0.612100448203879
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.000955278608560054,0.0018924756773306,-0.00275397371900792,0.00466453093612803,0.613722239546238
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,37039,-0.00183945921352335,0.00364808168280336,-0.00898969931181793,0.00531078088477122,0.61411069691671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,0.00187169202900036,0.00372315707073054,-0.00542569582963151,0.00916907988763222,0.61517210640908
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,36962,-0.00312599687366864,0.00623744434859179,-0.0153513877969085,0.00909939404957127,0.61626251272268
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37056,0.00137104104205558,0.002744261547767,-0.00400771159156775,0.00674979367567891,0.617363041478256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00194874144475568,0.00390466065225564,-0.00960187632317674,0.00570439343366538,0.617729392797875
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.00225547582514017,0.00452399752853228,-0.0111225109810634,0.00661155933078309,0.61809878798272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37169,0.00408179806805888,0.00823638430045483,-0.0120615151608326,0.0202251112969503,0.620198029097432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.0023091604324585,0.00472402699388393,-0.011568253340471,0.006949932475554,0.624983022476963
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00249487532255454,0.00510483430375774,-0.0125003505579197,0.00751059991281063,0.625042476932866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39477,0.00401094248405101,0.00829821592302775,-0.0122535607250834,0.0202754456931854,0.628854035593603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.00332728648419003,0.00688639583072477,-0.0168246223124106,0.0101700493440305,0.628982956766332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00135817934459547,0.00281857593532377,-0.00416622948863913,0.00688258817783006,0.62990830605405
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00242182713967168,0.0050573526310721,-0.012334238296573,0.00749058401722964,0.632036029170866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,37056,0.00343122483180622,0.00716976831170152,-0.0106215210591288,0.0174839707227412,0.632253603987624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,0.00179824132190293,0.00378972340212504,-0.00562961654626214,0.009226099190068,0.635147878296549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00265300249138327,0.00560107618303924,-0.0136311118101402,0.00832510682737364,0.635750450973983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00260495407414743,0.00550759894682595,-0.00818993986163143,0.0133998480099263,0.63623917469893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0011800304527412,0.00250656494003641,-0.00373283682973017,0.00609289773521256,0.637808329180325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00283683124522623,0.00605393189441514,-0.0147025377582799,0.00902887526782744,0.639366982835618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37382,-0.00498127423666842,0.0106710080903301,-0.0258964500937155,0.0159339016203787,0.640647300935091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.00130148337446105,0.00278925751044259,-0.00676842809492853,0.00416546134600643,0.640789731213832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,36818,-0.00170743422165623,0.00367477470665028,-0.00890999264669078,0.00549512420337833,0.642199641871436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,-0.00158111760165389,0.00341073426875655,-0.00826615676841673,0.00510392156510895,0.642962768987786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39456,-0.00268355065999805,0.00581950472163554,-0.0140897799144037,0.00872267859440761,0.644711468131061
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00136200361262245,0.00296909217443461,-0.0044574170492694,0.00718142427451429,0.646437587930703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00111549114961139,0.00243367565070941,-0.00365451312577906,0.00588549542500184,0.646702561026094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,39826,-0.00113162788975826,0.00246919526830105,-0.00597125061562832,0.0037079948361118,0.646744413196821
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00107427276241875,0.00236362298862418,-0.00355842829528464,0.00570697382012214,0.649473231518713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.00357356139787668,0.00787099741223978,-0.0118535935301133,0.0190007163258666,0.649824473164023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00131565425019652,0.00290029895247755,-0.00436893169665949,0.00700024019705253,0.650103328637561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.00290006758819157,0.00641694447258565,-0.00967714357807629,0.0154772787544594,0.651320342271082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37056,-0.00124969549928168,0.00277657183302289,-0.00669177629200655,0.00419238529344319,0.652655983274617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.00163420224685673,0.00363988056255201,-0.00549996365574521,0.00876836814945867,0.653458401367505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00207725710337548,0.00464320108590987,-0.00702341702500787,0.0111779312317588,0.654609747945677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,-0.00116025352731658,0.00260632936343784,-0.00626865907965474,0.00394815202502157,0.656205902574889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00377958182905442,0.00853536845290135,-0.0205089039967411,0.0129497403386322,0.657907434194091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37021,0.00278858276350168,0.00632587568725877,-0.00961013358352552,0.0151872991105289,0.659349381569958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37021,-0.0020105426307799,0.00457166991771069,-0.0109710156694928,0.00694993040793305,0.660101515446617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.00210919830316959,0.0048453699442828,-0.0116061233939639,0.00738772678762469,0.663350845657827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,39952,0.00160865665288155,0.00369700561312364,-0.00563747434884079,0.00885478765460389,0.663478105508806
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37021,0.00240400461574526,0.00553760952104263,-0.0084497100454983,0.0132577192769888,0.66420611520151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00170069302124651,0.00392788784165151,-0.00939935319088346,0.00599796714839044,0.665037098441993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00346374757350558,0.00800550855458198,-0.0122270491934751,0.0191545443404863,0.665261253085261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,39587,-0.00211448735552686,0.0049407243889648,-0.0117983071578979,0.00756933244684414,0.668678006125714
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00158444004111855,0.00370966046338848,-0.00568649446712287,0.00885537454935997,0.669304830024003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39489,0.00176481697969045,0.00417135442717707,-0.0064110376975766,0.0099406716569575,0.672242654078491
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00205672894978145,0.00492228784626559,-0.0075909552288991,0.011704413128462,0.676070826062524
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.00167893787281943,0.00403387351713722,-0.00958532996640838,0.00622745422076952,0.677262136241236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00154463182684532,0.00372486645180209,-0.00575610641868678,0.00884537007237742,0.678382107298354
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.00188703001206325,0.00459124354579608,-0.0108858673618236,0.00711180733769707,0.681074608524445
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.00243970133267815,0.00595483049977685,-0.00923176644688448,0.0141111691122408,0.682031831527476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,-0.0015862778993642,0.00387950442812059,-0.00919010657848055,0.00601755077975215,0.682629426117736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00217945690437476,0.00535384117037719,-0.012672985598314,0.00831407178956452,0.683952581239001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00506886004462335,0.012594106076299,-0.0297533079541694,0.0196155878649227,0.687338062136795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00208348788743372,0.00519356922131263,-0.0122628835612065,0.00809590778633904,0.688303612766985
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37088,0.00115718064708773,0.00289781079977654,-0.00452252852047429,0.00683688981464975,0.689657055603869
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00146645067667497,0.00369602117329512,-0.0087106521763334,0.00577775082298346,0.691547356662308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00243903229304308,0.00615559296475428,-0.0145039945039615,0.0096259299178753,0.691941511066657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00237625008100833,0.00601026907326606,-0.00940387730259314,0.0141563774646098,0.692578925396879
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.00131548283736873,0.00333243861918568,-0.00784706253097265,0.0052160968562352,0.69303200864072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,37056,0.00386979332557548,0.00985437928602623,-0.0154447900750359,0.0231843767261869,0.694549019224738
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.00285877156971942,0.00728091674050025,-0.0171293683810999,0.0114118252416611,0.69459251067115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.00153545628570114,0.00391593207737762,-0.006139770585959,0.00921068315736128,0.694987060327876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00215953926105907,0.00551321994162109,-0.00864637182451827,0.0129654503466364,0.695284770670553
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,36991,-0.00163302019614672,0.00417559335686181,-0.00981718317559586,0.00655114278330242,0.695739289393413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00333665815088246,0.0085741065153841,-0.0134685906192704,0.0201419069210353,0.697167664742053
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.00284625051925026,0.00732338516853565,-0.0115075844110796,0.0172000854495801,0.697538631448845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39489,0.00183258569545063,0.00471786270883384,-0.00741442521386371,0.011079596604765,0.697699015736547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00118979530739929,0.00308581358861847,-0.00485839932629291,0.00723798994109148,0.699821855758796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00264023527094133,0.00686272132875607,-0.0108106985334206,0.0160911690753032,0.700450038190793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00227818972943021,0.00594112097416315,-0.00936640737992956,0.01392278683879,0.701383914640987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00235290577498874,0.00619547044543843,-0.00979021629807059,0.0144960278480481,0.704116068719329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,36991,-0.00335155759186518,0.0088453470768876,-0.0206884378625649,0.0139853226788345,0.704763583848374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.00186976637593273,0.00494490859690572,-0.0115617872258679,0.00782225447400249,0.70534791140495
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00141164594166337,0.00377090837255088,-0.00880262635186309,0.00597933446853634,0.708147597075768
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,-0.00128732812278723,0.00348547256036474,-0.00811885434110212,0.00554419809552766,0.711878533247252
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,39587,0.00205119826529502,0.00555736761495225,-0.0088412422600114,0.0129436387906014,0.712061661126982
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00108446166733934,0.00296340714917695,-0.00689273967972616,0.00472381634504749,0.714406456053633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37039,-0.00226269615963123,0.00619435496787252,-0.0144036318966614,0.0098782395773989,0.71490559592594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.00311864797514342,0.00855721887411489,-0.0136535010181218,0.0198907969684086,0.7155303471564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,39587,0.00133520209477459,0.00366888726388731,-0.00585581694244454,0.00852622113199372,0.715918440147091
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,37382,0.00391183839538021,0.0107509993979087,-0.0171601204245208,0.0249837972152812,0.715969650532216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00165080563674835,0.0045772729290011,-0.0106222605775905,0.0073206493040938,0.71836493548724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39489,-0.001762049347581,0.00493337053024985,-0.0114314555868707,0.00790735689170871,0.720969760803525
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.00232417161495589,0.00650839253881736,-0.0104322777611261,0.0150806209910379,0.721019849053332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,37437,0.00148426207920689,0.00416637122032971,-0.00668182551263935,0.00965034967105313,0.721660263972987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37388,0.00169068631247976,0.00475676816795836,-0.00763257929671862,0.0110139519216781,0.722274876624355
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,0.00181247191460848,0.00510043188960337,-0.00818437458901412,0.0118093184182311,0.722328130252001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,39862,0.00115698859240281,0.00330032185001963,-0.00531164223363567,0.00762561941844128,0.725916771872966
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.000966799388653803,0.00279656495721747,-0.00451446792749244,0.00644806670480004,0.729566315472691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.00309826155449553,0.00897508757731555,-0.020689433206034,0.0144929100970429,0.72994438463312
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00272615946023543,0.00804653510376892,-0.0184973682636225,0.0130450493431517,0.734766367189513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00145443834990208,0.00432236707623936,-0.00701740111952706,0.00992627781933122,0.736505736965922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37056,0.000887680036441072,0.00266081699439919,-0.00432752127258135,0.00610288134546349,0.73867778819125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.0013721000469223,0.00411625648340816,-0.00943996275440229,0.0066957626605577,0.738884377684963
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,-0.00136225403629983,0.00415896938188782,-0.00951383402479996,0.0067893259522003,0.743259987300047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,39587,-0.00149619891783241,0.00457659904927632,-0.010466333054414,0.00747393521874917,0.743729909063599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39477,0.00173028457930098,0.00529267042839313,-0.00864334946034955,0.0121039186189515,0.743732094461944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.000584280825544759,0.00179671783104797,-0.00410584777439878,0.00293728612330927,0.745039689360063
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,-0.00182578302016871,0.00561933261295777,-0.0128396749415659,0.00918810890122852,0.745253576416651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00167851134798242,0.00518509944777821,-0.00848428356966287,0.0118413062656277,0.746155578033543
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.000911147275838767,0.00283171029523486,-0.0064612994544991,0.00463900490282156,0.74763439667773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.00176338215739731,0.00554669045512529,-0.0126348954494429,0.00910813113464825,0.75055278287783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,39967,-0.00121394347121079,0.00383983819043686,-0.00874002632446704,0.00631213938204546,0.751896978044627
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00128271515474352,0.00407110001599427,-0.00926207118609229,0.00669664087660526,0.752707221228895
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00145587237702,0.00463664961174816,-0.0105437056160464,0.00763196086200638,0.753531061136263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37368,0.000813500589771795,0.00259604506043807,-0.00427474772868683,0.00590174890823042,0.754010864498054
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,0.00248490805008041,0.00794934073239815,-0.01309579978542,0.0180656158855808,0.754594088350726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37056,0.00140949222868535,0.00453167660017597,-0.00747259390765954,0.0102915783650303,0.755781913523374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.00119395107051075,0.00383884184667674,-0.00871808108999717,0.00633017894897567,0.755790527670047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00128211756659308,0.0041607939127839,-0.00687303850246337,0.00943727363564953,0.757978756325471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00112589161158976,0.00369846399770615,-0.00612309782391429,0.00837488104709381,0.760811535900522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00221520543609212,0.00733362943840374,-0.0165891191353634,0.0121587082631792,0.762610121230684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,37388,0.00244494118585192,0.00814817746696333,-0.0135254866493962,0.0184153690211,0.764136088361568
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,39913,0.00060653868450092,0.00203108981190268,-0.00337439734682833,0.00458747471583017,0.765228366741733
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00074715873649446,0.00252718297936303,-0.00420611990305709,0.00570043737604601,0.767502056088295
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.00139736051805701,0.00476287383940094,-0.00793787220716883,0.0107325932432829,0.769231748934527
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,0.000546393703730383,0.00186309437899213,-0.00310527127909419,0.00419805868655496,0.769318633571726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.000944222657634039,0.00322486943955752,-0.0053765214438987,0.00726496675916678,0.769683331803518
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,39691,0.00129900330322297,0.00446208372213701,-0.00744668079216557,0.0100446873986115,0.770963102774471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,39868,-0.000940377448817715,0.00327881994606841,-0.0073668645431118,0.00548610964547637,0.77426639841904
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00193926173639704,0.00677657308108065,-0.011342821502521,0.0152213449753151,0.774751324732177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.000841663987172497,0.00294188906261143,-0.0049244385755459,0.0066077665498909,0.774808053019778
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,36991,0.00257201836873888,0.00901535699949317,-0.0150980813502677,0.0202421180877455,0.775424164392595
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,39585,-0.00284168018371821,0.0101030897785268,-0.0226437361496308,0.0169603757821944,0.77850822452015
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000950154016908432,0.00337914400217038,-0.00757327626116237,0.00567296822734551,0.778575205535389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,36991,-0.00127321720643536,0.00456367613517924,-0.0102180224313867,0.00767158801851596,0.780257363201959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00194667688152039,0.0069990991430068,-0.0156649112018137,0.0117715574387729,0.78091433696845
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37056,0.00111551107810966,0.0040946028830181,-0.00690991057260581,0.00914093272882513,0.785292213016735
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00129346819173845,0.00479229185775293,-0.0106863602329342,0.0080994238494573,0.78723681864195
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00104263452796674,0.00388751682526616,-0.00866216750548841,0.00657689844955493,0.78854906914458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.0013713511741422,0.00513483491865816,-0.0114356276147122,0.00869292526642779,0.789420837084785
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00106025894736013,0.00397641810158642,-0.00673352053174925,0.00885403842646951,0.789753083351477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37039,-0.00173546534838189,0.00659260548694469,-0.0146569721027935,0.0111860414060297,0.792366458097951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,40042,-0.000792640108934525,0.00303481651140156,-0.00674088047128159,0.00515560025341253,0.793955313777031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,0.00352477978757576,0.0135085067203721,-0.0229518933843536,0.0300014529595051,0.79415029749389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.000684308387503156,0.00267815171380959,-0.00593348574656995,0.00456486897156364,0.798329177808669
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.0007291951816902,0.00287457260502527,-0.00636335748753973,0.00490496712415934,0.79975313092434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37411,-0.00373469571073754,0.0147279759539327,-0.0326015285804456,0.0251321371589706,0.79982517805074
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,-0.000981188051594998,0.0038763885147068,-0.00857890954042033,0.00661653343723034,0.800180015687685
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,-0.00116127358344326,0.00461249998136099,-0.0102017735469108,0.00787922638002427,0.801225390850729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,-0.000859478140945252,0.00344036075281765,-0.00760258521646784,0.00588362893457733,0.802728097808194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,0.00231494322704863,0.00929072868857856,-0.0158948850025653,0.0205247714566626,0.803235432747655
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00110435786541293,0.004457183735644,-0.00763172225644932,0.00984043798727517,0.804315981152485
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40052,-0.000949501786572083,0.00383560169501532,-0.00846728110880211,0.00656827753565794,0.804486024727894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00172231208069114,0.00697176102121739,-0.0119423395208949,0.0153869636822772,0.804880163678793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.00391479415967753,0.0159636398801077,-0.0273739400053336,0.0352035283246886,0.806280578785157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00162644536378814,0.00664425926533329,-0.0113963027962651,0.0146491935238414,0.806622480943178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.00194034804659164,0.00797132421516952,-0.0136834474151406,0.0175641435083239,0.807686925438075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,36962,0.00119824646876889,0.00498305370873944,-0.0085685388003604,0.0109650317378982,0.809974106385211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,36991,0.00119814828035831,0.00498898231254061,-0.00858025705222129,0.0109765536129379,0.810210858100676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37039,0.001091305897606,0.00456420171673224,-0.00785452946718918,0.0100371412624012,0.81103086492146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00133516167838657,0.00564002776005353,-0.00971929273131835,0.0123896160880915,0.812870222187481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.00253346576534422,0.0107106353863324,-0.0235263111225558,0.0184593795918674,0.813019278236521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.0012454006171339,0.0052770197214726,-0.0090975580369524,0.0115883592712202,0.813432818920812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.000829737172830219,0.00352989757836593,-0.00774833642642745,0.00608886208076701,0.81416584869565
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.00101864035116002,0.00434932000499105,-0.00750602685862244,0.00954330756094247,0.814828073784414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,0.00125648250309841,0.00536721762760187,-0.00926326404700125,0.0117762290531981,0.814907866450742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.00201304945555027,0.00860454914822139,-0.0188779657860642,0.0148518668749637,0.815026058717409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00115530670830484,0.0049461619468409,-0.00853917070750333,0.010849784124113,0.81531749103999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,39587,-0.000611024653604082,0.00263634782956486,-0.0057782663995512,0.00455621709234304,0.816720170387593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.00188530579785841,0.00829026648111654,-0.01436361650513,0.0181342281008468,0.820106327880492
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39173,-0.000448124609680671,0.00197695617147001,-0.00432295870576189,0.00342670948640055,0.820680253277893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,36962,-0.00150665844607432,0.00669649259625585,-0.0146317839347358,0.0116184670425871,0.821988869077592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37056,0.00132277040605966,0.00592843376826303,-0.0102969597797359,0.0129425005918552,0.823443168888046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00101096582885618,0.00455664464372299,-0.00994198933055324,0.00792005767284088,0.824421425685007
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37039,0.000723687426076721,0.00340559764665783,-0.00595128396137262,0.00739865881352606,0.831720739253561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00126397796190026,0.00596848586280669,-0.0104342543292008,0.0129622102530014,0.832285608307104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.000851115566691097,0.0040201619587023,-0.00702840187236542,0.00873063300574761,0.832335198076449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,-0.000682170509782717,0.00323102896419969,-0.0070149872796141,0.00565064626004867,0.832787718669352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00171724802064647,0.0082527409477742,-0.014458124236991,0.0178926202782839,0.835168041206108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39477,0.00100941956057023,0.00487938533803856,-0.00855417570198536,0.0105730148231258,0.836110703535988
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.0012315148032135,0.00596940918558484,-0.0129315568069598,0.0104685272005328,0.836556422858218
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,0.00053381893528177,0.00259575000322676,-0.00455385107104267,0.00562148894160622,0.837066045936871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.000624679570383594,0.00305913166294489,-0.00662057762975558,0.00537121848898839,0.838198622421616
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37043,-0.00136068375267471,0.0066699042312227,-0.0144336960458712,0.0117123285405218,0.838353919268624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00144300755414313,0.00731435305983874,-0.0128931244431408,0.0157791395514271,0.843608050313464
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,39971,0.00209948872141696,0.0107104968118611,-0.0188930850298307,0.0230920624726646,0.844595731867412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,36962,0.00083354139628152,0.00428496037225168,-0.00756498093333177,0.00923206372589481,0.845766106300884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00113667130683605,0.0058750560786905,-0.0126517812210694,0.0103784386073973,0.846590664589972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.000556734105961525,0.00289146006695089,-0.00511052762526222,0.00622399583718527,0.847318821595708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.00103639577213225,0.00557442567876409,-0.0119622701025099,0.00988947855824536,0.852510493567429
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,-0.00159609686192732,0.0086058385286296,-0.0184635403780413,0.0152713466541867,0.852865825791237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.000384684858037286,0.00212250492685281,-0.00377542479859423,0.0045447945146688,0.856180703830671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,39720,0.00211434095813774,0.0117849379043854,-0.0209841373344577,0.0252128192507332,0.85761772210558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39477,-0.00231489394141345,0.0129169181290399,-0.0276320534743317,0.0230022655915048,0.857771912556267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.00059851471318063,0.00334323231722523,-0.00595422062858081,0.00715125005494207,0.85792250290125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00126677219820927,0.00713104015990503,-0.0127100665152046,0.0152436109116231,0.859006882127751
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.000549737616879254,0.00310315097204381,-0.00663191352208511,0.0055324382883266,0.859389199734619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,0.0012715271950538,0.00720884538789664,-0.0128578097652236,0.0154008641553312,0.859994739623229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,-0.000686460179648256,0.00390983476594664,-0.00834973632090367,0.00697681596160716,0.860632378042663
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.000550147244699063,0.00318559347553083,-0.00569361596734136,0.00679391045673949,0.862891077200067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,36962,0.000958777181798182,0.00561799512185156,-0.0100524932570309,0.0119700476206272,0.864492333438905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.000553645767445199,0.00331381488861126,-0.00704872294912327,0.00594143141423288,0.867315961024808
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.000581223537464702,0.00351833101314496,-0.00747715232322882,0.00631470524829941,0.868790160721781
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000510568821368672,0.00313854083734149,-0.00564097121982066,0.006662108862558,0.870775078970832
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,-0.00101399352333787,0.00639418987592795,-0.0135466056801567,0.0115186186334809,0.874001860396427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,37299,-0.000417100919747255,0.00266549155357114,-0.00564146436474668,0.00480726252525217,0.875655613471052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,0.000596004443685816,0.0038270484326806,-0.00690501048436817,0.0080970193717398,0.876244490608206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00168203628502912,0.0108441311244113,-0.0229365332888753,0.019572460718817,0.876736762266976
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,39585,-0.000390278112655125,0.00255310772791858,-0.00539436925937555,0.0046138130340653,0.878507532773788
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.00180896796473083,0.0119045416700758,-0.0251418696380795,0.0215239337086178,0.879223507571333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.000501987842330386,0.00336070394834706,-0.00608499189642984,0.00708896758109061,0.881264087142264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.000693810338499813,0.00465694983151981,-0.00843381133127902,0.00982143200827864,0.881568655268916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.000683433809059058,0.00459021822627459,-0.00831339391443915,0.00968026153255726,0.881643368754397
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000438601705531538,0.00302019214762394,-0.00635817831487447,0.00548097490381139,0.884536951712903
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37056,-0.000668083252858604,0.00461466099706149,-0.00971281880709912,0.00837665230138191,0.884891466844105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,37388,-0.000359738632059003,0.0025150712128033,-0.00528927820915348,0.00456980094503547,0.886266107455548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.000863438775697395,0.00611555759699841,-0.0111230541144195,0.0128499316658143,0.887723824387559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37411,0.000494877031275935,0.00357698775104613,-0.00651601896077448,0.00750577302332635,0.889965695410826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.00330772503705124,0.0242573275346531,-0.0442366369308688,0.0508520870049713,0.89153891087588
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.000691932767708622,0.00519986675881071,-0.00949980607956037,0.0108836716149776,0.894142105776087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.00103173392634567,0.00784231682719532,-0.0143392070549572,0.0164026749076485,0.895334413773198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,39844,0.00152877131215527,0.0116937102945444,-0.0213909008651518,0.0244484434894623,0.895986988557699
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37021,-0.000571146978129271,0.00440560792875099,-0.00920613851848122,0.00806384456222267,0.896852523702962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.000347980313916121,0.00273419035728532,-0.00501103278636311,0.00570699341419535,0.89872861537528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,-0.000338752313708256,0.00271964514880444,-0.00566925680536496,0.00499175217794845,0.900875490116522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.000576552853953691,0.00476285221488552,-0.00875863748722193,0.00991174319512932,0.903651684667559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37445,-0.0002572134751846,0.0021272254726419,-0.00442657540156272,0.00391214845119352,0.903760146636186
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.00135120651900205,0.0112858847280483,-0.0207691275479727,0.0234715405859768,0.904702257051865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37169,0.000648219922526798,0.00559526766976761,-0.0103185047102177,0.0116149445552713,0.907772014600739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,-0.000371692860964551,0.00334401811910259,-0.00692596837440562,0.00618258265247652,0.91149780199745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37021,0.000626636961483339,0.00571530288149632,-0.0105753566862494,0.0118286306092161,0.912695010338313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.000715925511850174,0.00659100128005469,-0.012202436997057,0.0136342880207574,0.913504187043222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37043,0.000178891694233919,0.00167572064017921,-0.00310552076051733,0.00346330414898516,0.914984907596455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.00042290513398855,0.00400112341948554,-0.0082651070361802,0.0074192967682031,0.915824436016437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.000587839259805507,0.0058533110073086,-0.0108846503145193,0.0120603288341304,0.920005672056285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,36991,0.000326481706340151,0.00329729848772192,-0.00613622332959481,0.00678918674227512,0.921127944841828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40058,0.000365303074937787,0.0037607232245251,-0.00700571444513141,0.00773632059500698,0.922619284843635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.000235731955939076,0.00244188652441312,-0.0050218295437888,0.00455036563191064,0.923095701055025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.000399777863048214,0.00415925626394522,-0.00775236441428441,0.00855192014038084,0.923428594993011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.000464476307711854,0.0051282351909234,-0.0105158172819217,0.00958686466649802,0.927833565426311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.000311411554089619,0.00348477972162344,-0.00651875670029233,0.00714157980847157,0.928794523436608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37437,0.000672640149924478,0.00809892347444558,-0.0152012498599889,0.0165465301598378,0.933810596224508
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.000476053230462984,0.00573405054314758,-0.0117147922950322,0.0107626858341063,0.933835153801705
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.000196557894028931,0.00238950177664823,-0.00487998137625947,0.00448686558820161,0.93444201386806
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,36962,0.000411424853649935,0.00504794396665812,-0.00948254532099999,0.0103053950282999,0.935042825460834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.000199973146748877,0.00245868422888596,-0.00501899423536537,0.00461904794186761,0.935177829769884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.000242019637403127,0.00303100104081892,-0.00618278167740821,0.00569874240260195,0.936359100914673
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,37161,-0.000698366569294044,0.00918257095307049,-0.0186962056373122,0.0172994724987241,0.939377686245777
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.000418034787432651,0.00552734806038852,-0.0112516369857941,0.0104155674109288,0.939714395766842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.000224452064604299,0.00298070031825461,-0.00606662468838333,0.00561772055917473,0.939975741538253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39489,0.000307176313163499,0.00420634367002077,-0.00793725728007721,0.0085516099064042,0.941785631938553
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.000247058981242318,0.00342939684148327,-0.00647455882806489,0.00696867679054953,0.942569947017431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,37388,-0.000143992469892435,0.00211077600939996,-0.00428111344831635,0.00399312850853148,0.945613275541028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,36962,0.000388775686196064,0.00572294860545227,-0.0108282035804904,0.0116057549528825,0.94584019798072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37169,-0.00014377378655334,0.00213262634311622,-0.00432372141906112,0.00403617384595444,0.946251302438678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37368,0.000284122635779333,0.0042274933000534,-0.00800176423232533,0.00857000950388399,0.946416872714711
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37021,0.000318522559890598,0.00482999955177524,-0.00914827656158888,0.00978532168137007,0.947421257225052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,-0.000501253003674847,0.00776473992831263,-0.0157201432631676,0.0147176372558179,0.948529275088737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,39992,-0.000251936700398633,0.00396606965407473,-0.00802543322238511,0.00752155982158784,0.949350820310013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37021,-0.000239073567976328,0.00377442322866331,-0.00763694309615643,0.00715879596020377,0.949496388520442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000286764248579426,0.00460366923833967,-0.00873642745856633,0.00930995595572518,0.950332545129281
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.000330756195955185,0.00540075913260454,-0.0102547317039497,0.0109162440958601,0.951166821320185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.000432784514508924,0.00720551770197878,-0.0145555992103873,0.0136900301813695,0.952106427236693
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,36962,-0.000216621611056313,0.00370386249025152,-0.0074761920919493,0.00704294886983667,0.953362941302414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.000282985607467229,0.00485153509464908,-0.00922602317804497,0.00979199439297943,0.953487385262078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.000251848859850423,0.00457555986187092,-0.00871624846941657,0.00921994618911742,0.956105661703841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,-0.000167708618112417,0.00324733692886425,-0.00653248899868634,0.00619707176246151,0.958812230754387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,39453,0.000164786827994334,0.00322814391802588,-0.00616237525133639,0.00649194890732505,0.959288780518972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,37021,-0.000293187906346528,0.00603801641603692,-0.0121277000817789,0.0115413242690858,0.961273082836721
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.000155618685583136,0.00345629365177079,-0.00692995424305388,0.00661871687188761,0.964088280072198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37056,-0.000133433664443706,0.00301045726906538,-0.00603392991181186,0.00576706258292444,0.964647300012701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37169,0.000209262325717217,0.00482177429270881,-0.00924141528799204,0.00965993993942648,0.965383771588311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-7.85492555078606e-05,0.00237401640498398,-0.00473162140927647,0.00457452289826075,0.973605639016938
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37039,-7.00490461474671e-05,0.00212269675775558,-0.00423053469134841,0.00409043659905347,0.973675067418289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,37169,0.00011772228124301,0.00392124141025141,-0.00756791088284975,0.00780335544533577,0.976050207602813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,36703,0.000193151577795738,0.00658963664883307,-0.0127225362539171,0.0131088394095086,0.976616678005585
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,9.40450752235711e-05,0.00327134751060448,-0.00631779604556122,0.00650588619600836,0.977065849135745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37056,0.000113490570874064,0.0043964169531286,-0.008503486657258,0.00873046779900613,0.979405819980151
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-6.99267118277995e-05,0.00279294073717208,-0.00554409055668508,0.00540423713302948,0.980025808049098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,8.61792506450053e-05,0.00372546618379317,-0.0072157344695896,0.00738809297087962,0.981544895362902
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,37056,-8.58150018929117e-05,0.00382048103887265,-0.0075739578380833,0.00740232783429748,0.982079897864657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40052,2.47014866227355e-05,0.00300028276336491,-0.00585585272957249,0.00590525570281796,0.993431149862285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-3.59393238888276e-05,0.00532628807741111,-0.0104754639556146,0.010403585307837,0.994616388283658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,36962,-2.47311492072369e-05,0.00382732014486292,-0.00752627863313857,0.0074768163347241,0.994844411354488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,-1.8911061522747e-05,0.00299647239549388,-0.00589199695669074,0.00585417483364525,0.994964593028617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,3.67393600298996e-05,0.00720855039693176,-0.0140920194179563,0.0141654981380161,0.99593356653136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,1.92880380878577e-05,0.00455492986335405,-0.00890837449408609,0.00894695057026181,0.99662139953472
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,9.76998196078417e-06,0.00435438736380013,-0.00852482925108747,0.00854436921500904,0.998209807741803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,39587,-1.48648519332403e-05,0.00726412011488336,-0.0142525402771046,0.0142228105732381,0.998367284838924
